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Abstract 
Human immunodeficiency VlfUS (HIV) and Mycobacterium tuberculosis (Mtb) 
infections are two of the most devastating pandemics of the modern era. Recent 
escalations in the incidence of all forms of tuberculosis (TB) have paralleled the 
worldwide expansion of the HIV epidemic, making HIV the single most important 
underlying promoter of the current TB epidemic. Approximately 2 million South 
Africans are currently HIV ffB co-infected, a large proportion of whom develop 
skeletal disease often involving the spine. Spinal TB, a devastating disease which 
may lead to severe deformity and/or paralysis, has escalated by 30% in the local 
setting over a 5 year period to 2005. Fibrous encapSUlation of spinal granulomas 
forms isolated compartments dually-infected with HIV -lffB, and heavily infiltrated 
with macrophages. Due to rapid viral turnover, dynamic site-specific fluctuations in 
HIV quasi-species are common with unhindered migration between anatomical 
compartments. Understanding the origins and genetic evolution of HIV -I at these 
sites is important to developing effective and targeted treatment strategies. Moreover, 
the South African HIV epidemic is characterized by an escalating incidence of 
atypical opportunistic and non-tuberculous mycobacterial (NTM) infections, both 
posing significant diagnostic and therapeutic challenges. Previous reports of the 
spinal TB have, to date made no association between HIV infection and susceptibility 
to opportunistic spinal infections. 
This study therefore, classified the infective organisms by genotyping in order to 
establish the occurrence of Mtb as well as atypical mycobacterial infections in this 
cohort. In addition, this study investigated viral heterogeneity in the coinfected lesion 
by analysing the HIV-I env (C2V5 region) sequences isolated from plasma and 
granuloma compartments The occurrence of viral heterogeneity was correlated with 
the level and pattern of macrophage infiltration and ultrastructural changes in 
granulomas. . 
Tissue biopsies of epidural granulomas were collected at surgery, from 60 patients (38 
HIV-; 22 HIV+); clinically and radiologically diagnosed with TB spondylitis. All 
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patients received a mean of 8 weeks anti-TB therapy (range 5-24 weeks). A separate 
biopsy, collected simultaneously, was submitted for routine TB diagnostic assays 
(microscopy; culture). Blood collected at surgery from all patients, was submitted 
for routine haematological investigations including CD3+, CD4+ and CD8+ T-cells 
counts, HIV -1 serology and viral loads, in the case of HIV -positive patients (n=22; 
I 00~1 plasma; 1 0-12mg tissue). 
A portion of tissue was processed for histopathology (H&E, ZN, PAS) (20 HIV-; 15 
HIV+) , immuno-Iocalisation of CD68+ (macrophage/monocyte marker), CD4+ and 
CD8+ cells (20 HIV-; 15 HIV+) , and transmission electron microscopy (TEM) (8 
HIV- and 5 HIV+). TEM sections were viewed using a Jeol JEM-1011 and image 
analysis for histopathology, ruc and TEM used the SIS software. Bacterial DNA was 
extracted from heat inactivated positive cultures; a 500bp region of the 16S rDNA 
gene was PCR amplified and sequenced in order to genotype the infective bacterial 
organism. Viral RNA, extracted from plasma and granulation were RT-PCR 
amplified, cloned and sequenced from co-infected patients. Paired PCR-amplified 
products and sequences were available in a subset of 7 of the co-infected population. 
All phylogenetic analyses were performed using PAUP, PAML, MEGA and prosite. 
Modified Swofford-Maddison and Slatkin-Maddison tested compartmentalization; 
LAMARC determined migration and coalescence. 
The overall mean age was 32 years (range = 2-71 years), 34 years in the HIV- and 29 
years in the HIV+ groups. Forty-one (41160) specimens were culture negative (68%). 
Of these organisms, 16 were identified as Mtb (8/38 HIV-; 8122 HIV+) and 3 as NTM 
(3/38 HIY). In 7/38 HIY and 8/22 HIV+ patients, CD4+ T-cell counts were <500 
cellsll,.ll while in 4/22 HIV + adult patients CD4+ T-cell counts were <200 cells/I.ll. 
All patients were ARV naIve despite fulfilling WHO guidelines for treatment 
initiation since this study preceded initiation of the national roll-out. 
Histopathological features were diagnostic of TB in 91.4% of specimens while the 
remaining 8.6% displayed features atypical of a TB infection. Although not 
statistically significant, a trend towards greater intensity and distribution of CD68 
immuno-reactivity in the HIV- group was noted. CD4 reactivity was sparse to absent 
and was independent of HIV status while CD8 reactivity was greater in the HIV-
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infected group. Ultra-structural features were consistent with an active immune 
response and healing in HIV-, in contrast with the predominantly degenerative and 
necrotic HIV+ specimens. Neutrophils, macrophages and immune cells were detected 
in the former group but were rare in the HIV+ group. Multi-nucleated giant cells were 
present both HIV -uninfected and infected specimens. The predominance of grossly 
dialated rough endoplasmic reticulum (rER) seen to be infiltrated with an amorphous, 
granular material was a unique finding. This phenomenon was evident largely in the 
HIV -infected group. Lysosomal/phagosomal inclusions resembled degenerative 
material, intact bacilli and virus-like particles. 
There was a 40% concordance between routine TB culture identification and 16S 
rDNA genotyping. Three Mtb (2 HIV-; IHIV+); 2 NTMs (2 HIV-) and 5 
environmental bacilli (3 HIV-; 2 HIV+) were identified. NTMs included M 
intracellulare and M jortuitum, and environmental bacilli included S.maltophilia, 
S.marscens and B.sanguinis. These NTMs, although typically associated with 
immune-suppressed hosts, were more common to the HIV- group. Moreover 
evidence of CD4+ lymphopenia was noted in two HIV -uninfected patients; one with 
an Mtb and the other with an environmental bacterial infection. 
Granulation-specific compartmentalization of HIV -1 was observed in I paediatric and 
3 adult patients. The remaining 3 patients (2 paediatric, 1 adult), showed evidence of 
viral migration between plasma and tissue compartments. The mean inter-patient 
diversity among plasma-derived sequences was 15.3 ± 1.1, compared to 12.5 ± 1.0 for 
granuloma-derived sequences. Strong coalescence forces were present in the tissue 
sequences of 3 patients (2 paediatric, 1 adult). All 3 showed evidence of virus 
migration from tissue to plasma; while plasma to tissue migration was evident in 
remaining 4 patients. The intensity of CD68+ immunoreactivity correlated with 
diversity between tissue and plasma viruses (r=-0.867; p<0.05). 
This study illustrated that TB spondylitis in combination with HIV infection is a 
serious health hazard in KZN. The genotypes of the infective organisms were 
variable and independent of HIV -status, highlighting the need for a broad-range 
diagnostic tool in this setting. CD68 immuno-Iocalisation demonstrated similar 
distribution patterns of macrophage/macrophage-derived cells in HIV -infected and 
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un-infected specimens. CD4 and CD8 immunolocalisation confirmed the chronic 
nature of spinal TB. In addition, this study demonstrated divergent viral evolution in 
spinal granulomas. Ultra-structural evidence of intra-lysosomal virus-like particles 
indicated phagocytic cells and macrophages as a possible cellular reservoir. The role 
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Chapter 1 - Introduction and Literature Review 
1.1 Introduction 
1.1.1 Statement of the problem 
As a direct result of human immunodeficiency virus (HIV) and tuberculosis (TB) co-
infection, indications are that the HIV epidemic in Kwa-Zulu Natal (KZN) is two years 
ahead of the rest of South Africa (SA) (Colvin et al., 2001). Furthermore, records place 
TBIHIV fatality rates from a treatment center in SA at 24.7% in 1995, an increase of 
135% from 199111992 (Connolly et al., 1998). Dual infection, unfortunately, results in 
poor outcomes accounting for approximately a quarter of a million annual deaths 
worldwide (Gayle and Hill, 2001, WHO, 2004). These reports relate to pulmonary TB. 
The incidence of spinal TB at King George V Referral Hospital (KGV), KZN, SA, has 
increased by 30% from 2000-2005 (Govender, 2006). 
Favourable outcomes were observed in spinal TB infected patients even among HIV co-
infected individuals following surgery and standard anti-TB chemotherapy (Go vender, 
2006). This is despite receiving no anti-retroviral therapy (ART). Unlike the plethora 
of literature characterizing pulmonary TB at an immunological and molecular level, 
related knowledge of spinal disease remains poorly defined (Alothman et al., 2001, 
Govender et al., 2000a, Govender et al., 2001a, Ho et al., 1995, Niu et al., 2000). 
1.1.2 Rationale behind study 
Clinical presentation forms the basis of spinal TB diagnosis and is often, not 
substantiated by laboratory testing. Therefore there is no indication of the nature of the 
infective organism, its relative virulence or drug resistance patterns. As a result, 
individualized pathogen-specific chemotherapy regimes cannot be implemented. Even 
the most advanced culture methods currently available e.g. Mycobacteria Growth 
Indicator Tube (MGIT) , have a low recovery rate (-10%) from clinical samples and 
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require extended incubation times for a positive result (Jayakumar et aI., 2001). But 
with molecular technology, organisms can be identified in a single assay (Beggs et al., 
2000, Cloud et aI., 2002, de Baar et aI., 2001, Martin et aI., 1993, Mikhailovich et al., 
2001, Patel et al., 2000, Rhee et al. , 1999, Tortoli et al., 2001). The 16S rDNA gene is 
a favourable genotyping target as it is highly conserved across all Eubacteria (Cloud et 
al., 2002, Edwards et aI., 1989, Mondragon-Barreto et al., 2000, Raghava et al., 2000, 
Ruiz et al., 2002). 
Prior to the national ART rollout co-infected patients were solely reliant on anti-TB 
chemotherapy, enhanced nutritional support and surgery for disease resolution. Yet 
patients improved clinically, incorporated allograft and instrumentation and recovered 
neurologically (Govender et al., 2001b, Govender et aI., 2001a). In addition, bringing 
clarity to the pathogenesis of spinal disease particularly in HIV co-infected patients will 
enhance current understanding of both diseases and may steer the development of 
vaccines, individualized interventions and diagnostic tools. The cost of anti-TB 
chemotherapy and therapeutic drug monitoring is an added economic burden to 
emerging nations. A comprehensive understanding of the disease complex, its 
progression and the related host response is necessary to determine whether short-term 
therapy is practical and therapeutically sound for infective spondylitis. 
In contrast to TB, the HIV genome is highly heterogeneous, particularly in the 
nucleotide (NT) sequence of the envelope (env) gene (Collins et al., 2000). Genetic 
variability is most often a result of extremely variable viral replication rates (Collins et 
aI., 2000) within compartmentalized microcosms in different organ systems. TB is 
known to increase HIV viral loads and consequently viral heterogeneity in co-infected 
patients (Stenger and Rollinghoff, 2001). It is proposed that viral infectivity and 
pathogenesis is genome linked and is primarily a product of transcriptional regulation of 
the long terminal repeats (LTRs). The rapid dissemination of subtypes E and C in SE 
Asia and sub-Saharan Africa (Montano et aI., 1997) and, interestingly, parallels the 
explosion of the TB epidemic in these regions. Identifying the circulating SUbtype in 
this cohort may be an important indicator of the evolutionary and/or replicative 
pressures exerted on the HIV genome in the absence of ARVs. 
3 
Bearing in mind that HIV and TB are both macrophage tropic intracellular pathogens 
and have exerted a notable public health impact in the South African setting in recent 
years, appropriate preventative and therapeutic interventions are crucial. Although it is 
known that the cascade of events characterizing the immune response to TB is 
dominated by macrophages and lymphocytes, their specific phenotypes and relative 
distribution within the granulomatous spinal lesion remains unclear (Gonzalez-Juarrero 
et aI., 2001). The distinct interactions between macrophages and antigen-specific T 
cells play an important role in disease development and progression (Hoshino et aI., 
2002, Stenger and Rollinghoff, 2001). In addition, discrete and uniform aggregates of 
immune cells, such as CD4+ and CD8+ cells occur in pulmonary granulomas (Gonzalez-
Juarrero et al., 2001). Since, few reports of the immune response to spinal TB 
(Govender et al., 2000a, Govender et al., 200la) are presently available it is unclear 
whether the same applies to this disease. There is no single determinant of 
susceptibility or resistance but a number of synergistic factors related to the host and 
pathogen. The success of the invading mycobacterium may, in part, be due to their 
ability to invade, replicate and persist within mononuclear cells (Beatty et aI., 2000). 
Exploring tissue morphology of spinal granulomas will yield important insights into 
diseases pathogenesis and latency. 
1.1.3 Objectives of the study 
This study aimed to: 
1. Compare and contrast the histopathology of spinal TB granulomas of HIV-
infected and -uninfected patients. (Chapter 3) 
2. Compare the phagocytic response by CD68 immuno-Iocalisation in HIV-
uninfected with HIV co-infected specimens Chapter 3) 
3. Describe the ultra-structural changes induced by HIV co-infection (Chapter 
3) 
4. Genotype the bacterial pathogen from clinical and/or culture specimens. 
(Chapter 4) 
5. Compare plasma- with tissue-derived HIV-1 variants as a measure of viral 
heterogeneity in HIV ffB co-infected granulomas (Chapter 5) 
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1.1.4 Hypothesis 
Fibrous encapsulation of spinal granulomas creates a umque microenvironment 
infiltrated with immune cells that is permissive for divergent HIV evolution. 
1.1.5 Experimental approach 
A total of 60 patients (38 HIV -uninfected; 22 HIV -infected) were recruited into the 
study based on the rate of intake at a primary referral hospital in the KZN region. Blood 
and tissue specimens were subjected to the following: 
1. Routine HIV and TB diagnostic assays 
2. Quantification of haematological markers i.e. FBCs 
3. Histopathological and ultrastructural evaluation 
4. Immunolocalisation of CD68+ macrophages/macrophage derived cells 
5. Bacterial genotyping 
6. HIV cloning and sequencing 
Each method will be discussed in a stand-alone chapter comprising of a brief 
introduction, a summary of related materials and methods, results and a discussion of 
the results including the limitations. A random sub-sampling of the study population 
(N=60) was undertaken for each investigation, while ensuring that, each sub-population 
included representative HIV -infected and -uninfected specimens. The final sample size 
for histo-pathological, immuno-histology and ultra-structural investigations were 
dependant on the quality of the processed tissue specimens. Bacterial genotyping and 
HIV -heterogeneity analysis was based on obtaining analysable amplification products. 
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1.2 Literature Review 
1.2.1 Tuberculosis 
1.2.1.1 Historical perspective 
Tuberculosis is one of the oldest human pathogenic diseases known to man dating as 
far back as 5000BC (Wellons et al., 2004). Disease involving the spine and bone and 
joint has also been reported following radiological and molecular analyses of paleo-
pathological specimens (Conlogue, 2004). The origin of human TB infections remains 
controversial. It is hypothesised that human disease stemmed from zoonotic 
transfection to Indo-European cattle herders (Smith, 2003a), however the absence of M. 
bovis in early paleo-pathological specimens refutes this hypothesis (Zink et al., 2003). 
Current theories, supported by phylogenetic evidence showing independent evolution of 
M. tuberculosis (Mtb) and M. bovis from a common ancestor, allude to a precursor 
complex related to M. africanum or M. canetti (Brosch et al. , 2002). 
TB spread throughout Europe during the 16th and 17th centuries, beoming the leading 
cause of death on the continent for nearly two centuries (18 th and 19th centuries). The 
subsequent decline in both incidence and mortality was a consequence of adaptive 
Darwinian evolution and/or natural selection (Smith, 2003a). Spread to Asia, Eastern 
Europe and Africa, regions where TB was virtually unheard of, was doubtless, initiated 
by colonisation and contact with European travellers having a devastating effect in these 
regions (Jackson et al., 2006, Mhalu, 2005). 
The mid-19 th century heralded the fIrst in a long history of interventions directed against 
TB with the fIrst sanatorium strategy initiated by Herman Brehmer (Europe) and Dr EL 
Trudeau (America) (Bloom and Murray, 1992). At the time nutritional support, bed rest 
and isolation was the only treatment strategy. The discovery of rifampicin in 1943 
revolutionized TB treatment. It is still used today. Later, the advent of isoniazid and 
streptomycin saw a 5% per annum decline in TB incidence rates from 1953 to 1984 
(Zajac and Melcher, 1991). This downward trend was not sustainable and, after a 
levelling off in 1985, was reversed (Zajac and Melcher, 1991) to the overwhelming 
number of current infections due, largely, to the human immunodefIciency virus (HIV) 
6 
(Health_Protection_Agency_Tuberculosis,2004). Such that TB has once again reached 
epidemic proportions, approximately 5000 years after its first infections. 
1.2.1.2 Epidemiology 
1.2.1.2.1 Patient demographics 
Worldwide TB commonly occurs in people between the ages of 15-60 (WHO, 2002) 
although children as young as 24 months have been diagnosed with spinal TB 
(Govender and Parbhoo, 1999). Country, age, race, gender and socio-economic status 
impact case rates (Beers and Berkow, 1999). Since childhood TB is commonly 
contracted from adults, paediatric epidemiology parallels that of adults and accounts for 
8-20% of TB-related deaths (Kabra et al., 2004). Children stand a 2-5% annual risk of 
infection and a 5% risk of progressing to active TB in developing countries (Kabra et 
aI., 2004). These rates are 6 times greater among HIV-infected children. It is 
generalised that TB is an adult disease in developed nations but a disease of individuals 
in their first 3 decades of life in other regions, particularly impoverished nations 
(Kumar, 2005). 
1.2.1.2.2 The global epidemic 
TB is now recognised as the leading cause of death due to a single pathogen second 
only to HIV (Dye et al. , 2006). New infection rates projected to reach 1 billion by 2020 
(WHO, 2004) have already been exceeded twice over. At present, developing nations 
bear the greatest disease burden with half of all TB cases concentrated in Asia and 29% 
in Africa (WHO, 2006, Narain and Lo, 2004). The African epidemic is 6 times greater 
than the European epidemic but SE Asia far exceeds both at 33% of all incident cases 
(WHO, 2006). Ninety nine percent of resultant deaths occur in developing countries 
(WHO, 2003). Increased incidence rates in developed countries such occur 
predominantly (63% of all TB cases) among the immigrant popUlations 
(Health_Protection_Agency_Tuberculosis, 2004). A concomitant increase in extra-
pulmonary TB has also been observed worldwide (Houshian et al., 2000, WHO, 2006). 
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In addition, patients in Eastern Europe and Central Asia are 10 times more likely to 
contract multi-drug resistant (MDR) TB. In South Asia, and most developing nations, 
weak public health infrastructure, inadequate resources and education, and MDR-TB 
infections impede control of the TB epidemic (Zaidi et aI., 2004). As a result, MDR-TB 
infection rates parallel the upward trend in overall TB incidence (Cho et al. , 2000). 
More recently, the emergence of extensively or extreme drug resistant TB (xDR-TB) in 
rural KwaZulu-Natal, SA, raised the alarm of a new and deadly epidemic (Sidley, 
2006). Whether drug resistance is a consequence of patient non-compliance or the 
natural evolution of the bacilli is presently unclear. Regardless, the unfortunate and 
alarming consequence remains increased therapeutic failure and mortality rates. 
1.2.1.2.3 The South African epidemic 
South Africa (SA) has the highest number of TB cases in Africa and features strongly 
among the top 10 TB incidence nations worldwide (WHO, 2002). From a national 
figure of 526 cases /100 000 people in 2000, TB prevalence rates increased to 556/100 
000 in 2001 (WHO, 2002). There were 339 078 new infections in 2004 alone. 
Currently, in excess of 500000 South Africans are TB-infected, approximately 6 000 of 
whom have MDR-TB (Sidley, 2006). Of its nine provinces KwaZulu-Natal (KZN), 
Eastern Cape (EC) and Gauteng (G), in descending order, are the three highest 
incidence regions (DOH, 2002). Proportionally, the number of HIV ITB infected 
individuals is highest in KZN. Clearly, KZN is the epicentre of both epidemics in SA 
(Table 1.1). Both HIV and TB are also included in the 5 leading causes of death in SA 
according to government surveys (DOH, 2002). The highest prevalence of TB was 
detected among males and was the most common cause of death in the 40-49 years age 
group. Ethnicity also exerted an impact on HIV - and TB-related mortality rates. 
Current trends indicate a rise in TB incidence rates in developing nations particularly in 
sub-Saharan Africa which parallels the explosive HIV epidemic; and a decline or 
plateau in other countries where TB and HIV chemotherapies are readily available. 
These findings further underscore the urgent need to expand existing anti-retroviral 
(ARV) and anti-TB treatment programs in regions where these epidemics converge. 
T bl 1 1 Estimates of TB infection and HIV ffB co-infection rates by province in a e . : 
2002 
Estimated no. of Proportion of 
Province 
TB cases HIV+ffB+ (%) 
KwaZulu-Natal (KZN) 39650 49.8 
Eastern Cape (EC) 38783 25.2 
Gauteng (G) 30176 30.0 
W. Cape (WC) 22942 16.8 
N. Province (NP) 15667 21.5 
N. West (NW) 10 821 30.7 
Mpumalanga (MP) 10052 44.3 
Free State (FS) 9429 36.9 
N. Cape (NC) 298 18.5 
National Total 180507 32.8 
HIV/AIDS and TB- the deadly pair. Health information, evaluation and research (DOH, 2002). 
1.2.1.2.4 Epidemiology of extra-pulmonary TB 
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The figures quoted thus far refer solely to the pulmonary TB epidemic and does not 
account for infections at other anatomical sites such as the pleura, bones and joints. TB 
at these extra-pulmonary sites accounts for approximately 15-20% of TB cases among 
HIV-uninfected patients, but in the wake of the explosive HIV epidemic this figure has 
risen to 50% of all TB cases (Sharma and Mohan, 2004). In developed countries, 
related incidence rates have increased significantly in recent years among immigrant 
popultations. In some instances, an increase of 50 times that of local inhabitants as well 
as in increase in the number of sites involved, was noted (Houshian et al., 2000). 
Osteoarticular TB occurs in approximately 3-4% of all TB cases worldwide, (Tuli, 
2003). Affected sites include the knee and elbow joints, and the bones of the feet and 
hands (Sharma and Mohan, 2004). Mycobacterial infections of the upper extremities 
and non-weight bearing bones are as uncommon as skull and intra-cranial infections 
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(Allison et al., 1999). Often misdiagnosis considerably underestimates related 
incidence rates. In excess of 50% of osteoarticular TB cases involve the spine. 
Currently, an estimated 2 million individuals are afflicted with infections of the spine 
(Rajaskeran, 2003). Mortality rates among these patients range from 2 to 30% (Cuffe et 
al., 1994). 
1.2.1.3 The bacterium 
The etiologic agents of TB, belonging to the genus Mycobacterium, are slow growing, 
obligatory aerobic, gram-positive, intracellular pathogens (Cole et aI., 1998). Of the 
more than 70 species currently characterized, approximately 30% are known human 
pathogens (Cloud et aI., 2004). Mycobacteria are one of a few pathogens capable of 
infecting any organ in the body but prefer the oxygen-rich pulmonary tissue (Raja et al., 
2004, Sharma and Mohan, 2004). Infection ensues following anatomic invasion by 
Mycobacterium tuberculosis (Mtb) , occasionally by M.avium complex (MAC) or 
M.kansasii (Smith, 1991). 
1.2.1.3.1 The bacterial genome 
The Mycobacterial genome was largely a mystery until recent advances in molecular 
technology enabled the sequencing of the full 4.4 mega base long Mtb (H37RV 
bacterial stain) genome encoding 4 000 genes (Smith, 2003a) .. 
The greater proportion of the genome is dedicated to genes of, as yet, unknown function 
(38.2%), followed by genes responsible for intermediary metabolism and respiration 
(22.0%) (Smith, 2003a) presumably activated during latency. The third most prominent 
genes are those producing proteins for the cell wall and cell processes. Approximately 
30% of its genome or 200 genes are dedicated to lipid synthesis and enzymes involved 
in fatty acid metabolism, which enable the organism to utilise fatty acids as a carbon 
source (Cole et al., 1998, Smith, 2003 a). The bacterial cell wall is its most complex 
cellular component (Russell, 200Ia). In response to oxygen (02) depletion (reduced O2 
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levels) studies have demonstrated cell wall thickening indicative of protective 
adaptation (Cunningham and Spreadbury, 1998). 
The TB genome is distinguished by limited sequence diversity, an extended generation 
time and slow adaptive evolution (Tanaka, 2004). Consequently, the genome is highly 
conserved. However, the contention that TB has a stable conserved genome is refuted 
by the rapid emergence of drug resistance in treated populations (Tanaka, 2004). In an 
analysis of Mtb IS6110 sequences, Tanaka (Tanaka, 2004) demonstrated the influence 
of positive selection on the TB genome in infected hosts but admits that the data is not 
conclusive for various reasons (Tanaka, 2004). Among them is that bacterial 
populations may have been removed from the mutational-drift equilibrium, the actual 
bacterial heterogeneity may not have been reflected in the sampling and the small 
sample size may account for the low rate of polymorphisms (Tanaka, 2004). Host 
immune responses and anti-microbial interventions exert strong selection pressures 
(Tanaka, 2004) on evolutionary changes but these factors do not act independently. It is 
likely that selected regions of the genome remain highly conserved. 
1.2.1.4 Spinal Tuberculosis 
Although pulmonary tuberculosis is the most common form of human Mycobacterial 
infections extra-pulmonary diseases involving various anatomical sites also occur (Das 
et aI., 2003). These include the tonsils, lymph nodes, abdominal organs, and bones and 
joints (Beers and Berkow, 1999). Spread of bacilli from a primary focus of infection to 
remote anatomical sites, initiates extra-pulmonary disease. Despite the influx of a 
number of organisms, few survive since the large majority of bacilli are unable to 
initiate infection while others become dormant (Beers and Berkow, 1999). These 
remote infection loci may therefore provide microenvironments for adaptive bacterial 
evolution (Tanaka, 2004), which may generate tissue specific isolates. One such site is 
the spine and the vertebrae, intervertibral discs and epidural tissue associated with the 
spinal column. 
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1.2.1.4.1 Disease pathology 
The spinal cord is the inter-digitating centre of motor, sensory and visceral activity in 
the central grey matter (Manz, 1983). Maintaining the integrity of the spinal cord is 
imperative as even small lesions cause significant neurological deficits (Manz, 1983). It 
is for this reason that spinal pathologies are so debilitating. 
Infection of the spine is commonly through haematogenous (Wellons et al., 2004) or 
lymphatic spread from a pulmonary or, less commonly, a renal or gastrointestinal 
reservoir (pertuiset et al., 1999, Rajaskeran, 2003). A direct blood supply to the inter-
vertebral disc, via an extensive network of para-vertebral and intra-osseous collateral 
arteries, enables direct haematogenous spread of infection (Allison et al., 1999, Pertuiset 
et al. , 1999). This secondary spread may be either a reactivation event or leaching from 
an active primary site. Direct infection from a local site occurs rarely (Cheung and 
Leong, 2003). Evidence for re-activation events was inferred following genotyping of 
multi-lesional TB-strains from pulmonary and extra-pulmonary sites (du Plessis et al., 
2001). Exogenous re-infection is an additional route of disease acquisition in patients 
experiencihg a second disease occurrence (Sharma and Mohan, 2004). Moreover, 
spinal TB patients often (55%) report previous contact with pulmonary TB-infected 
patients (Govender et al., 2000a). Two types of osteoarticular TB are described 
namely; a Caseous, exudative abscess-forming type common to children and a granular 
type associated with adults (Kumar, 2005). 
The infect~on initially involves the adjoining metaphyses and the vertebral disc but can 
spread to multiple, often successive, vertebral bodies (Rajaskeran, 2003). Infection of a 
single vertebral body may also occur (Allison et al., 1999, Sharma and Mohan, 2004). 
The thoraco-lumbar region is commonly involved however lumbo-sacral TB, although 
rare, occurs in 2-3% of all spinal TB cases (Govender et al., 2001b, Govender and 
Parbhoo, 1999, Govender et al. , 2001a, Sharma and Mohan, 2004, Wellons et al., 2004) 
while discr~te sacral infection is even more exceptional. Also uncommon is infection at 
multiple vertebral levels with just one such report involving the cervical, thoracic and 
lumbar spine in current literature (Turgut, 2001). 
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1.2.1.4.2 Clinical pathology of spinal TB 
As with pulmonary TB, spinal infection is typified by granuloma and Langerhans giant 
cell formation (Cheung and Leong, 2003). Clinical features are also similar. However, 
the primary differences include a lack of pulmonary manifestation (cough), and 
localised back pain becoming increasingly incapacitating. 
Recent infection manifests as extensive granuloma formation with accompanying fluid 
pus. As the disease progresses an abscess with caseous white pus forms. Abscess 
formation, a characteristic of advanced disease, presents as a para-vertebral swelling at 
the site of infection which may advance down the psoas muscle to the thigh with 
advancing disease (Beers and Berkow, 1999), (Lifeso, 1990). The abscess can take 
many forms, such as a retropharyngeal (cervical spine), fusiformlbulbous para-vertebral 
(thoracic spine), mediastinal, or psoas (lumbar spine) abscess (Sharma and Mohan, 
2004). Extradural granulation tissue and extensive abscess formation are characteristic 
of both HIV-infected and -uninfected patients (Govender et al., 2001a). An abscess 
wall forms around the infected tissue in the large majority of cases (Govender et al., 
2001a). Thus fibrosis effectively contains the infection forming a discrete granuloma. 
However, ~ith disseminated disease, a more diffuse pathology results. Mechanical 
back pain often accompanied by abscess formation, is followed by bone destruction 
(Cheung and Leong, 2003). Infected bone becomes softened and compressed due to 
pressure from adjacent un infected vertebral bodies (Sharma and Mohan, 2004). The 
disease then infiltrates the bony cortex and in so doing, impedes the inter-vertebral 
blood supply resulting in necrosis and eventual collapse of the disc ensues. The most 
debilitating and unfortunate clinical presentation of spinal TB is paraplegia (Pott's 
paraplegia), which occurs in approximately a third of all spinal TB-infected patients 
(Sharma a~d Mohan, 2004). Bone destruction and collapse, is the primary cause of cord 
compression, neurological deficit and ultimately, paraplegia. This develops during the 
active phase of disease pathology (Sharma and Mohan, 2004). Therefore, progressive 
disease, inevitably, leads to collapse of the vertebral bodies and debilitating deformity 
(15% of cases), or severe deformity (3-5% of cases). Clearly, the clinical impact is 
devastating and disease resolution may not be as simple as administering conventional 
anti-TB chemotherapy (Govender, 2005). 
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Bone destruction and TB spondylitis is often seen in children (Govender and Parbhoo, 
1999). Poor nutrition, delayed treatment and/or an impaired immune response, such as 
in HIV-infected patients, exacerbates bone destruction (Govender et al., 200lb, 
Govender let al., 2001a). Spinal compression and neurology occurs when pus, bone and 
disc fragments infiltrate the spinal canal and exert pressure on the spinal cord. 
Consequently, granulomatous inflammation coupled with TB spondylitis leads to 
secondary cord (Rajaskeran, 2003) angulations, compression (Manz, 1983) and 
deformity. Exudates from the granuloma may penetrate the ligaments, travelling along 
fascial planes, blood vessels and nerves to manifest as a cold abscess at remote sites 
(Sharma and Mohan, 2004). 
Overall, children experience more disseminated pathology compared with adults (Lifeso 
et al., 1985), which is commonly associated with and exacerbated by HIV co-infection 
(Kabra et al., 2004). The distinctive physiology and immature immune systems of 
children make paediatric TB vastly different from that of adults. Paediatric disease is 
characteristically pauci-bacillary, and is often difficult to diagnose (Lodha and Kabra, 
2004). It is also more aggressive with greater deformity and neurological deficit as 
compared f ith adults (Bailey et al., 1972, Fountain et aI., 1975). 
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1.2.1.5 The immune response to infection 
1.2.1.5.1 The stages of infection 
Although primary infection can become active at any site in the body, it usually occurs 
in pulmonary apices. If untreated, an actively infected individual is capable of infecting 
from 10 to 15 others per year (WHO, 2004). Most intriguing is that only 5-10% of 
infected individuals develop active TB, and is usually associated with a compromised 
immune system (Davies and Grange, 200la). Thus of the millions of individuals 
exposed to TB approximately 90% mount an effective immune response against the 
pathogen. 
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TB pathogenesis, as described in this section, refers to pulmonary TB. Infection is 
multiphased and is described as either a three (primarylinitial, a latent, and a 
reactivation) (Beers and Berkow, 1999) or four (Iseman, 2000) phased model. The 
latter model will be discussed in this review of the literature. Briefly, Phase I refers to 
the transmission of infection and is dependant on functional alveolar macrophages, the 
virulence 6f the bacilli and their robustness. Phase II is when the infection initiates, 
bacilli proliferate culminating in the spread of infection locally, to the hilar lymph nodes 
and systemically. Dissemination of infective bacteria occurs via several mechanisms 
such as lysis of infected macrophages (Ehlers et al., 2003) through either necrosis or 
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apoptosis (Russell, 2001a). This is also the phase during which the immune response 
is activated, specifically the humoral immune response, and a burst of activity to 
phagocytose the bacteria as well as attact immune-effector cells to the site of infection 
ensues. Unfortunately, the process of phagocytosis also provides a breeding ground for 
the bacill~ within macrophages. The cellular immune response or cell-mediated 
immunity (CMI) is initiated during Phase ill. Antigen presenting cells (APC) playa 
vital role at this stage, not only attracting immune cells to the site of infection but also 
activating T-cells to release cytokines such as interferon-gamma (IFN-y) that stimulate, 
attract and activate a host of other immune cells important to the anti-TB immune 
response. If the immune response is robust, the bacterial load plateaus, eventually 
declines and the primary infection resolves (Raja, 2004, Tanaka, 2004). The infection, 
in the immuno-competent host, is effectively halted at this point and is characterised by 
a dermal delayed-type hypersensitivity reaction but an absence of clinical manifestation 
(Fenhalls et al., 2000). The infecting bacilli are not eliminated, rather become 
sequestered in discrete lesions or granulomas (Kaufmann, 2002, Raja, 2004). Bacilli 
may remain latent within these granulomas for an extended period or may be reactivated 
or released into the airways. Since bacilli are still present within the host, the risk of 
disease persists (Kaufmann, 2002). Clinical disease may develop within months or 
years once infection is established (Beers and Berkow, 1999). In contrast, the immuno-
compromised host develops primary disease immediately following exposure 
(Kaufmann, 2002). This constitutes Phase IV. For a more detailed description the 
reader is referred to the publication by Iseman (2000). 
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1.2.1.5.2 Granuloma formation 
Granuloma formation is the hallmark of an effective anti-TB immune response. 
Granulomas are widely associated with tuberculous, pathogenic, meningial or 
opportunistic infections, such as mycoses (coccidiomycosis and histoplasmosis) 
(Williams, 1991). Other causative agents include organic or inorganic particulates, 
foods and chemical agents. 
Granulomas are multi-cellular structured masses (Mornex et al., 1994) and form unique 
microenvironments, each with their own unique cytokine expression profiles (Fenhalls 
et al., 2000). The granuloma is a layered structure, consisting of a centre of necrosis, 
and radiating outwards, epithelioid histiocytes, giant cells, lymphocytes and finally a 
fibrotic cuff. Poly-morphonuclear leukocytes may line the cavity wall (Fig. 1.1). 
Histologically, the central core of necrosis appears caseous (Roitt et al., 2001). 
Langerhans Giant cells (LGs), collagen fibrils, lymphocytes and a sparse distribution of 
plasma cells occur commonly within these structures while epithelioid cells, 
macrophages and giant cells occur towards the granuloma core of necrosis. Granulomas 
are not restricted to pulmonary tissue, as they develop in every organ system of the 
body (Ioachim, 1983, Mornex et al., 1994). Regardless of their location, the 
mechanisms that govern granuloma development are the same (Ioachim, 1983). A 
granuloma will persist until the pathogenic or irritant particle is destroyed, or resolved, 
as much as possible, after which the granuloma resolves (Adams, 1983). 
Granuloma formation, which is induced and maintained by selected cytokines, is 
essential to disease containment (Kaufmann, 2002). The process is a complex spatiaI-
temporal interaction between the TB bacilli, representative host immune cells (CD4+, 
CD8+ T-cells, macrophages) and effector molecules (cytokines and chemokines) 
(Ioachim, 1983, Sergovia-Juarez et aI., 2004). This phenomenon is dependant on the 
migration to and aggregation of macrophages at the site of infection, occuring as rapidly 
as 24-hours post-infection (Desjardin et al., 2002b). Factors essential to modulating 
granuloma formation include chemokine diffusion, prevention of macrophage 
overcrowding, temporal/ spatial distribution and density of lymphocytes, and 
macrophage activation (Sergovia-Juarez et al., 2004). Finally, fibrous encapsulation of 
the necrotic focus is the last step in the immune response towards disease containment 
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(Raja, 2004) and occurs when fibroblast and extra-cellular matrix deposits around and 
within the granuloma (Momex et aI. , 1994). This lymphocytic layer surrounding the 
granuloma is comprised predominantly of CD4+ T -cells but may also contain dendritic 
cells (DC), and epithelioid cells (Raja, 2004). 
N eaodc zone and 
capsule b.·del'hl, cavity 
Figure 1.1: Light micrograph of a typical pulmonary TB granuloma illustrating distinct 
cellular and a-cellular zones (with kind permission Prof J. McKinney (McKinney, 2004)) 
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1.2.1.5.3 Immune cells involved in the anti-TB response 
Granulomas centre on the activity of monocytes or mononuclear phagocytes as well as 
lymphocytes, plasma cells, myofibroblasts, B-cells and eosinophils, which migrate to 
the site of inflammation (Qiu et aI. , 2001). 
Macrophages are the scavengers of the immune system, and have evolved to 
phagocytose and dispose of pathogens and other foreign particles (Roitt et aI., 2001). 
The unique and varied functions of macrophages, from phagocytosis to antigen 
presentation, are determined by their local microenvironment. Macrophages display 
extensive morphological heterogeneity and differentiate into epithelioid cells, for 
example, following stimulation (Holness and Simmons, 1993). Macorphages may also 
fuse together to form a multi-nucleated giant cell (Adams, 1976). Macrophages are 
highly motile but, may be tissue or organ specific (Holness and Simmons, 1993). They 
display effective microbicidal activity if activated by IFNy, prior to a TB infection 
(Russell, 2001a). Tissue macrophages are long-lived cells that are encountered on 
infection by the TB bacillus, therefore, are in constant communication with various 
cellular populations involved in the immune response (Desjardin et aI., 2002b). 
Functional differences between adherent and non-adherent cultured monocytes are 
major determinants of infectivity and intra-cellular growth (Barker et al., 1996). 
A primary function of macrophages remains their phagocytic activity and the CD68 
antibody has been used to localise phagocytic/endocytic cells such as macrophages of 
the germinal centre, tonsils, splenic red pulp, dermal connective tissue, Kupffer cells 
from the liver, alveolar macrophages and blood monocytes (Pulford et al., 1989, Roitt et 
aI., 2001). The molecule belongs to the family of lysosomallendosomal associated 
trans-membrane proteins (LAMP) (Holness and Simmons, 1993). Several studies have 
attempted to define CD68 function. It is proposed that this protein aids in macrophage 
localisation to tissue and organ specific sites by binding to selected lectins and selectins 
(Holness and Simmons, 1993). Others have associated CD68 proteins with class-A 
scavenger receptor (SR-A) protein expression in macrophages (Fenhalls et al., 2000, 
Gough et al., 2001). Furthermore, it has been proposed that CD68+ cells secrete IFNy, 
within TB granulomas to enable macrophages to auto-regulate their localised activation 
(Fenhalls 9t aI., 2000). However, IFN-y has no significant up-regulatory effect on 
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CD68 expression (Holness and Simmons, 1993). 
Although the initial phase of infection is characterised by macrophages phagocytosing 
the TB bacilli, they are not activiated and thus cannot destroy the pathogen but rather 
play an effector role by initiating the immune response and presenting the TB antigens 
to T-cells (Iseman, 2000). Activated T-cells rapidly migrate to the site of infection to 
interact with antigen presenting cells (APCs) and effectively contain the spread of 
infection (Raja, 2004) (Table 1.2). Following phagocytosis by macrophages, MHC 
class II molecules present the bacterial Ags to CD4+ T-cells (Raja, 2004). The T-cell 
pOPulatioJs, involved in the immune response, are predominantly T-helper typel (Thl) 
cells (Table 1.2) (Kaufmann, 2002). Both Thl and Th2 responses have been detected in 
TB-infected human and in animal models (Raja, 2004). Thl-secreted cytokines (~-2, 
IFN-y) playa protective role, while that of Th2-cytokines (IL-4, ~-5, ~-1O) may be 
extraneous or negative to the immune response (Raja, 2004). Moreover, the intensity of 
the Thl response can be correlated with clinical disease pathogenesis (Raja, 2004). 
Favourable clinical outcomes were shown in patients with detectible granuloma ~-4 
levels by immunohistochemistry (IHC) (Fenhalls et aI., 2000). 
CD4 cells (Table 1.2) are vital to the anti-TB immune response (Fenhalls et aI., 2000). 
In CD4-depleted patients, reactivation of latent TB often produces a fatal pathology 
with incr~ased bacterial numbers. CD8+ T-cells are also involved in the anti-TB 
immune response as early as 12 hours post-infection. These cells are initiated sooner 
than the CD4+ cells, and have been implicated in the lyses of infected macrophages and 
dendritic cells (Raja, 2004, Stenger et al. , 1997). Their presence correlates with slower 
disease progression (Yu et aI., 1995). 
19 
Table 1.2: T-cell populations involved in the immune response agaInst TB 
T-cell Mode of action 
CD4 Recognise Ags processed & presented by MHC class II 
Produce lymphotoxin a (LT a), cytokines ego IFN-y 
CD8 
I 
Recognise Ags processed & presented by MHC class I 
Secrete perforin, granulosin and cytokines ego IFN-y 
Gamma/d~lta Recognise unusual Ags not processed/presented by MHCs 
T-cells Targets infected macrophages 
CD1 Recognise glycolipids presented by CD1 molecules 
I 
Secrete perforin and granulosin - targets infected macrophages 
Adapted , om Kauffman (Kaufmann, 2002) 
1.2.1.5.4 <themokines and cytokines 
Cytokine and chemokine expression profiles have been established for pulmonary TB in 
various a1mal models and human studies (Collins, 2001, Collins and Kaufmann, 
2001b, DJvies and Grange, 2001a, Davies and Grange, 2001b, Rhoades et al., 1995, 
Shigenaga1et aI., 2001) have established cytokine and chemokine expression profiles for 
pulmonary TB. These profiles differ between the early and late phases of disease 
(Rhoades et al., 1995). However, to our knowledge, only two reports of the immune 
response to spinal TB (Govender et aI., 2000a, Govender et aI., 2001a) are presently 
available. 
chemokinl s and cytokines are essential to granuloma formation and maintenance 
(Adams, 1983, Kaufmann, 2002, Qiu et aI., 2001) serving either a synergistic or 
antagonistic function by fulfilling one of three roles namely as simulators of 
hematopoJsis, regulators of the innate or adaptive immune responses. A cascade of 
cytokines and chemokines characterize the immune response against TB (Table 1.3). 
Interferon gamma (IFNy), an important component of the immune response, is produced 
by macrophages (Table 1.3 and 1.4), activated T-, B- and NK cells (Ehlers, 2003). 
Fenhalls et aI, (Fenhalls et al., 2000) demonstrated TNF-a, IFN-y and IL-4 expression 
in CD68+ jyeOIOid cells. These were novel findings, since IFN-y and IL-4 are usually 
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expressed by T -cells. Tumour necrosis factor (TNF) plays a role in apoptosis, cell 
activation, recruitment and differentiation serving a protective role against disease 
(Kaufmann,2002). Sustained disease containment is also mediated by TNFa since it is 
involved in continuous recruitment of inflammatory cells (Ehlers et al., 2003). Any 
disruption in TNFa production, at any stage of disease progression, would severely 
retard the immune response and result in disseminated, uncontrolled infection (Fenhalls 
et al., 2000). Moreover, latent TB is reactivated and primary infection is aggravated in 
its absence (Ehlers et aI., 2003). Conversely, TNF has been shown to aggravate the 
immuno-pathology of TB (Roach et al., 2002) while anti-TNF therapy (thalidomide) 
resulted in clinical improvement (Tramontana et al., 1995). In addition, IL-10 
influences a decrease in the lytic activity of CD4 and CD8 cells and inhibits MHC 
cytotoxicity against infected cells (de la Barrera et al., 2004). Finally, varying 
expression profiles of other cytokines associated with lymphocyte-mediated cytotoxicity 
such as IFN-y can be demonstrated between healthy and TB infected (p<0.03) 
individuals (Toossi et al., 2004b). For a more detailed description of cytokines, 
chemokines and their role in the anti-TB immune response, please consult the 
publications of Iseman (2000) and Raja (2004a). 
1.2.1.5.5 Antimicrobial response 
Included among the antimicrobial arsenal of macrophages is the production of reactive 
oxygen intermediates (ROI) e.g. hydrogen peroxide (H20 2) and reactive nitrogen 
intermediates (RN!). Darwinian evolution of Mtb to combat the effect of NO toxicity 
(Chan et aI., 2001) has produced currently circulating TB isolates. Nitric oxide synthase 
(NOS) and reactive nitrogen intermediates (RNI) are potent, and arguably the best 
studied mechanisms of anti-microbial activity in macrophages (Chan et al., 2001). The 
primary mediator NOS2, is essential for Mycobacterial control in the acute and chronic 
phases of disease. A human control mechanism involving RNIs is more ambiguous 
requiring further elucidation, unfortunately, related investigations are complicated by a 
lack of an appropriate in vitro model (Chan et aI., 2001). 
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Table 1.2: Immune modulators important to the host immune response against TB 
Immune Function 
Secretory 
modulator cell / organ 
Activate macrophages, regulate Thl1Th2 balance, protects 
against T-cell apoptosis, intracellular infection, enhance Ag CD4+ CDS+ 
IPN-y 
, 
presentation, correlated with stage of disease and nutritional and NK cells 
status 
Promotes migration of cells to infection, modulates 
Macrophages, 
TNF-a expression of adhesion, cytokine and chemokine molecules, 
DCs, T -cells 
mediates granuloma formation, contains/ sequesters infection 
Important for biological defence mechanisms. In conjunction 
Monocytes 
IL-l with TNF-a modulates acute phase of disease (fever, 
Macrophages 
cachexia), enhances IL-2 and IL-2 receptor expression 
IL2 
Protects T-cells against apoptosis, intracellular infection, CD4+ T-
mediates expansion of Ag specific lymphocytes lymphocytes 
IL-6 
Involved in inflammation, hematopoiesis and T-cell 
differentiation, may be important to initial immune response 
Negative or no effect on immune response, deactivates 
Macrophages, ILlO macrophages by down-regulating IL-12 and thereby IPN-y, 
inhibits CD4+ T-cells T-cells 
IL12 Possible role in ThlITh2 cellular differentiation; induce Thl 
response in undifferentiated cD4 cells 
Important anti-inflammatory, deactivates macrophage 
TGF-~ 
production of ROI and RNI; inhibits T-cell proliferation, 




IL-S Recruits neutrophils, T lymphocytes and basophils, uncommonly 
- fibroblasts, 
keratinocytes 
MCP-l Decrease during convalescent phase of disease 
RANTES Decrease during convalescent phase of disease Macrophages 
MIPIa,2, 
MCP-I , -3,- Formation and maintenance of granuloma Macrophages 
5, IPlO 
Adapted from Raja, 2004 (Raja, 2004) 
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Phagosome-lysosome fusion and intra-lysosomal acidic hydrolase degradation is a 
primary mechanism of TB elimination (Raja, 2004). Yet another response to TB 
infection is apoptosis. Apoptosis, or programmed cell death, was demonstrated in TB-
infected monocyte/macrophages, particularly from HIV -infected patients (Mustafa et 
aI., 2005, Placido et aI., 1997). The induction of apoptosis is dose dependant and 3-fold 
greater in TB-infected patients compared with normal controls. Markers of apoptosis 
such as caspase 1 and 8 are strongly associated with levels of caspases and with HIV-
infection (Wanchu et al., 2004). Others have correlated levels of caseation with 
macrophage and T-cell apoptosis (Fayyazi et aI., 2000). They showed that regressive 
granulomas lack apoptotic cells, while active granulomas with caseous necrosis, contain 
numerous apoptotic CD68+ macrophages and T-cells (Fayyazi et aI., 2000). 
1.2.1.5.6 Host genetic and environmental factors 
With the successful deciphering of the human genome, a number of genomic regions 
conferring resistance/susceptibility to a range of infections have been described 
(Kwiatkowski, 2000). Mounting evidence implicates host genetic factors as primary 
determinants of susceptibility to infection and risk of developing acute pathology 
(Kwiatkowski, 2000). In relation to TB, these factors include diabetes, age, gender, 
ethnicity and integrity of immune response (Bellamy, 2003, Bellamy et al., 1999, 
Bellamy et al., 1998, Selvaraj et aI., 2000, Selvaraj et al., 1999, Selvaraj et al., 1998). 
Other contributors include stress, poor living conditions, co-infections, malnutrition, 
vitamin deficiency and natural immunity (Zajac and Melcher, 1991). In addition the 
human leukocyte antigen (HLA) (Raja, 2004) (Table 1.4) plays an important role in host 
susceptibility to infection. Associations between TB infection and HLA types have 
been demonstrated (Table 1.4) (de Vries, 1989, Dubaniewicz et al., 2000, Dubaniewicz 
et al., 2005, Lombard et aI., 2006), (Ravikumar et al., 1999, Selvaraj et al., 1998, 
Shanmugalakshmi and Pitchappan, 2002). 
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Table 1.3: Summary of the HLA alleles implicated in the host response to TB' £ III ectlOn 
Reference 
Nationality HLA types conferring HLA types conferring 
of cohort susceptibility resistance 
HLA-DRBI 




(Dubaniewicz et aI., 2003) Polish -
HLA-Cw5 
(Vejbaesya et al., 2002) Thai HLA-DQB 1 *0502 
HLA-DQAl *0601 
HLA-DQBl *0301 
(Shanmugalakshmi and HLA-DRBI *02 
Indian -
Pitchappan, 2002) HLA-DRBI *1501 
(Dubaniewicz et aI., 2000) Polish HLA-DRBI *16 HLA-DRBI *13 
HLA-DRBI *1501 
(Ravikumar et al., 1999) Indian HLA-DPB 1 *04 
HLA-DQBl *0601 
1.2.1.5.7 Latency and immune evasion 
As previously stated, macrophages are essential to containing and eliminating a TB 
infection. However, selected bacilli are able to evade the host's natural defence 
mechanisms and survive within intracellular phago-Iysosomes (Fossati et al., 2003). 
Determining how this is achieved remains a challenge to researchers. This is because 
the bacillus has to avoid, not only the complex and varied immune responses directed 
against it, but also the antagonistic intra-lysosomal environment, and possible 
concurrent chemotherapy (Fenhalls et al., 2002b). 
Granulomas may also represent a significant reservoir of latent infection (Karakousis et 
aI., 2004). During latency, the live bacilli exist in a non-replicating, hypo-metabolic 
state, which may persist for several years (Karakousis et al., 2004). Mycobacteria either 
evade or diminish immune induction and response once it is activated (Russell, 2001 b, 
Russell, 200la). The bacilli have devised various mechanisms (Table 1.5) to survive 
within macrophages (Chan and Flynn, 2004, Russell, 2001b, Russell, 2001a). In 
addition, mechanisms invoked during this process prevent the activation of a localised 
host immune response and consequently Mycobacterial killing. Reports have described 
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bacterial induction of a basic pH within lysosomes that is also associated with lower 
vacuolar ATPase levels (Sturgill-Koszycki et aI., 1994). Others have characterised 
genes that enhance intracellular survival in macrophages (Dahl et al., 2001, Wei et aI., 
2000) or h,ave implicated various factors such as calmodulain dependent Ca2+ signalling, 
Ag processing and lipoarabinomannan (LAM) (Chan and Flynn, 2004, Karakousis et 
al., 2004) but the actual mechanism of induction of latency remains ill-defined. 
1 db TB b ·ll" Table 1.4: Strategies of immune evaSIOn employe )y aCl 1 
Immune evasion TB mechanism Reference 
Alter antigen presentation by Induce cells to produce TGF-p, 
(Hmama et aI., 2004) 
macrophages / APCs IL-lO, IL-6 
Modulate antigen presentation (Raja, 2004) 
Scavenge oxygen radicals 
Sulphatides, LAM, pholic-
(Chan et al. , 2001) 
glycolipid-I 
Inhibition of neutrophil Disruption of glycolytic enzyme 
(Anderson et al., 1991) 
migration phosphofructokinase 
1.2.1.6 Treatment of TB 
Current interventions comprise a 4 drug-cocktail (ethambutol hydrochloride, isoniazid, 
pyrazinarnid and rifampicin) for 2 to 9 months, typically over a short course of 6 months 
(Cunningham and Spreadbury, 1998, Lodha and Kabra, 2004). The patient is rendered 
non-infectious within 10-14 days following initiation of treatment (Beers and Berkow, 
1999). Prophylactic interventions are administered to individuals with a recent TB 
infection who are most likely to develop active disease, such as children, young adults 
«25 year old) and the elderly (Beers and Berkow, 1999) but is strongly indicated in 
HIV -infected individuals. However, adherence to protracted regimes and misuse or 
abuse of drugs is a persistent concern, as is the resultant emergence of drug resistant 
bacterial variants. Delays in accessing treatment impacts disease progression cure 
rates , mortality and morbidity. The primary reasons for delayed interventions include 
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patient stigmatisation and a propensity of many in developing countries to seek 
traditional rather than conventional medicine. The emergence of drug resistant stains is 
thus inev~table in these instances. In developed countries multi-drug resistant TB 
(MDR-TB) accounts for more than 15% of all infections while 6 000 of the 500 000 
current TB infections (1.2%) in South Africa, are drug resistant (Sidley, 2006). 
1.2.1.6.1 Treatment, surgical interventions and complications of spinal TB 
The preferred treatment regimes for TB spondylitis are usually conservative (rifampicin, 
isoniazid, pyrazinamide and ethambutol) for up to 18 months (Beers and Berkow, 1999, 
Govender et aI., 2001b, Govender and Parbhoo, 1999). However, in certain instances, 
surgical intervention is necessitated, and is only undertaken once patients achieve 
clinically acceptable haemoglobin (> 100g/l} and albumin (>300gfl) levels, usually 
within 5-9 weeks of sound nutritional support (Govender et aI., 2001a). The 
indications for surgery vary but is not influenced by HIV status and/or CD4 count, 
treatment response, or severity of neurological deficit (Kumar, 2005). Surgery is often 
necessary in paediatric cases since the deformity usually does not resolve after anti-TB 
chemotherapy but advances with growth (Rajaskeran, 2003). During surgery, diseased 
bone and tissue is removed, and a femoral allograft containing morsellised 
intramedullary rib harvested from the patient is inserted (Govender and Parbhoo, 1999, 
Govender et al., 2001a). Fixation or insertion of instrumentation is only indicated in 
patients with advanced deformity (Beers and Berkow, 1999). 
Outcomes following surgery are favourable regardless of HIV status and may relate to 
the immune response stimulated following allograft insertion (Govender et al., 2007, 
Govender et aI., 2001b, Govender et al., 200la). Paediatric patients show allograft 
incorporation within 18-24 months compared to 3-5 years in adults (Govender et al., 
2001b). The accelerated incorporation of the allograft among children can be attributed 
to a greater osteogenic potential stimulated by the intra-medullary rib material. 
Neurological recovery within 6 months post-surgery has been reported in a cohort of 
South African children (Govender and Parbhoo, 1999). Unfortunately no indication of 
the patient's HIV status was presented therefore the impact of HIV co-infection on post-
surgical recovery rates could not be assessed. In general, outcomes depend on the 
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degree and duration of cord compression as well as the age and general clinical status of 
patients (Kumar, 2005). Again, this report (Kumar, 2005) did not describe the impact of 
HIV co-infection on neurological and clinical recovery rates. Few postoperative 
complications associated with malnutrition, diabetes or neutropenia have been reported 
in patients treated at the King George V Hospital, KZN independant of HIV status 
(Go vender et al., 2001a). 
1.2.1.7 Diagnosis of TB 
Diagnostic assays are significant to clinical outcomes by directing treatment initiation or 
conclusion (Sharma and Mohan, 2004). It is only through cautious and appropriate 
diagnostic procedures, coupled with early initiation of anti-TB chemotherapy, that TB 
can be treated with any degree of success (Sharma and Mohan, 2004). 
Presumptive diagnosis of infectious spondylitis based on clinical and radiological 
presentation rather than conventional histopathology often directs treatment, since 
laboratory results are indeterminate, in most instances. Diagnosis is often based on 
presentation of backache, fever and malaise (Sinan et aI. , 2004). Magnetic resonance 
(MR) imaging, a common diagnostic tool (Beers and Berkow, 1999, Sinan et aI., 2004) 
also has limitations particularly in drug-resistant cases (Sharma et al., 2003), but still 
offers exceptional visualisation of the TB lesion and the best likelihood of an early 
diagnosis (Sinan et aI., 2004). 
In terms of its laboratory diagnosis, there still remains a dependency on traditional 
diagnostic methods such as the Mantoux skin test, microscopy (Ziehl-Neelsen and/or 
fluorochrome staining), radiography, liquid/solid culture identification and gastric 
lavage (Garg et aI., 2003). Unfortunately, the findings of these laboratory assays are 
often inconclusive or negative (Garg et al. , 2003). In addition these assays are 
protracted often yielding results several weeks after patients have first presented, further 
exacerbating patient morbidity and mortality. The most common TB diagnostic assay, 
the tuberculin skin test has been utilized for more than 85 years (Garg et al., 2003), 
despite its associated interpretive difficulties in BeG vaccinated individuals. In 
addition, false negatives in a non-Mtb infection (Garg et al., 2003) pose further 
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challenges. This is further complicated by regional differences in host genetic factors 
and exposure profiles to endemic bacteria (de 0 Liverato et al., 2004). Moreover, 
childhood TB is diagnostically challenging due to difficulties in obtaining an adequate 
clinical sample (Kabra et al., 2004). 
1.2.1.8 Mycobacterial identification 
Apart from clinical features, the most common diagnostic tools presently employed 
include microscopy (Haematoxylin & Eosin, Ziehl Neelsen techniques), TB culture, 
enzyme linked immunosorbent assay (ELISA) and molecular techniques (Mukherjee et 
al., 2002). The current diagnostic gold standard is demonstration of Mycobacteria in 
body fluids such as blood, urine and broncho-alveolar lavage (BAL) fluid (Lodha and 
Kabra, 2004) by microscopy or culture. Often additional assays are performed to 
identify organisms that are indeterminate by conventional means. As Scarparo et al 
(Scarparo et al., 2002), demonstrated only a fraction of the total number of clinical 
samples is successfully grown in culture with the result that a large proportion (>60%) 
of infections remain undiagnosed. Improved culture techniques include the BACTEC 
radiometric assay, Septicheck AFB system and the Mycobacterial growth indicator tube 
system (M'OIT) (Kabra et al., 2004). The M'OIT, which uses a fluorescence based 
detection system, relies on Mycobacterial growth for a positive result (Kabra et al., 
2004). However, it carries a high potential for false negative findings. 
Newer diagnostic approaches exploit molecular techniques, such as the polymerase 
chain reaction (PCR) and include restriction fragment length polymorphisms (RFLP), 
fluorescence amplified fragment length polymorphisms (FAFLP) (Ahmed et al., 2003), 
molecular beacon assays and sequencing (Cloud et al., 2002). Single base differences 
using molecular beacon technology enables the pathogen identification (de Baar et aI., 
2001, Martin et aI., 1993, Patel et aI., 2000, Tortoli et al., 2001), provides an 
understanding of their infectivity, pathogenicity (Rhee et al., 1999) and drug resistance 
patterns. It is cautioned, however, that a negative PCR diagnosis can never completely 
discount a TB infection nor can a positive result be conclusive for a positive TB 
infection (Lodha and Kabra, 2004). Despite these advances, identification is still 
dependant on bacterial cultures. It may, therefore, prove useful to genotype the 
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infective organism directly from the clinical samples, as this translates to obvious and 
significant benefits to the patient. 
Comparative studies have consistently demonstrated the superiority of sequencing over 
conventional identification techniques where the former showed improved specificity 
and sensitivity (Cloud et aI., 2002, Martin et al., 1993, Patel et al., 2000, Tortoli et al., 
2001). Several genomic sites have been examined including the hsp65, and 16-23S 
internally transcribed spacer (ITS), but the 16S rDNA region (Cloud et aI., 2002) 
provides the most favourable target. This region is highly conserved across the genus, 
but still retains sufficient base differences to be phylogenetically relevant. In addition, 
the 16S genome is common to all Eubacteria, (Zumarraga et al., 1999), therefore may be 
applied as a general diagnostic tool. Unfortunately, the foremost restriction to 
implementing newer diagnostic technologies, particularly in developing nations, is their 
high cost. In addition, improved sensitivity is not always complemented by greater 
specificity, necessitating the expansion of more attractive alternative diagnostic tools. 
1.2.2 Human Immunodeficiency Virus (HIV) 
1.2.2.1 Historical perspective 
The Human Immunodeficiency Virus (HIV) is undoubtedly, the definitive disease 
condition of the present generation, the likes of which had not been seen since the 
advent of modem medical practices. The first cases of HIV were documented in 1981 
among homosexual males, exhibiting severely compromised immune responses (Fauci, 
2003, Gottlieb et al., 1983). Their point of convergence was severely depleted CD4+ T 
lymphocyte counts. Later, recognition of similar symptoms among the greater 
population implied a common infectant subsequently identified as HIV. 
1.2.2.1.1 The origins of HI V 
Phylogenetic evidence places the origin of the virus in Central West Africa in 1950 
while epidemiological data established HIV in the US as early as 1978 (CDC, 1987). 
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Much controversy however, still persists regarding the origins of the virus. Subsequent 
studies comparing the HI virus with the simian immunodeficiency virus (SN) 
confmned two zoonotic transfection events (Fauci, 2003, Van Heuverswyn et al., 2006 ) 
from the Pan troglodytes troglodytes (chimpanzees) to humans. Recently, 
P.t.troglodytes was identified as the natural reservoir of HN-l Group M and N 
subtypes (Keele et aI., 2006) while viruses resembling Group 0 variants were isolated 
from gorillas in Cameroon (Van Heuverswyn et al., 2006). The origin of HN-1 group 
M was estimated at between the 1920's and 1930' s, while, according to phylogenetic 
and mathematical modelling, the zoonotic transfection to humans is purported to have 
occurred approximately 300 years ago (Korber et al., 2000, Salemi et al., 2001). 
However, it is argued that this estimate represents the coalescence of the simian 
ancestor of HN-l group M and its closest SNcpz ancestor (Salemi et al., 2001). The 
actual infancy of the HIV epidemic may have effectively been shrouded by the remote 
setting of its origins in Central and West Africa, and the lack of infrastructure and 
communication in this region. Similarly, molecular modelling places the origins of 
Group 0 isolates at a similar time frame as group M, at around 1920 (1890-1940) 
(Lemey et al., 2004). 
1.2.2.1.2 Circulating forms of HIV 
Two main forms currently circulate namely, HIV-l and HN-2. HN-l is, further, 
classified into 3 main groups; M (main), 0 (outliers) and N (non-MI non-O) viruses. 
Group M viruses account for almost all of the HN infections worldwide and are 
divided, based on variation in the envelope (env) and gag genes, into SUbtypes ranging 
from A-J. Several recombinant forms that merge 2 or more subtypes (Collins et al., 
2000), (Robertson et al. , 1991) presently circulate worldwide. Until the late 1980's 
HN -1 SUbtype B was predominant worldwide, but HN -1 SUbtype C began an explosive 
outbreak in southern Africa and Ethiopia (Gordon et al., 2003) that has yet to subside. 
Many factors have been proposed to account for this explosive increase in SUbtype C 
infections including greater diversity at the protease cleavage sites (De Oliveira et al., 
2003), an extra NF-KB site in the long terminal repeat (LTR), greater stability of C 
viruses, viral attenuation (Ball et al., 2003) and a 5 amino acid insertion in the vpu 
region (Alimonti et aI., 2003). These factors remain speCUlative, as no conclusive 
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account for the advance in the HIV subtype C epidemic, through Africa, Asia and 
Eastern Europe, has been proven. While HIV -1 has swept throughout the world, HIV-2 
remains concentrated in West Mrica (Shanmugam et al., 2000). HIV-2 is less virulent 
and infective compared with HIV-l and has even been shown to reduce the infectivity 
of the latter (Kanki et aI., 1996), (Nkengasong et al., 2000). In addition, survival rates 
are significantly greater in HIV-2 compared with HIV-l infected individuals (Marlink et 
aI.,1994). 
1.2.2.2 HIV epidemiology 
1.2.2.2.1 The global epidemic 
At the end of 2001, approximately 40 million people globally were living with HIV (Fig 
1.3) (UNAIDS, 2006). Worldwide, a cumulative total of more than 60 million people 
up to 2003, have been infected with HIV since it was first described in 1989, almost a 
third of whom have since died (Fauci, 2003). 
Initially the epidemic was concentrated in North America, Western Europe and sub-
Saharan Mrica, but has spread to encompass all nations of the world (Shankarappa et 
al., 2001). Of the current infections, 9S% occur in developing nations (Chakraborty, 
200S). Presently sub-Saharan Africa has, by far, the highest incidence and prevalence 
rates globally (Karim, 2000, UNAIDS, 2006). India has the world's second largest 
HIV -infected population of 4.S8 million people following an introduction estimated to 
have occurred in the mid-1980's (Shankarappa et aI., 2001). The Indian epidemic is 
further compounded by TB co-infection (Zaidi et aI., 2004). Approximately a third of 
people living with HIV/AIDS are between the age of IS-24 years constituting an 
economically important demographic that includes women of childbearing age 
(Chakraborty, 200S). Most infected individuals do not know their status! 
Meeting the millennium goal of a two third reduction in child mortality by 201S cannot 
be achieved if the present rate of paediatric disease is not stemmed or controlled (Zaidi 
et aI., 2004). Mother-to-child transmission (MTCT) rates ranged from IS-20% in 
Europe, lS-30% in the USA and 2S-40% in Africa in 1999 (McIntyre and Brocklehurst, 
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1999). Globally, approximately 600 000 new infections occur annually, 1500 occurring 
daily in sub-Saharan Africa, equating to a 25-42% vertical transmission rate in the 
region (Chakraborty, 2005). The Indian epidemic is heterogonous with regional 
differences in patterns of spread (Zaidi et aI., 2004). It is said that HIV and AIDS 
'increasingly has a woman's face' (Pope and Haase, 2003) since heterosexual 
transmission has increased such that half the infected adults are female of childbearing 
age (Chakraborty, 2005). Of these women, 77% reside in sub-Saharan Africa 
(UNAIDS, 2006). 
Despite the fact that the majority of HIV -infected persons worldwide are infected with 
HIV -1 sUbtype C (Shankarappa et al., 2001) investigation of HIV immuno-pathogenesis 
and molecular evolution has centred on subtype B (Mani et al., 2002). It is thus 
primary to the development of vaccines and appropriate therapies that studies be 
conducted in subtype C endemic regions such as the local KZN setting. The alarming 
and unfortunate truth is that the magnitude of the HIV / AIDS pandemic has yet to be 
realised (Fauci, 2003). 
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Figure 1.3: Global map illustrating estimates of HIV infection in adults and children 
as of 2003. 
1.2.2.2.2 The South African epidemic 
The South African HIV epidemic began much later than others in the region but has 
since exploded to constitute one of the highest infection rates in the world. From less 
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than 1 % prevalence among pregnant women attending antenatal clinics in 1990 the 
number of pregnant women infected with HIV expanded to 25% in 2001 (DOH,2002). 
In 2004 the prevalence rates in South Africa ranged from 15.4% in the Western Cape 
Province to 40.7% in KwaZulu-Natal (DOH, 2004). The national average increased 
from 26.5% (95% CI = 25.5-27.6%) in 2002, and 27.9% (95% CI = 26.8-28.9%) in 
2003 to 29.5% (95% CI = 28.5-30.5%) in 2004 (DOH, 2004). By the year 2000, HIV-
related deaths were the leading cause of mortality among young adults in the country 
(Dorrington et al., 2002). Current figures indicate 5.5 million South Africans were 
living with HIV/AIDS in 2005, which is a prevalence rate of 18.8% (Global Health, 
2006). 
1.2.2.3 The HIV genome 
HIV comprises a 9kb genome, which codes for 9 gene products divided into 3 structural 
and 6 regulatory/accessory genes. These genes encode more than 15 gene products 
(Fauci, 2003). HIV-l produces three transcripts of 9kb, 4-5kb and 2kb in length, which 
following splicing produces 30 different mRNA's (Fauci, 2003, Kuiken et al., 2002) and 
associated gene products. The structural (gag, pol, env), regulatory (tat, rev) and 
accessory genes (vif, vpr, vpu, vpx, nef) (Kuiken et aI., 2002) can be viewed in greater 
detail in Appendix A. The env gene, codes for the viral glycoprotein, the external 
glycoprotein gp120 and the transmembrane protein gp41 (Kuiken et al., 2002). This 
gene product is important since it contains the binding site for the CD4 receptor and the 
amino acids that determine the co-receptor usage for viral entry (Kuiken et al., 2002). 
In addition, viral tropism is determined by specific amino acid profiles of the V3 region 
of the env gene. 
1.2.2.3.1 HIV clades 
HIV evolution is dynamic, typified by the rapid radiation of HIV -1 M strains into 
individual SUbtypes or clades (Robertson et al., 1991, Weiss, 2003). Indeed clades 
differ by 10 to 25% of their genetic material (McMichael and Hanke, 2003). 
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Regional and country differences within clades have been demonstrated (Shankarappa 
et al., 2001). The analysis of HIV-1 subtype C sequences from 23 countries including 
India, South Africa, Zimbabwe, Burundi and Botswana by Shankarappa et al 
(Shankarappa et al., 2001) revealed a significant (p<O.OOOl) country-dependant 
distribution. The sequences from South Africa and Zimbabwe, furthermore, display 
scattered phylogenetic distributions, indicative of introductions from numerous lineages 
(Gordon et al., 2003, Shankarappa et al., 2001). The Indian epidemic, on the other 
hand, exemplifies either a founder effect or limited spread of new introductions through 
the population. Of the HIV -1 subtypes, SUbtype C isolates infect more individuals than 
any other clades and predominate in marginalized countries such as India, sub-Saharan 
Africa and Brazil (Shankarappa et al., 2001). 
1.2.2.3.2 HIV replication and heterogeneity 
The replication rate of HIV is high with 1010 virions produced daily and 106_10 10 cells 
infected at anyone time (Rodrigo et al., 1999). HIV regeneration time is estimated at 
1-2 days/generation, resulting in highly diverse sequence populations within an 
individual (Collins et al., 2002a), (Rodrigo et aI., 1999). Various factors increase viral 
replication rates including cytokines such as TNF-a, and co-infections such as TB. 
Higher viral loads in turn result in a more rapid disease progression (Toossi et al., 
2004b, Toossi et al., 2004a). Viral set-point defined as the level at which viral load 
remains stable is also predictive of clinical outcomes and disease progression (Mani et 
al.,2002). 
The high heterogeneity of HIV is due primarily to the error-prone reverse transcriptase 
and is manifest primarily in the nucleotide (NT) sequence of the envelope glycoprotein 
(en v ) and the gag genes (Collins et aI., 2000). Variability most often results from high 
viral replication rates that in turn, differ (Collins et al., 2000) within compartmentalized 
microcosms of different organ systems. Despites a high turnover rate and high genomic 
variability, amino acid substitutions rarely influence function (Weiss, 2003), infectivity 
, 
or route of transmission. Greater variability leads to rapid development of drug 
resistance, and immune escape with the added implication of complicating drug 
development (Peleg et al., 2002). It is thus expected that the future of the epidemic will 
34 
not conform to current mono-clade geographic distributions with an emergence of 
circulating recombinant forms (CRF) of multiple clades and even of Group M and 0 
forms (y./eiss, 2003). 
The HIV genome is interspersed with conserved as well as variable regions. Conserved 
regions at the gene level relate to functional RNA secondary structure, while 
conservation at the protein level is a result of functional and structural protein 
constraints (Peleg et al., 2002). Important protein secondary structures include the 
transactivation-responsive (TAR) and the rev-responsive elements (RRE). More 
recently, a previously undescribed secondary structure was reported in the C1 region of 
the env gene (Peleg et al., 2002). This finding revealed the importance of the C1 region 
of the env gene compared with the less conserved C2-C5 region of the same gene (Peleg 
et al., 2002) implying the presence of a functionally important protein-coding region in 
the former. The functional role of these conserved regions has not been fully elucidated 
and illustrates the importance of evaluating nucleotide polymorphisms in conjunction 
with disease pathology to be relevant to the clinical setting. 
1.2.2.4 HIV entry and pathogenesis 
1.2.2.4.1 Transmission 
The terms 'immunological synapse' (y./eiss, 2003) and 'genetic bottleneck' (Leitner and 
Albert, 1999) have been applied to the process of viral transmission. HIV enters the 
host via one of 4 main routes; sexual, parenteral (IVD, blood and blood products), 
exposure in health care settings and mother to child transmission (Chakraborty, 2005, 
Weiss,2003). No evidence for transmission by insects has as yet been verified. 
More than 80% of infections are via sexual contact; 70% of which are vaginal and 10% 
anal (Roitt et al., 2001). HIV transmission is dose dependant with a probability of 
approximately 0.001 (95% CI 0.0008-0/0015) per sexual encounter (Gray et al., 2001). 
High viral loads, genital ulcers (Gray et al., 2001) and localised inflammation are 
primary determinants of transmission (Bhoopat et aI., 2001). Langerhans and dendritic-
type cells are, likely, the first to be infected (Bhoopat et aI., 2001). Increased 
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inflammation, characterized by elevated Langerhans and associated dendritic celis, was 
more common to HN-infected (83%) compared with -uninfected (21%) patients 
(Bhoopat et al., 2001). A 0.4-2.0% diversity separates the average genetic distance 
between the donor and transmitted viral variants (Leitner and Albert, 1999). Any 
ruptures in the mucosal barrier which expose susceptible cells in the sub-mucosa allows 
the entry and dissemination of viral particles following sexual exposure (Bhoopat et aI., 
2001, Pope and Haase, 2003). On the other hand, intact mucosal surfaces are no barrier 
to transmission in high-risk individuals. 
MTCT transmission is primarily vertical, during labour and delivery (66%), but may 
also occur perinatally in-utero or postnatal via breast-milk (BM) (Chakraborty, 2005). 
Perinatal maternao-foetal transfusion or compromise of the placental barrier, which 
allows virions to migrate trans-placentally to the foetus, promotes in-utero transmission. 
The most common means of MTCT occurs during labour when the infant skin or 
mucous membranes are exposed to maternal blood and other secretions (Chakraborty, 
2005). Finally, continued exposure of the infant to HN-infected BM results in variable 
transmission frequencies over the first year of life with the highest rates of 84% 
occurring by 12 months of age (Nduati et al., 2000). Recent findings have demonstrated 
exclusive breastfeeding for the first 6 months of life significantly reduces transmission 
rates when compared with mixed feeding in a South African population (Coovadia et 
aI.,2007). 
1.2.2.4.2 Early events following transmission 
The virus rapidly targets dendritic (DC), Langerhans (LC) and CD4+ T cells found in 
profusion in vaginal mucosa (Bhoopat et al., 2001, Collins et al., 2002b). Of the 
infected cellular population in the vaginal mucosal, 40- 60% are LCs compared to only 
30% T-cells (Bhoopat et al., 2001). Two models have been proposed to describe the 
immediate events following sexual exposure to HN (Fig. 1.4). The first contends that 
HN replicates at the site of infection for several days as demonstrated in SN models 
(Zhang et al., 1999) while the second proposes that HN is transported almost 
immediately to the lymph nodes where it is disseminated. Again, the latter contention 
was demonstrated in SN models where HIV was noted in the lymph nodes within 48 
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hours of exposure (Joag et aI., 1997) suggesting that a pre-existing inflammatory 
condition may have assisted in the rapid transport of the virus (Pope and Haase, 2003). 
Establishing HIV infection is complex and multi-factorial (Fauci, 2003) but occurs 
rapidly (Pope and Haase, 2003). Infection is initiated in the CD4+ T-Iymphocytes at the 
site of exposure (Pope and Haase, 2003). The virus rapidly installs itself in the lymph 
nodes where prolific replication, dissemination to lymphoid organs and establishment of 
disease ensues (Collins et al. , 2002b). Despite dissemination to possibly all organ 
systems, the foremost site of viral replication, storage and persistence remains the 
lymphoid tissue (Fauci, 2003, Pope and Haase, 2003). Macrophages and DCs appear to 
aid viral pathogenesis by recruiting and enhancing viral replication in T -cells without 
activating cellular defence mechanisms (Pope and Haase, 2003). 
The HIV -1 molecule enters the target cell via one of two mechanisms; namely by fusing 
with the cell membrane at the cell surface and releasing it's contents into the cytoplasm, 
or by endocytosis (Weiss, 2003). These mechanisms of entry occur with equal 
frequency in T-cells. They can occur independently, since fusion requires both CD4 
and related co-receptors, while endocytosis is facilitated by CD4 receptors only 
(Schaeffer et aI., 2004). The authors (Schaeffer et al., 2004) demonstrated that 
restriction of one mode of entry results in exploitation of the other. Most notable is the 
nef region which facilitates the endocytic trafficking of HIV (Geyer et aI., 2002). 
Earlier studies have also shown membrane and receptor mediated endocytosis and the 
occurrence of viral particles within endocytic vacuoles (Dezutter-Dambuyant et aI., 
1991, Pudney and Song, 1994, Tacchetti et al. , 1997). 
1.2.2.4.3 Cellular entry 
HIV entry into cells occurs when a tri-molecular complex forms between the gp120 
. region of the env gene, the CD4 receptor and either the chemokine co-receptor CCRS or 
CXCR4 (Fauci, 2003, Murphy, 2001). Stimulation by Ab additionally, enhances viral 
entry using Fc receptors indicating an alternative route of infection should CD4+ T-cells 






Figure 1.4: lllustration of the hypothesized cellular events following sexual transmission 
transmission of HIV -1. Adapted from Shattock & Moore, (Shattock and Moore, 2003) 
DCs, macrophages and T -cells expressing the CCRS molecule are initially targeted to 
establish disease (Pope and Haase, 2003) while viral gene products promote 
macrophage and DC association with T -cells in order to advance the infection. For the 
most part, the type of cells infected is determined by substrate availability. Isolates may 
be dual- (RSX4) or monotropic (RS or X4) and will be elaborated on in Section 1.2. 
The RS receptor molecule is imperative to viral entry such that individuals with a 32 
base pair deletion in the CCRS gene are highly resistant to infection despite repeated 
exposures (Fauci, 2003, O'Brien and Moore, 2000). These fmdings also illustrate the 
transmissibility of RS viruses compared with X4 variants which emerge later (Pope and 
Haase, 2003). Therefore, in addition to the normal loss of CD4+ T-cells, HIV 
preferentially infects and destroys this cellular SUb-population (Pope and Haase, 2003). 
In instances where the cells are infected with multiple provirus particles development of 
recombinant forms, greater viral heterogeneity, drug resistance and escape mutations 
may ensue (Weiss, 2003). 
The greatest paradox of HIV infection is the atypical stimulation of the immune 
response and the simultaneous depletion of immune cells (Fauci, 2003). The specific 
mechanisms by which HIV achieves cellular killing remain ambiguous but several 
alternatives seem likely. They include RNA and unintegrated DNA accumulation 
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within cells and intracellular binding of CD4 and gp120; infected binding uninfected 
cells leading to syncytium formation; gp12-specific CTL responses; surface-bound 
gp120 rendering cells vulnerable to Ab dependant cell-mediated cytotoxicity (ADCC); 
HIV peptides mimicking super-Ags resulting in expansion and eventual killing of large 
numbers of cells; apoptosis, and finally, budding weakening the cell wall (Roitt et al., 
2001). 
1.2.2.4.4 Viral tropism 
The env gene codes for two glycoproteins; the gp120 and gp41 the former responsible 
for host cell receptor binding and cellular tropism (Williams and Dye, 2003). Viral 
tropism determines the cellular sub-population that the virus will infect and is dependant 
on the HIV subtype, species of the host and the specific tissue that is infected (Cullen, 
2001, Huff, 2003). Entry and successful completion of the viral life cycle is 
determined by host cellular factors and co-factors (Cullen, 2001). 
HIV -1 tropism is extremely narrow both with respect to host species and tissue targets. 
Earlier studies in primate models identified the gag gene as the major determinant of 
HIV-1 species tropism (Cullen, 2001). Viral isolates can be categorised into either T-
cell or macrophage tropic phenotypes. The former refers to isolates able to replicate in 
T -cells, utilize the CXCR4 co-receptor, are highly sensitive to neutralisation by soluble 
CD4 and monoclonal Abs and their inability to induce syncytium formation in T-cell 
cultures. These viral isolates are referred to as non-syncytium inducing (NS!) variants. 
On the other hand, viral isolates that replicate in primary CD4 T cells" utilizes CXCR4 
co-receptor, and induce syncytia under similar conditions (Cullen, 2001) are referred to 
X-tropic or syncytium inducing (SI) variants (Huff, 2003). You have this paragraph 
mixed up. Macrophage-tropic variants also infect primary CD4 T cells (but not 
immortalized T cells) and are NSI. SI variants can infect CD4 cells (both primary and 
immortalized) but they do not infect macrophages. 
Factors conferring tropism were later localised to the V3 (third variable region) or the 
gp120 region of the env gene (Hwang et aI., 1991, O'Brien et al., 1990). HIV-1 
replication in vivo and in vitro is limited by its affinity for CD4 and the availability of 
cellular co-receptors (Cullen, 2001). Disease progression and end-stage disease is now 
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widely associated with a switch from an R5- to an X4-tropic variant (Jensen et al., 
2003) while early disease is characterised by isolates almost exclusively of R5-utilising 
phenotype (Cullen, 2001, Jensen et aI., 2003). It is theorised that a switch in tropism is 
a result of either selection pressure (drug or immune) or a reflection of the natural 
evolution of the virus. 
HN -1 SUbtypes also differ in their co-receptor usage, for example biological assays as 
well as bioinformatics analysis demonstrated that subtype B variants utilise either R5 or 
X4 co-receptors while subtype C variants are largely R5-tropic (Cullen, 2001, De 
Oliveira et al., 2003, Gordon et al., 2003, Johnston et aI., 2003). However, X4-tropic 
viruses have been reported in treated SUbtype C infected patients, in contrast to un-
treated patients with exclusively R5 (NSI)-tropic variants (Johnston et al., 2003). The 
syncytium inducing variants isolated from treated patients also displayed a propensity 
for the R5-coreceptor indicating circulation of dual-tropic variants in treated patients 
(Johnston et al., 2003). This has obvious bearing on vaccine and drug development. It 
has been suggested that characterising the mediators of syncytium formation would be 
an important step towards controlling infection since syncytium inhibition (SI) 
antibodies correlate directly with clinical outcomes in children (Brenner et aI., 1991). 
Several studies have described various mechanisms by which syncytium formation is 
inhibited and they relate to CD4 expression (LaBonte et al., 2003), DC-SIGN (Noble et 
aI., 2003) and antibodies targeting gp41 fusion intermediates (Golding et al., 2002). 
1.2.2.5 Viral kinetics and disease progression 
Viral kinetics studies have shown that viral replication is constant and drives CD4+ T-
cell turnover (Ho et aI., 1995). However, a limited number of virions infect non-
dividing cells, or ha subset of infected cells reverts to an inactive state giving rise to a 
popUlation of latently infected cells (Fauci, 2003). This pool of latently infected cells 
are capable of, and do migrate to various parts of the body. In this way, both cellular 
and anatomical reservoirs are formed. Latently infected patients display undetectable 
viral loads « 50-100 copies/ml), but quiescent infected cells produce a minute quantity 
of virions or transcripts (Pope and Haase, 2003). Activation of a latent reservoir and/or 
reactivation of virions that is complexed with follicular DCs, leads to the production of 
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infective virus (Pope and Haase, 2003). This inevitably culminates in viral rebound 
which may be delayed by months. Latently infected cells may, furthermore, playa 
prominent role in HIV dissemination since they feature significantly at transmission 
(Pope and Haase, 2003), while active cells expand the infection. 
Viral set-point defines the course of clinical disease. A higher set-point is associated 
with rapid immune-suppression, disease progression and a shorter period of latency 
(Hatano et al., 2001). Due to the rapid disease progression in paediatric patients, viral 
set point is short-lived while in adults is maintained through latency (Lifson et aI., 
1997). High viral loads that persist for the first 2 years of life in paediatric patients 
(Newell and Peckham, 1994) result in poor outcomes. This elevated viral load may be 
attributed to viral kinetics, the magnitude of HIV -permissive cellular population and the 
lack of appropriate and effective immune responses against the virus (Chakraborty, 
2005). 
1.2.2.6 Clinical features of infection 
Clinically, primary HIV infection manifests as malaise, muscle ache, swollen lymph 
nodes, sore throat and rashes (Roitt et al., 2001). Chronic infection without clinical 
manifestation persists for variable time periods but averages 10 years (Lama and 
Planelles, 2007). Delayed or long-term non-progression, where patients remain 
asymptomatic with no significant immune changes for up to and in excess of 10 years, 
occurs both in adults and children and in the absence of ARVs (Warszawski et al., 
2007). Progressive and late stage disease is characterised by fevers, night sweats, 
diarrhoea, weight loss and disorders affecting the mucosa and skin such as oral 
candidiasis, shingles, anogenital HSV and other dermatological infections (Roitt et al., 
2001). The impact of opportunistic infections (01) is felt throughout HIV pathogenesis 
due to reactivation of latent infection or to atypical opportunistic pathogens (Roitt et aI., 
2001). OIs are characteristic of late stage disease and the onset of AIDS. Disease 
progression in perinatally-infected infants is more rapid such that the number of HIV-
related deaths among children is 5-times the infection rates in this demographic 
(Barnhart et aI., 1996, Chakraborty, 2005). Paediatric disease manifestation is varied 
and includes hepatosplenomegaly, hepatitis, nephropathy, developmental delay, 
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recurrent bacterial infections and malignancies (Chakraborty, 2005). A primary co-
factor is tuberculosis particularly in developing nations where the bacilli are endemic. 
1.2.2.7 Other elements of the HIV immune response 
The primary characteristic of the HIV immune response is that it is depleted since the 
breadth of the immune response is diminished (Roitt et al., 2001). Both cell mediated 
and humoral immune factors are recruited against an HIV infection (Fauci, 2003, Letvin 
and Walker, 2003). 
1.2.2.7.1 Cytokines and chemokines 
Since chemokines and cytokines are integral to an effective immune response against 
infections (Murphy, 2001), viruses have devised means of corrupting their role through 
molecular mimicry of these peptides and their receptors (Murphy, 2001). These mimics 
can be categorized into 5 classes; anti-chemokines, leukocyte chemo-attractants, cell 
entry, cell growth and angiogenic factors. Cytokine and chemokine profiles of SIV 
infected primates during chronic infection, revealed a negative correlation between 
CD4+ T-cell counts and mRNA expression of, ILlO, MIP-1a, -1~ and Rantes 
(Hofmann-Lehmann et aI., 2002). Interestingly, cytokine and ~-chemokine production 
was not correlated with VL but with CD4+ cell counts. In this context, elevated IL-10 
levels and rapid disease progression was believed to result from increased immune 
activation and a shift from a Thl (IL12, IFNy) to Th2 immune responses. Hofmann-
Lehmann et al, (Hofmann-Lehmann et aI., 2002) propose that the discrepancy between 
Th1 and Th2 cytokines stems from increased Th2 cytokine production rather than 
insufficiency in their Th1 counterparts. 
Viral homologues include members of the CC and CR gene families, most notably, the 
CCR5 receptor molecule of HIV (Murphy, 2001). HIV tat, additionally, acts as a 
chemokine mimic in its extra-cellular state, where it may display chemotactic properties 
towards neutrophil, basophils, mast cells and monocytes and antagonistic properties 
towards CXCR4 (Murphy, 2001). The biochemical properties of X4 is a likely rationale 
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for the blockade reaction of tat towards these molecules, as compared to the more basic 
R5 molecule, that is induced to evolve over X4 or remains unaltered. 
1.2.2.7.2 Antibody responses 
There have been conflicting views on the role of antibodies (Ab) in the host's defence 
against HIV infection. In fact, related research has centred exclusively on the cellular 
immune responses. While it is known that neutralizing antibodies (nAb) recognise the 
V3 loop, CD4 binding site and gp4l transmembrane protein of the env gene (Letvin and 
Walker, 2003), their role in the control of viremia remains contentious. The highly 
immunogenic properties of the env have thus generated much interest with regards a 
vaccine candidate. Studies have demonstrated the production of nAb, specifically, 5 
monoclonal Ab's, in the sera of HIV-infected patients (Moore et al., 2001). It is 
expected, unfortunately, that nAb's may not prove viable since extremely high titres are 
required to generate a response (McMichael and Hanke, 2003). Furthermore, HIV is 
easily and rapidly able to generate polymorphisms or antigenic variants to escape these 
nAb. 
1.2.2.7.3 Cytotoxic T-lymphocytes and MHCs 
In contrast, virus specific CTLs pose a strong immune response and have been observed 
at all stages of infection (Letvin and Walker, 2003). More importantly, CTLs are found 
in all anatomic compartments including blood, pulmonary spaces, lymph nodes, spleen, 
skin, CSF, semen, vaginal and GI mucosa (Letvin and Walker, 2003). Control of 
viremia particularly at the early stages of infection is positively correlated with the 
emergence of a CTL response giving rise to the current widely-held assumption that a 
strong T-cell response will initiate abortive infection or control viremia (McMichael and 
Hanke, 2003). Animal models show that vaccinated individuals display significantly 
lower viral loads than unvaccinated controls, even up to 1000 fold less (McMichael and 
Hanke, 2003). Within 6 hours memory T-cells mature and are activated by Ag to 
produce cytokines (TNFu, IFNy), chemokines (RANTES, MIP-lu, -l~) and cytolysins 
(granzymes, perforin) (McMichael and Hanke, 2003). Among the HIV regions targeted 
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by vaccine design are the nef, reverse transcriptase (RT) and env genes (McMichael and 
Hanke, 2003). It must be remembered, that while CTLs seem the answer to the HIV 
epidemic and unquestionably do stimulate a strong immune response, they cannot 
prevent HIV infection as nAb can (McMichael and Hanke, 2003). This is due to the 
fact that CTLs only react to peptides presented by cells already infected by HIV. Since 
full anti-viral activity takes days to develop they serve to control disease, not protect 
against infection. 
The MHC Class I alleles additionally, are predictive of the rate at which disease 
progresses, are the major determinant of the specific viral peptides presented and direct 
the scope of the immune response (Letvin and Walker, 2003). The inherent variability 
of these alleles in a population confers variable responses as exemplified by diverse 
outcomes and rates of disease progression in HIV-infected individuals. Selected HLA 
alleles, for instance HLA-B5701, are associated with long-term non-progression to 
AIDS (Migueles et al., 2000). MHC molecules and the CTL response are purported to 
present the most promising answer to effectively containing and/or eliminating HIV 
infection. In MTCT, the commonality between infant and maternal HLA-c1ass 1 
molecules is high, allowing the virus to evade the host immune response in the infant 
and culminating in accelerated rates of disease progression in this demographic 
(Goulder et al., 1996). 
Although HIV targets CD4+ T -cells, these cells do playa significant role in the immune 
response against HIV. The focus of research efforts from the onset has, thus, been the 
lymphocyte population but it is now hypothesised that the T-cell infection is the 
observable pathology obscuring the more insidious macrophage disease (Weiss, 2003). 
1.2.2.8 HIV immune escape 
Despite evidence for both cellular and humoral immune responses against HIV, the host 
still fails to stem disease progression (Letvin and Walker, 2003). The most likely 
rationalization is the emergence of genetic mutants in selected epitopes that allow these 
isolates to escape the immune response. These mutants, stimulated by immune or drug 
selection pressure, can out-compete wild-type virus (Letvin and Walker, 2003). It is for 
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this reason, amongst others, that a lasting vaccination, and the development of an 
appropriate vaccine, has proven so complex. Susceptibility and resistance to viral 
infection is complex and made more difficult by the diversity in viral and HLA-genes 
(Letvin and Walker, 2003). 
1.2.2.9 HIV treatment 
Current approaches to treatment include adaptive therapy, cytokine therapy, therapeutic 
immunization, combination highly active anti-retroviral therapy (HAART) and 
treatment interruption (Letvin and Walker, 2003). The drug azidovudine (zidovudine, 
AZT) targeting the HIV reverse transcriptase was the first effective drug to be 
implemented in 1987 (Fauci, 2003), resulting in short-term outcomes of reduced 
mortality rates and delayed progression to AIDS (Roitt et al., 2001). Targeted drug 
design yielded more effective drugs aimed at disrupting susceptible sites in the viral 
replication cycle. These include the protease, fusion and entry inhibitors (Fauci, 2003). 
Reducing HIV viral loads, to levels below 1500 copies/ml or lower , to undetectable 
levels, is the aim of ART therapy (Pope and Haase, 2003). In addition to the obvious 
clinical benefits, slowing the replication rate of HIV assists in reducing the rate of 
mutation and consequently, the rate at which immune-escape and drug resistant mutants 
emerge (Roitt et al., 2001). Greater understanding of the cellular and humoral immune 
responses has yielded promising targets for future drug interventions and vaccines 
(Letvin and Walker, 2003). The most encouraging is a combination of a T-cell epitope 
and a strong Ab-stimulating vaccine (McMichael and Hanke, 2003). Whether co-
operation between these tenets will yield a vaccine remains to be seen. 
Nucleotide and amino acid polymorphisms resulting from drug selection pressure have 
been described (Gordon et al., 2003) but the greater danger is the emergence of multi-
drug resistant strains (Weiss, 2003) in the wake of large-scale ARV interventions. 
While it is important to treat every infected individual, it is equally important to treat 
these patients optimally, since sub-optimal drug levels result in rapid generation of 
resistance mutations. It is, thus, critical that compliance be monitored and sharing of 
drugs is prevented (Weiss, 2003). Unfortunately, the high costs of ARV treatment and 
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monitoring are prohibitive in developing countries. Despite setbacks, the SA-ARV 
rollout was implemented in 2003 and has gained momentum in recent years (AFSA, 
2005). In January 2005, approximately 29 000 HIV-infected persons were on treatment 
nationally; 8467 of whom were from KZN and the majority were adults (AFSA, 2005). 
The significant discrepancy between infected patients requiring treatment and those 
receiving treatment, persists but the inequity between them, is closing. 
1.2.2.10 HIV-l Compartmentalisation 
HIV populations are homogenous only at primary and end-stage disease (Leitner and 
Albert, 1999). The high rate of viral replication and accumulation of mutations typical 
of HIV generates highly diverse or heterogeneous sequence populations at other stages 
of disease (Collins et aI., 2002a). HIV -1 disseminates to various organ systems leading 
to compartmentalization and divergent evolution of subpopulations or quasi-species 
(Collins et al., 2002a). Migrations of these variants may proceed unrestrained from 
discrete locations into circulation and vice-versa encouraging greater systemic 
heterogeneity and divergent evolution at these isolated sites (Collins et aI., 2002a, 
Delwart et al., 1997). Quasi-species are, thus, discrete, subpopulations of those in 
circulation or phylogenetically related to virions evolved independently in tissue 
compartments such as the pleura and lungs in TB co-infected patients (Collins et al., 
2002a). Both spatial and temporal intra-patient phylogenetic fluctuations occur 
commonly as a consequence (Grenfell et aI., 2004). Of the many remote compartments 
studied thus far, the brain (Korber et al., 1994, Sanjuan et al., 2004), semen (Alimonti et 
al., 2003, Choudhury et aI., 2002, Delwart et al., 1998) and lymph nodes are the only 
confirmed discrete HIV compartments (Korber et al., 1994). Other organ systems that 
may form compartments include the lungs (Collins et al., 2000, Collins et al., 2002a), 
genital tract (Poss et al., 1998) and blood (Zhu et al., 1996). Autopsy specimens 
confirm viral sequestration and heterogeneity in the brain, lung and testis (Collins et aI., 
2002a, van't Wout et al., 1998). Van't Wout, et al (467) reported viral quasi species in 
blood that are phylogenetically related to virions evolved independently in tissue 
compartments such as the pleura and lungs. Whether the same is true about the spine 
has not been investigated. 
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Bearing in mind that viral diversity, which is influenced directly by mutation rate, is 
positively correlated and proportional to the number of rounds of replication, it follows 
that viral heterogeneity will be compounded temporally (Mani et al., 2002). In 
addition, Mani et al, (Mani et aI., 2002) correlated greater divergence with viral load, 
but could not determine whether differences in diversity and viral load were gender 
dependant. 
At transmission, HIV populations are homogenous or less diverse, but change 
temporally, becoming progressively more heterogeneous (Learn et al., 2002, Meyerhans 
et aI., 1989). It has been argued that the stage of disease and occurrence of quasispecies 
are not correlated, and that vast differences are detected between different isolates 
(Meyerhans et al., 1989). The assumption that a single variant is transmitted to 
establish disease (Leitner and Albert, 1999) has generated much controversy. It is 
argued that an early selection process that targets functionally important sites in the env 
and gag genes produces a more homogenous viral population early in infection (Learn 
et aI., 2002). On the other hand, co-infections, particularly TB, greatly influence HIV 
evolution and diversity, and is mediated by constant localised immune stimulation 
(Collins et aI., 2002a). 
TB co-infection increases HIV viral loads by up to 160 fold, which may be reversible 
following anti-TB therapy (CIPLADOC, 2001/2002). Immune stimulation, especially at 
low levels, impacts viral adaptation, due to the high selective pressure exerted on the 
viral genome (Grenfell et al., 2004). Higher viral diversity in actively infected TB 
patients, is promoted by the microenvironment (granulation tissue) created by the 
bacillus itself (Collins et aI., 2002b, Garrait et aI., 1997). Hence, TB acts to increase 
viral replication and subsequent viral diversity in two ways - it induces HIV replication 
in activated, infected immune cells (Toossi et aI., 2001) and encourages secretion of 
stimulatory cytokines and chemokines, such as TNF-a, a recognised promoter of HIV 
replication (Collins et al., 2002b, Garrait et al., 1997, Raja, 2004). Collins, et al 
(Collins et aI., 2002b) reported an association between tissue-localized immune 
stimulation and greater viral heterogeneity, higher viral loads and altered cytokine 
profiles. 
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Although the increase in viral replication rates and sequence heterogeneity is reversible 
in patients with acute immune stimulation (Ostrowski et al., 1998), the same has not 
been verified in chronically infected patients such as those with TB (Collins et aI., 
2000). In some instances, co-infection paradoxically results in slower disease 
progression, high CD4 counts and low viral loads but a more rapid accumulation of HIV 
sequence heterogeneity (Collins et al., 2000, Meyerhans et al., 1989). 
1.2.2.10.1 HIV heterogeneity and the immune response 
It has become increasingly evident that identifying and analysing viral reservoirs is 
important to present understanding of intra- and inter-patient HIV evolution and 
phylodynamics. Not only do these compartments impact on treatment, but also on 
patient outcomes, as escape mutants generated at these remote sites may become 
dominant with progressive disease or following treatment. Adaptive events that 
generate escape mutants occur every 25 generations (Williams and Dye, 2003). This is 
the most rapid adaptation rate ever recorded producing a sizeable viral population that is 
inaccessible to the immune response (Williamson, 2003). Treatment and patient 
outcomes are thus greatly impacted since CTL's control virema, and persistence of 
infection (Borrow et aI., 1997). 
HIV genetic variants differ in their replication efficiency, cellular tropism and their 
sensitivity to immune selection pressures (Korber et al., 1994, van't Wout et al., 1998). 
Effective treatment of HIV, with current and future drug regimes, can only be achieved 
if treatment reaches all infected cells (macrophages or T-cells) which, van't Wout et aI, 
(van't Wout et aI., 1998) suggest is a likely reservoir within non-lymphoid tissue. 
Cosenza et aI, (Cosenza et al., 2004) illustrated the potential of macrophages and 
microglial cells as viral reservoirs and demonstrated their resilience against apoptosis. 
Macrophage tropic isolates (CCR51R5 exploiting) are the predominant cell population 
in TB-infected individuals (Santucci et al., 2004). HIV-l replication and consequent 
increased R5 expression was demonstrated in M. avium-infected cells (Wahl et aI., 
1998). In contrast increased CXCR4 (X4) expression was demonstrated in AMs of 
pulmonary MtblHIV -infected patients (Hoshi no et al., 2002). Differences between 
these findings may be a result of an in vitro versus an ex vivo assay, and an M. avium 
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versus an Mtb infection. It may, additionally, reflect an expansion of the initial 
infecting variant rather than a switch from one co-receptor usage to another. Still others 
report expansion of R5 tropic variants (Morris et aI., 2001, Santucci et al., 2004). 
Morris et al (Morris et al., 2001), in a South African cohort of HIV subtype CffB 
infected individuals, demonstrated that, despite advanced disease, no change in co-
receptor usage occurred. Their findings would suggest that R5-utilising macrophage-
tropic variants were preferentially amplified. This is also consistent with other reports of 
limited prevalence of X4 variants in sUbtype C populations (Gordon et aI., 2003, Tien 
et al., 1999) with few exceptions (Shankarappa et aI., 2001). 
When disease is established the tropism of virions is restricted to the particular cell 
population that carried the virus into the compartment therefore a distinct "clade" with 
corresponding tropism emerges (Korber et al., 1994). Indeed, immunohistological 
staining of brain tissue correlated a greater population of macrophages and microglial 
cells with distinct separation / compartmentalisation of brain and blood viral variants 
while lymphocyte infiltration of the tissue was correlated with intermingling or 
migration between the compartments (Korber et al., 1994). Similarly, macrophage 
tropic variants form clear subsets in the nervous system and testicles of isolates from 
autopsied individuals (Collins and Kaufmann, Collins et aI., 2002a, Sanjuan et aI., 
2004) were unable to conclusively demonstrate compartmentalisation of HIV in pleural 
tissue, a site that is infiltrated by activated leukocytes in response to TB infection. 
Spinal tissue on the other hand is infiltrated by macrophages that mature to giant cells 
and epithelioid cells. It is thus most likely that the predominant cell type infiltrating the 
infected tissue is one of the primary determinants of tissue-localised divergent HIV 
evolution. It was noted that the cells infiltrating the TB-infected tissue were activated 
leukocytes, a large proportion of which would be HIV -infected and would not have 
been present prior to TB infection (Collins et al., 2002a). Furthermore, the close contact 
between HIV-infected lymphocytes and TB-infected macrophages at the site of 
infection invariably leads to interaction between them and ultimately to HIV 
transmission, activation and up-regulation (Collins et al. , 2002b). 
Sequence analysis largely ignores the structural implications of amino acid 
polymorphisms and incorrectly assumes site-specific amino acid substitution models to 
be uniform or homogeneous (Yang, 2000). Codons can undergo positive, negative or 
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neutral selection. Codon substitution models measuring the selective constraint on a 
protein, calculates the ratio of non synonymous / synonomous (dn/ds) mutation. A 
nonsynonymous mutation is neutral if m = 1, positive or advantageous if m >1 and 
purifying or deleterious if m<l (Yang, 2000). Positive selection refers to amino acid 
polymorphisms that confer a fitness and/or virulence advantage to the isolate. In 
addition, chemical properties of an amino acid, may be more informative than the rate 
of substitution itself (Yang, 2000), since amino acids with similar chemical properties 
seem more inclined to replace each other in order to preserve the functional integrity 
and fold conformation of the peptide. Chemotherapy and immune selection pressures 
are most commonly implicated as strong inducers of positive selection and viral 
evolution. Due to its importance to the immune response, changes in receptor fit and 
evasion of the immune response are potential sources of positive selection (Williamson, 
2003). It has been shown that transmission is a neutral event where selection pressure 
has no influence on the overall substitution rate (Leitner and Albert, 1999). Fixed 
substitutions therefore survive transmission. However, it is deceptive to assume that the 
transmitted isolate is the dominant donor variant (Leitner and Albert, 1999). Leitner 
and Albert, (Leitner and Albert, 1999) also contend that viral evolution is a neutral 
event where nucleotide substitutions are a stochastic rather than a deterministic 
phenomenon. 
The phenomenon of variable positive selection and evolutionary rates is reiterated at 
different protein coding regions over the entire HIV genome (De Oliveira et al., 2003). 
Studies have demonstrated that different regions of the env gene experience varying 
rates of positive selection (Mani et aI., 2002, Williamson, 2003). Surprisingly, the V1-
V2 region has the highest adaptive rate (1 eventl2.5 months) followed by the C2-V3 (1 
eventl5.9 months.) and V4-V5 regions (1 eventl12.2 months.) (Williamson, 2003). 
Accordingly, calculating the rate of positive selection over the entire HIV genome, or a 
substantial portion thereof, may not fully illustrate selection pressures exerted at specific 
sites. There are strong associations between the stage of disease and the frequency and 
strength of positive selection (Ross and Rodrigo, 2002). Computational analysis of HIV 
SUbtype Band C sequences revealed that tat and rev, rather than the env gene is under 
positive selection (De Oliveira et al., 2003). The findings of these studies have 
illustrated viral diversity in, predominantly SUbtype B isolates and from patients in the 
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acute or late stage of disease. The dynamic, is expected, will be vastly different in 
patients in the disease-free stage of HIV infection (Mani et al., 2002). 
1.2.3 HIV and TB co-infection 
1.2.3.1 Historical Perspective 
Opportunistic infections (Ol) are, by definition, exploitative organisms and the 
explosive HIV epidemic has provided, potentially, more than 40 million immune-
compromised hosts (Weiss, 2003). The 01 most often associated with HIV is TB 
(Narain and Lo, 2004). Mammals susceptible to lentiviruses such as HIV are also 
vulnerable to Mycobacterial infection (Collins et al., 2002b). Early in the HIV/AIDS 
epidemic, co-infection with atypical Mycobacteria such as M. avium-intracellulare and 
the M. avium complex were reported, but it was only in recent years that HIV and Mtb 
has been significantly associated (Smith, 1991). The risk of developing active disease 
increases with progressive immune-suppression. 
1.2.3.2 Epidemiology of co-infection 
At present 2.5 million of the 1 billion individuals infected with TB are co-infected with 
HIV (Narain and Lo, 2004). Sub-Saharan Mrica is severely affected, with 40% of all 
TB cases in the region associated with HIV. The equivalent global figure lies at a mere 
8% (WHO, 2002). A Nigerian study placed the HIV-prevalence among TB-infected 
patients between 1990 and 2002 at 28% (Seleye-Fubara and Etebu, 2004). Overall, in 
excess of two-thirds of the 15 million co-infected patients worldwide, reside in sub-
Saharan Mrica (WHO, 2006). Global estimates places the percentage of all new TB 
cases attributed to HIV at 9% while in Mrican countries this may be as high as 31 %. 
HIV is recognised as the single most important determinant of the escalation in TB 
incidence in Africa (WHO, 2004). There has been a 7-fold increase of TB cases in the 
worst affected countries such as Vietnam (Nguyen et al., 2004) a burden against which 
current treatment strategies are proving ineffective. Add to this the fact that 15% of all 
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AIDS deaths are due to TB and one is able to appreciate the devastating impact of 
HIV ffB co-infection. In fact, HIV increases the risk of developing active TB by a 
factor of 20 (Collins et al., 2002b). While HIV -uninfected patients are at a 10% lifetime 
risk of developing TB, HIV -infected individuals stand a 10% chance per year and a 
60% lifetime risk of progressing to active disease (Nguyen and Pieters, 2005, 
CIPLADOC, 200112002). Interestingly, the Eastern Mediterranean, despite 
acknowledging TB as a serious health hazard in the region does not acknowledge any 
impact of HIV on TB epidemiology (Gillini and Seita, 2002). However, concerns are 
currently mounting, that the impact of co-infection, particularly in light of the explosive 
SUbtype C epidemics in Asia and sub-Saharan Africa will become increasingly 
significant (Collins et al., 2002a, Montano et al., 1997). Indeed, the UK cites TB as the 
leading cause of HIV related deaths and the most common AIDS defining condition of 
2002 (Health_Protection_Agency _Tuberculosis, 2004). It is an unfortunate reality that 
the marginalized popUlations of the world that are most affected by the HIV and TB 
epidemics. Limited access to education and treatment strategies is the primary 
impediments (Narain and Lo, 2004) to making an effective impression on these 
epidemics. However, interventions can be successful and to date, Kerala (India) and Sri 
Lanka have reduced their HIV and TB burdens (Zaidi et aI., 2004). 
HIV has impacted the balance between TB-infected and uninfected individuals, as well 
as the epidemiology, natural history and clinical evolution of Mycobacterial infections 
(de 0 Liverato et aI., 2004). Highest rates of co-infection occur in younger individuals 
(25-44 year age group) while TB alone seems confined to older individuals (de 0 
Liverato et al., 2004). In view of the fact that the 24-44 year age group represents the 
most economically viable demographic of any country, depletion of their numbers 
would result in significant social, economic and political consequences. Most alarming 
is that the spread of infectious and highly virulent strains of, both HIV and TB, may 
parallel the increase in human migration and travel (Ahmed et aI., 2003). In Africa, 
where the HIV pandemic is rampant, infectious diseases are on the increase. The dire 
prediction of an explosion in TB infections, appearing as and when HIV becomes 
established, has already manifested in Southern Africa and South East Asia. The impact 
on the young is equally alarming. In Jamaica, significant increases in the incidence of 
active TB were noted from 1999 to 2002 among children, all of whom received the 
BCG vaccine (Geoghagen et aI., 2004). Of these, 46% were HIV -infected, experienced 
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more severe disease pathology and a higher mortality rate (Geoghagen et al., 2004). 
Similarly, HIV rrB co-infection occurred in 48% of a paediatric cohort from Durban, 
South Africa (Jeena et aI., 2002) illustrating that co-infection was more common than 
previous estimates. The authors reaffirm that the disease pathology among dually 
infected children is often acute (43%) and misdiagnosed (21.2%) requiring extreme 
diligence in order to reduce patient morbidity and mortality in the HIV -infected patients 
(Jeena et aI., 2002). Collectively, these studies suggest that a region with an explosive 
HIV epidemic is likely to experience an elevated TB incidence (Narain and Lo, 2004). 
1.2.3.3 Pathology of co-infection 
On acquiring HIV, progression to active TB occurs rapidly (Narain and Lo, 2004). The 
profile of opportunistic infections (01) among HIV infected children differs from that of 
HIV-infected adults (Mofenson et aI., 2004). Adults acquire Ors prior to HIV infection 
whereas children manifest a primary infection when their immune response is greatly 
depleted from an established HIV disease. Children are liable to manifest non-
pulmonary diseases particularly in reference to TB (Mofenson et al., 2004). In contrast 
to other Ols, TB occurs at all stages of HIV infection (Toossi, 2000). Recent findings 
from HIVIM. Zeprae infected patients suggests that each disease progresses as a single 
infection (Pereira et aI., 2004). Cell mediated immunity is impaired resulting in both 
qualitative and quantitative defects in the CD4+ T-cell population (Seligmann et aI., 
1987). 
Recently it was shown that HIV -1 replication was inhibited in monocyte-derived-
macrophages that were stimulated by heat-inactivated Mtb and culture filtrates (Goletti 
et al., 2004). The authors established that inhibition of replication occurred soon after 
viral entry and hypothesise that HIV replication is suppressed by Mtb-induced soluble 
factors. In an earlier publication, Goletti et al (Goletti et al., 1998) investigated the 
influence of cytokines on TB-induced HIV replication. Their findings indicated that 
inhibition of IL-2, ll-lP and TNF-a resulted in a decrease in TB-associated HIV-1 -
replication. IL-lO and TGF- p neutralisation on the other hand, enhanced HIV 
replication (Goletti et al., 1998). These findings contradict conventional understanding 
that co-infection manifests as a more severe pathology with enhanced viral replication. 
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Indeed, 5-160 fold increases in viral replication rates were recorded in co-infected 
patients during the acute phase of TB pathogenesis (Goletti et al., 1996). The rate of 
replication in these patients was influenced by previous TB purified protein derivative 
(PPD) sensitisation and level of cellular activation (Goletti et al., 1996). 
In adults, co-infection, most probably arises from a reactivation of latent TB while in 
new infections, disease progression is much more rapid than in HIV -un infected patients 
(Ahmed and Hasnain, 2004) (Kabra et al., 2004). Similarly, co-infected children 
experience a much more severe, more disseminated disease particularly (Swaminathan, 
2004). While pulmonary TB has a non-specific presentation (Raja, 2004), it is 
contended that HIV -infection does not influence clinical manifestation (Mofenson et al., 
2004). This is indeed debatable. The clinical profile of TB is said to be changing 
(Kabra et al., 2004) particularly among children who experience a more rapid 
progression to death, compared with HIV -uninfected paediatric or adult patients 
(Swaminathan, 2004). In both adults and children, the clinical manifestation of a TB 
infection is directly related to the degree of immune-suppression (Smith, 1991). 
Moreover, delayed diagnosis and/or diagnostic errors delay treatment interventions 
(Kabra et aI., 2004) (Narain and Lo, 2004). Included among the primary reasons for 
diagnostic difficulties are greater incidence of sputum negatives among the co-infected, 
non-specific X-ray findings, non-specific clinical presentation (Smith, 1991) and other 
pulmonary infections (Narain and Lo, 2004). Diagnosis is dependant on bacterial 
isolation from clinical samples, but clinical specimens are often AFB negative in co-
infected patients. 
Clinical outcomes are very poor in dually infected patients since HIV and TB each 
advance the progression of the other (Gayle and Hill, 2001). HIV co-infection has been 
cited as the most important risk factor associated with reactivation of latent TB infection 
(de 0 Liverato et al., 2004). The specific manifestations of HIV-associated TB and 
non-HIV-associated disease, remains contentious. By and large, early features in co-
infected individuals resemble that of TB+ IHIV- patients, while a more advanced phase is 
typified by unusual clinical findings stemming from a depletion of CD4 cells (de 0 
Liverato et al., 2004). 
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Approximately 50-72% of patients with extreme immune suppression manifest extra-
pulmonary TB infections consequently these infections are included among AIDS-
defining conditions (Smith, 1991). The most common site of extra-pulmonary TB 
associated with HIV is the lymph node (27-33%) (Sharma and Mohan, 2004, Smith, 
1991) and other sites include neurological tissue, pleura, pericardia and abdominal 
systems. Despite the parallel emergence of the HIV and pulmonary TB pandemics 
globally, similar trends could not be established with spinal TB and HIV in developed 
nations (Pertuiset et al. , 1999). In a retrospective study (Pertuiset et al., 1999) of spinal 
TB over the period 1980-1994 none of the patients were HIV positive. 
In light of their extreme immune-suppression, HIV -infected patients at late-stage 
disease, become susceptible to virtually any opportunistic pathogen (Smith, 1991) even 
the most seemingly innocuous organisms. Just as HIV heterogeneity is increased by TB 
co-infection, distinct TB genotypes have been demonstrated in HIV infected and 
uninfected patients (Ahmed et aI., 2003) and were correlated with host immune status. 
It is, therefore, proposed that a favourable microcosm for TB evolution, particularly of 
less virulent strains, is provided in an HIV -infected host; where immune selection 
pressure is weakened or absent entirely (Ahmed and Hasnain, 2004). Infection with 
isolates belonging to the Mycobacterium avium complex (MAC); include M. avium and 
M. intracellulare; occur at greater frequency with increasing age and decreasing CD4+ 
T-cell counts (Mofenson et aI., 2004). Organisms such as M. kansasii, M. gordonae, M. 
xenopi, M. fortuitum, M. chelonei, M. haemophilum and M. bovis are all non-pathogenic 
environmental Mycobacteria, not commonly associated with human disease. However, 
their association with disseminated TB pathogenesis in HIV -infected individuals is 
escalating (Smith, 1991). The spread of these less virulent strains can be rapid and 
extensive particularly with strong international economic, social and travel links of 
modern society. The South African setting, with its explosive HIV epidemic and high 
index of exposure for Mycobacteria and opportunistic pathogens, is likely to mirror this 
emergence of less virulent or atypical Mycobacterial infections. 
1.2.3.4 HIV ffB co-infection and the immune response 
It has been demonstrated that HIV/pulmonary TB co-infection produces overlapping 
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and distinctive immune responses (Hertoghe et aI., 2000). Commonality between the 
HN and TB immune responses and pathogeneses include a significant reliance on CMI 
(Narain and Lo, 2004). Moreover, CD4+ cells are an absolute requirement to an 
efficient immune response to TB (Scanga et aI., 2000). However, HN decimates this 
cellular subpopulation (Narain and Lo, 2004, Raja, 2004). Consequently, disseminated 
disease cannot be prevented. 
It is hypothesised that the CD4+ T cell population is responsible for maintaining TB 
latency in infected individuals and preventing disease reactivation (Scanga et aI., 2000). 
This contention was investigated in a murine model of latency, where it was 
demonstrated that IFNy, iNOS and macrophage activation were unaffected by CD4+ 
depletion but disease pathology was advanced and fatal. The apparent conclusion is that 
CD4 + T -cells are required to maintain latency, the mechanisms of which surpass mere 
IFNy production and macrophage activation (Scanga et al., 2000). The failure of the 
immune response is postulated to encompass several factors such as CD4 + T cell 
depletion effecting up-regulation of macrophage deactivating cytokines and possible 
loss of CD8 cytolytic function (Scanga et aI., 2000). 
Recent findings have shed light on the persistence of TB in macrophages and 
contributed significantly to present understanding of the host effecter mechanisms of 
TB and TBIHN co-infection (Cassol et al., 2005, Toossi et al., 2004a). Macrophages 
are known primary reservoirs of TB infection (Russell, 200la) and have been recently 
implicated as cellular reservoirs of HN -1 infection (Cassol et al., 2005). 
Mycobacterium tuberculosis infected monocytes and alveolar macrophages (AM) are 
able to activate the HIV-LTR region in the presence or absence of HN tat which is 
mediated by TNF-a (Toossi et al., 2004a). Thus, Mtb infected monocytes and 
macrophages can transactivate HN in latently infected cells (Toossi et al., 2004a). On 
the other hand, TNF-a, is correlated with NO production (Sharma and Mohan, 2004) 
and plays an important immune-modulatory role in TB clearance and control of disease 
progression. Interestingly, TBIHN co-infection stimulates greater cytokine responses, 
as measured by IFNy and TNFa than HN -infection alone and this response is 
reconstituted following ARV therapy (Oh et al., 2005). This was furthermore, 
demonstrated in patients with CD4 cell counts of <200 cells/mm3. Moreover, TB 
increases the susceptibility of lymphocytes to HIV infection (Santucci et al., 2004). 
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Similarly, a depressed Thl immune response, characteristic of HIV infection, results in 
increased susceptibility to TB (Sharma and Mohan, 2004). 
It has been shown that CD4+ and CDS+ T-cell counts are lower in dually infected, 
compared with HIV or TB infected individuals (Rodrigues et al., 2003). This is an 
expected finding. However, the authors report varying degrees of decline in CD4 levels 
in naive, memory and effecter cellular populations, which was independent of single 
(HIV or TB) or dual (HIVrrB) infection. The depletion of CD4+ cells is reflected in a 
failed immune response and poor granuloma formation (Raja, 2004). Despite 
considerable decline in CDS+ T-cell numbers activation status is elevated in HIV+rrB+ 
patients even in excess of HIV -infected patients, which was attributed to the co-
circulation of HIV and TB in the patients studied (Rodrigues et al., 2003). It was 
recently demonstrated that the activity levels of NK and CDS+ cells rather than the 
number of cells, is more significant to the immune response (Raja, 2004). CD4 
depletion without concomitant reduction in IFNy levels alludes to other possible 
producers of IFNy including macrophages, CDS+, NK and CD4-CDS- T-cells (Fremond 
et al., 2004). As a consequence of gp120 protein of HIV env gene binding to the CD4+ 
receptors, Ag presentation of TB peptides by MHC Class II molecules, is impaired in 
co-infected patients (Raja, 2004). 
In HIV infected spinal TB patients, CD4+/CDS+ lymphocyte ratios were reversed, with 
significantly lower CDS+ counts (p<0.05), which was strongly associated with mortality 
rates (Govender et al., 2001a). Thus, CD4+/CDS+ cell counts remain the primary 
determinant of outcomes and mortality rates (Narain and Lo, 2004). In direct contrast, 
it was demonstrated, in a South African cohort, that higher mortality rates were 
associated with CD4+ T-cell counts of >200cells/~ and those not at advanced 
disease/AIDS at baseline (Badri et al., 2001). In another South African cohort, IFN-y 
was inversely correlated with CD4 counts (Mayanja-Kizza et al., 2001). 
1.2.3.5 Combining Anti-retroviral therapy (ARV) and TB chemotherapy 
Of the 25 countries with the highest HIV prevalence, only 4 have achieved their TB 
treatment targets as outlined by the WHO (Maher et al., 2005). Response to anti-TB 
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chemotherapy is similar in HIV -infected and uninfected persons and its efficacy is not 
dependant on degree of immuno-suppression (Narain and Lo, 2004). However, adverse 
effects arising from TB treatment are common to HIV-infected patients (Narain and Lo, 
2004, Pereira et al. , 2004). This is believed to be a consequence of immune 
reconstitution triggered by ARVs. 
It has been proposed that combining anti-retrovirals (ARV) and TB chemotherapy could 
save up to 500000 dually infected African people (WHOIUN, 2004). Fewer than half 
the global HIVtrB co-infected patients are receiving anti-TB therapy. This is despite a 
much lower cost compared with ARV therapy (WHOIUN, 2004). It is only with 
collaboration between TB and HIV treatment strategies that any impact can be made on 
this dual epidemic. Interventions that may prove useful include simultaneous ART, 
increased rates of TB case finding, and preventative therapy in the form of isoniazid and 
cotrimoxazole (Maher et aI., 2005, Mwaungulu et al., 2004). Cotrimoxazole is, in fact, 
a potent anti-TB chemotherapy, implementation of which resulted in notable reductions 
in mortality rates and dramatically improved outcomes, in co-infected patients in a 
Malawian cohort (Mwaungulu et aI., 2004). One of the primary constraints to treatment 
delivery remains delayed diagnosis. Therefore, in order to prevent transmission to 
patient contacts including health workers, it is recommended that TB treatment be 
initiated in the interim, based on a high index of suspicion rather than conclusive culture 
or microscopy (Smith, 1991). 
Unfortunately, drug therapy is more complex in the HIV -infected, since protease 
inhibitors (PI) and non-nucleoside RT inhibitors (NNRTI) , prescribed as part of 
antiretroviral therapy (ART) interacts adversely with rifampicin (Narain and Lo, 2004). 
Combining these drugs results in increased anti-TB drug-related toxicity and delivery of 
ARTs at sub-therapeutic levels (Small and Fujiwara, 2001). While complex, 
combining therapies is not impossible but necessitates a complete understanding of the 
related drug interactions. It is however, recommended that protease inhibitors be 
administered after completion of the TB chemotherapy (Narain and Lo, 2004) and that 
HAART is initiated early in the treatment of co-infected patients with CD4 counts :s 100 
cellslJlI (Kwara et al., 2004). Of course this study was conducted in a developed nation 
with an HIV SUbtype B epidemic and outcomes may differ when compared to those in 
the KZN SUbtype C endemic region. The phenomenon of the paradoxical reaction, 
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where patients receiving HAART become non-responsive to anti-TB treatment, results 
in a more disseminated and severe pathology (Breen et aI., 2004). 
1.2.4 Microscopy and disease pathology 
The utility of microscopy over other more widely applied methods such as flow 
cytometry, has been demonstrated, displaying the ability to discern specific cellular 
morphologic features, otherwise indistinguishable by any other means (Giuliani et aI. , 
2001). 
1.2.4.1 Light microscopy 
Diagnosis of TB remains problematic since current methods may be time-consuming, 
non-specific, of low sensitivity and almost wholly reliant on culture (Zajac and Melcher, 
1991). Assessment of clinical samples by direct staining and microscopy is widely used 
and purported to be one of the more economical and rapid techniques presently 
available to disadvantaged nations (Kivihya-Ndugga et aI. , 2004). The Ziehl-Neelsen 
(ZN) technique, is a routine diagnostic assay for acid-fast bacilli such as Mycobacteria, 
and localises lipids in the bacterial capsule. 
A specialised division of microscopy, immunohistochemistry (rne) had its beginnings 
in the early 20th century with great strides in sensitivity and specificity taken towards 
the end of the century (Bunea and Zarnescu, 2001). rne localises a range of tissue-
associated antibodies (Ab) or antigens (Ag) via in situ targeting of antigen-antibody 
interactions. The value of rne, in the clinical as well as the research setting, has been 
demonstrated (Bunea and Zamescu, 2001). However, one of its primary restrictions is 
the lack of appropriate and specific markers for various cells and their products. 
Monoclonal antibodies are preferable for a number of reasons including greater 
specificity and reproducibility despite their lack of avidity and the chances of cross-
reactivity when more than one epitope is present (Bunea and Zamescu, 2001). The 
alternative is a polyclonal antibody that recognises several epitopes, and is easy to 
prepare but Ag and Ab purification is required, it may not be reproducible, production is 
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limited and a high rate of non-specificity and background staining may arise (Bunea and 
Zamescu, 2001). The choice of Ab is thus very subjective and dependant on the 
specific requirements of the research enquiry. 
1.2.4.2 Electron microscopy 
Electron microscopy (EM) affords the opportunity to examine the ultra-structural 
features of a cell in response to various chemical and physiological changes in the 
localised tissue. 
Ultra-structural investigation of Mtb illustrated, among other features, widely 
distributed ribosomal particles, electron-dense polyphosphate granules and DNA fibres 
(Dahl, 2004, Dahl et al., 2001, Takade, 2003). The cellular envelope consists of a 
plasma membrane (PM), a thinner inner layer and a thicker outer layer termed an 
asymmetric PM compared with a symmetrical PM characteristic of a degenerative cell 
(Takade, 2003). The cell wall has three covalently bonded macromolecules namely, 
peptidglycans, arabinogalactans and mycolic acids with glycolipids and mycolic acids 
forming the outer-most layer of the cell wall. Despite differences in their relative 
virulence and infectivity, Mtb and M. Zeprae do not differ in their cell wall architecture 
(Takade, 2003) indicating factors other than the cell wall as determinants of 
pathogenesis. Mehta et aI, (Mehta et aI., 1996), in comparing murine and human 
macrophages, used EM to demonstrate similar patterns of infection and bacterial 
multiplication in the initial stages of disease, but vastly different rates of clearance in 
response to drug therapy. The most notable ultra-structural finding was that cell type, 
together with temperature, promoted intracellular bacterial replication, even in the 
presence of appropriate antibiotics (Mehta et al., 1996). It must be remembered that 
tissue culture environments will differ from the in vitro physiology and biochemistry; 
therefore, differences between in vivo and in vitro tissue and cellular morphology must 
be expected. 
Development of mononuclear phagosomes parallels the progression of granuloma 
formation and manifests as distinct histological changes. Mononuclear phagocytes 
contain profuse peroxidase positive granules, which are lost as the cells mature to 
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macrophages and epithelioid cells (Adams, 1983). Immunoelectron localisation studies 
of the HIV -1 env antisense protein (ASP) coded by the minus strand isolated the protein 
to the cellular membrane and in the released viral particle (Briquet and Vaquero, 2002). 
This transcript of the minus strand, while unusual, appears to play a role in viral 
structure and packaging. 
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Chapter 2 - Clinical and laboratory findings contrasting HIV-
infected with -uninfected patients 
2.1 Introduction 
South Africa (SA) is presently ranked among the 35 highest TB incidence and 
prevalence countries worldwide (Global Health, 2006), with 458 persons living with TB 
per 100000 population. Of the 9 provinces of SA, KwaZulu-Natal (KZN) boasted the 
highest incidence of TB and HIV rrB co-infection in 2002, and was among the 3 highest 
HIV incidence regions in the country (DOH, 2002, DOH, 2004). The leading causes of 
death in the province remain TB and HIV rrB with mortality due to pulmonary TB 
surpassing all other opportunistic infections. While comparatively less significant, 
spinal TB still impacts greatly on morbidity and mortality particularly since spinal 
deformity and paralysis is a common complication. 
Clinical investigations of spinal TB rank the condition as the most important site of 
extra-pulmonary disease (Sinan et al., 2004). The escalating HIV epidemic exacerbates 
an already sizeable pulmonary, and more recently expanding extra-pulmonary, epidemic 
(te Beek et al., 2006). More alarming is the increase in the number and location of 
extra-pulmonary sites including musculoskeletal, the extent of pathogenesis and 
incidence of drug resistant disease (Houshian et aI., 2000). 
Studies of spinal TB infections have largely focused on radiological findings and 
clinical reports(Govender et al., 2000a, Chang et al., 1989, Dass et aI., 2002, Pertuiset et 
aI., 1999, Srivastava and Sanghavi, 2000, Villoria et al., 1992). Few have focused on 
the Southern African epidemic, where the prevalence and incidence of both HIV and 
TB is high, and where HIV -1 subtype C is the predominant genetic clade (Govender et 
aI., 2001b, Govender et aI., 2001a). 
The main objective of this chapter was to contrast selected clinical, haematological and 
demographic factors of HIV-uninfected with mY-infected patients diagnosed with TB 
spondylitis, in order to identify related markers unique to the latter group. 
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2.2 Methods 
2.2.1 Study population 
This study was approved by the Biomedical Ethics Research Board of the University of 
KZN (Post-graduate reference #: H112/02). Patients, from a primary referral hospital 
(King George V Hospital, KZN), who consented to participate in the study, were 
recruited at the Spinal Unit. This referral institute receives patients from all peripheral 
hospitals in KZN and the Eastern Cape. Approximately 150 patients are treated at this 
institute per year; approximately 66% of this number requires surgical interventions due 
to pain, progressive deformity despite conservative treatment, and neurological deficit. 
Of the patients presenting with infective spondylitis, approximately 30-40% are HIV co-
infected. Only patients, who fulfilled the selection criteria, following a detailed clinical 
evaluation, were recruited into the study. The sample size was determined by the rate of 
intake over a l6-month period (July 2003-November 2004). The selection criteria were 
as follows: 
2.2.1.1 Inclusion Criteria 
1. Clinically and radiologically diagnosed TB spondylitis patients 
a. Clinical diagnosis 
1. Axial (spine) pain 
11. Deformity (Gibbus) 
111. Constitutional symptoms (loss of weight, loss of appetite and 
night sweats) 
b. Radiological diagnosis (Fig. 2.la,b) 
1. Large paraspinal abscess involving multiple vertebral bodies 
11. Bone destruction, collapse of the vertebrae, and deformity 
111. Compression of the spinal cord 
2. Patients who consented to participate in the study 
3. Patients already initiated on 5-24 weeks of standard anti-TB chemotherapy 
4. Infective spondylitis confined to ~ 4 contiguous vertebral bodies 
5. Patients who consented to HIV testing 
6. Patients> 18 months of age 
2.2.1.2 Exclusion Criteria 
1. Patients with active pulmonary tuberculosis or foci outside of the spine 
2. Patients who were AR V naIve 
3. Patients with concomitant immunosuppressive conditions ( Diabetes, chronic 
steroid use, chemotherapy, congenital disorders) 
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Figure 2.1: MRI micrographs of an HIV -infected patient showing a large extradural 
granuloma (arrow) involving multiple vertebral bodies in (a) longitudinal and (b) cross 
section. Bone destruction (dashed arrow), collapse of the spinal column resulting in 
deformity, and compression of the spinal cord (arrow head) is evident. 
2.2.1.3 Treatment interventions 
Interventions and treatment strategies for all patients recruited into the study were 
identical. All patients received pre-operative nutritional support (mean = 2 weeks) range 
2-4 weeks) to achieve safe haemoglobin and albumin levels (>100 gil and >300 gil, 
respectively), as well as standard anti-TB therapy (600 mg Rifampicin, 400 mg 
Isoniazid, 1500 Pyrizinamide 1500 and 1200 mg Ethambutol daily) for a mean period of 
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8 weeks (range = 5 - 24 weeks). HIV-infected patients were antiretroviral (ARV) naIve, 
even those conforming to the SA guidelines for treatment initiation. 
Surgical interventions involved removal of the diseased vertebral bodies, debridement 
and insertion of a femoral allograft in order to stabilize the spinal column. In selected 
cases, the allograft was further reinforced with instrumentation. 
2.2.2 Specimen collection and processing 
Blood (EDT A anti-coagulant) and patient-matched open tissue biopsies were collected 
from a total of 60 patients (22 HIV -infected and 38 HIV -uninfected) diagnosed with TB 
spondylitis. All patients were scheduled to undergo vertebral excision and anterior 
spinal decompression for the treatment of infectious spondylitis-related neurological 
deficit. Blood and tissue were collected under sterile conditions during surgery (in 
theatre). Part of the tissue biopsy was submitted to an accredited (South African 
National Accreditation System, SANAS) private pathology laboratory in addition to a 
government managed TB pathology laboratory for routine microscopy (Ziehl-Neelsen, 
Auramine stain) and culture (BACTEC MGiT system). The remaining excised tissue 
was processed immediately for HIV viral loads, molecular assays (Africa Centre 
Virology Laboratory [ACVL], Pfizer Molecular Laboratory, DDMRI*) and microscopy 
(Optics and Imaging Unit, DDMRI). Routine TB diagnostic testing (microscopy and 
culture) were conducted at the TB pathology laboratories according to their standard 
operating procedures. 
2.2.3 Laboratory and diagnostic assays 
Blood (EDTA anti-coagulant) was submitted to a government managed haematology 
laboratory for routine full blood counts (FBCs). CD4+ and CD8+ T-cell quantification 
(FACSCount method) was conducted at the HIV Pathogenesis Program (HPP, 
DDMRI). CD4+ and CD8+ T-cell counts were determined using a standard single-
platform Beckman Coulter TetraOne method and a Coulter XL flow cytometer. 
CD4/CD8 testing was not performed on bloods that were clotted or insufficient. HIV 
*The Doris Duke Medical Research Institute (DDMRI) houses the Africa Centre Virology Laboratory, the Pfizer Molecular 
Laboratory and the Optics and Ima~in~ Unit. 
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serology (Vironosika Uniformll [Biomeriux], Gac [Abbott] ELISA), and HIV RNA 
quantification were performed (ACVL, DDMRI) on all resultant HIV -infected 
specimens. The investigator conducted all viral load assays, thereby eliminating inter-
technologist variability. RNA was isolated from plasma (100/ll) and tissue (10-12mg) 
samples using the guanidine-silica Boom method as per the manufacturers protocols 
(Nuc1isens isolation kit, Organon Teknika). Tissue specimens were homogenized and 
incubated overnight in assay lysis buffer (9ml) to ensure complete lysis. The Nuc1isens 
HIV -1 QT assay (Organon-Teknika) quantifies HIV -1 RNA copies/ml plasma 
(detection limit = 40 to >500 000 copies/ml (cp/ml)). As per the manufacturer's 
protocols tissue viral loads were standardized per unit input mass (mg) which equated to 
1ml input volume of plasma. 
2.2.4 Statistical analysis 
Statistical analyses were performed using the SPSS Version 11 software package for 
this and all subsequent chapters. Statistical significance was accepted at a 5% level, 
unless otherwise stated. The distribution curves for all data were generated to 
distinguish parametric from non-parametric data sets in order to direct subsequent 
analyses. A comparison of the means using parametric (Student's t test) or non-
parametric (Kruskal Wallis) tests was undertaken to investigate differences between the 
HIV-infected and -uninfected groups, Correlations between the HIV-infected and _ 
uninfected data sets were drawn using the Pearson's and Spearmen Rho correlations for 
non-parametric data sets. 
2.3 Results 
2.3.1 Patient Demographics 
The study population was predominantly HIV-uninfected (63%) and female (68%) 
(Table 2.1). All patients presented with an extra-dural granuloma, vertebral collapse and 
progressive pathology that was unresolved following a mean of 8 weeks of anti-TB 
therapy (range = 5-24 weeks). At least two contiguous vertebral bodies (thoracic, 
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lumbar or, more rarely, cervical spine) were involved in all patients. The thoracic spine 
(TS-T12) was implicated in >80% of the cohort (Patient records, results not shown). 
Onset of disease was insidious in the majority of cases (6S%). Paralysis was rare (S%), 
with varying levels of neurology and deformity (no neurology to weakness and 
numbness) (Fig. 2.1a, b). Clinical and nutritional status was monitored against albumin 
(Alb) (normal range = 3.4-S.4 gldL) and erythrocyte sedimentation rates (ESR) (normal 
range = males: 1-13mmlhr; female: 1-20mmlhr). ESR and Alb levels also determined 
the patient's readiness for surgery. 
Table 2.1: Demographics patients clinically diagnosed with TB spondylitis contrasting 
HIV -infected (HIV+) and -uninfected (HIV-) patients. 
All patients HIV· HIV+ 
(n=60) (n=38) (n=22) 
Mean Age in years ± SD* 32 ± 19 34±21 29 ± IS 
(range) (2 -71) (2 -71) (2 - 6S) 
Male (%) 17 (28) 12 (32) 9 (SO) 
Female (%) 41 (68) 24 (63) 9 (SO) 
Missing data (%) 2 (4) 2 (S) o (0) 
Paediatric (%) 13 (22) 10 (26) 3 (14) 
Adult (%) 43 (72) 24 (63) 19 (86) 
Missing data (%) 4 (7) 4 (11) 0(0) 
.. * = Standard DeVIatIOn 
2.3.2 TB diagnosis 
Results from two routine TB pathology laboratories were in agreement and reported 
68% of the cohort to be Mycobacterium culture negative (Table 2.2). Consequently, 
these specimens could not be classified as drug sensitive or resistant and there was no 
change to the patient's treatment regimes. Of the culture positive specimens, drug 
resistance against Isoniazid (6 HIV-infected and 2 HIV-uninfected) and streptomycin (2 
HIV -infected and 1 HIV -uninfected) were noted. Culture identified NTMs occurred in 
the HIV-uninfected group alone (Table 2.2). A positive culture result was associated 
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with higher plasma viral loads (r=0.568; p<0.05) in HIV -infected patients. Routine 
microscopy was positive in one case, an HIV co-infected paediatric patient (Patient 32). 
The association between elevated viral loads and an Mtb infection was notable in the 0-
30 year age group but not among patients older than 30 years (p>0.05). 
Table 2.2: Findings of TB culture identification (Bactec MGiT) and drug reactivity 
All patients HIV- HIV+ 
(n=60) (n=38) (n=22) 
Culture identification 
No result (%) 41 (68) 27 (71) 14 (64) 
Mtb (%) 16 (27) 8 (21) 8 (36) 
NTM(%) 3 (5) 3 (8) o (0) 
Drug reactivity 
Isoniazid 
Sensitive (%) 14 (23) 8 (21) 2 (9) 
Resistant (%) 4 (7) 2 (5) 6 (27) 
No result (%) 42 (70) 28 (74) 14 (64) 
Ethambutol 
Sensitive (%) 16 (27) 8 (21) 8 (36) 
Resistant (%) 2 (3) 2 (5) o (0) 
No result (%) 42 (70) 28 (74) 14 (64) 
Rifampin 
Sensitive (%) 17 (28) 9 (24) 8 (36) 
Resistant (%) 1 (2) 1 (3) o (0) 
No result (%) 42 (70) 
Streptomycin 
28 (74) 14 (64) 
Sensitive (%) 2 (3) 2 (5) o (0) 
Resistant (%) 3 (5) 1 (3) 2 (9) 
No result (%) 55 (92) 35 (92) 20 (91) 
NB: the BACTEC MGIT assay was conducted in a pathology laboratory by trained technologists 
following their laboratory Standard Operating Procedures. 
2.3.3 Viral loads and CD4+/CD8+ T-cell counts 
A comparison of viral loads and CD4/CD8+ T-cell counts indicated that tissue and 
plasma viral loads were positively correlated (r=0.52; p=O.Ol) but were not significantly 
(p>O.Ol) different (Table 2.3). However, when tissue viral loads in paediatric and adult 
patients were compared, they were significantly (p<0.05) greater in former group (Table 
2.3). A positive correlation between tissue viral loads and platelet counts (r = 0.600; 
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p=0.02) over all HIV -infected patients was noted. Interestingly, a negative association 
was demonstrated when comparing tissue viral loads with the age of the patient (r=-
0.458; p=0.03) and percentage CD3 counts (r =-0.79; p<O.OI) illustrating that an 
immature, depressed or compromised immune response can be associated with 
unrestrained viral replication in co-infected tissue. 
CD4/CD8+ T-cell counts were available for 65% of the cohort due to unacceptable, 
insufficient sample or delay in sample delivery to the testing site (Table 2.3). CD4 T-
cell counts were in the normal range (> 500 cells/fl.ll) in 40% of all patients in the cohort 
(n=60). This trend was observed in the HIV-infected (41 %) and -uninfected (40%) 
groups alike. Onl y 4 HIV -infected patients displayed CD4+ T-cell counts below 
200cells/J..l1. When comparing absolute CD4+ T-cell counts, the HIV -uninfected group 
displayed significantly (p<0.05) greater levels when compared with the HIV -infected 
patients. CD4/CD8 ratios were largely inversed in the HIV -infected group (mean = 
0.50 cells/ill; range= 0.10-1.29 cells/ill) and significantly lower (p<O.OI) in comparison 
to the HIV-uninfected group (mean = 1.16 cells/ill; range= 0.34-2.23 cells/ill) (Table 
2.3) providing an indication of their immune compromised status. 
2.3.4 Clinical outcomes 
Clinical recovery was noted in 56/60 patients, and ranged from full recovery 46/60 
patients, partial recovery in 10/60 patients and no recovery in the remaining 4 patients. 
Recovery patterns were defined as follows: 
1. Full recovery - recovery of neurological deficit to full mobility, 
resolution of disease pathology and incorporation of allograft 
2. Partial recovery - recovery of neurological deficit to limited degree 
allowing for limited range of motion 
3. No recovery - no resolution of neurological deficit 
There were no significant differences in the rates and scope of clinical recovery patterns 
in the HIV -infected, compared with the -uninfected patients. 
Table 2.3: Viral loads and CD4+ICD8+ T-cell counts contrasting HIV-infected and uninfected patients 
All patieots HIV- HIV+ 
(0=60) (0=38) (0=22) 
Log plasma viral load in 
copies/ml (range) 
Overall (n=22) 4.14±1.59 «LDL - 6.40)* 
Adults (n = 19) 4.02±1.63 «LDL-5.79)* 
Paediatric (n = 3) 4.84±0.85 (4.20-6.39)* 
Log tissue viral load in 
copies/ml (range) 
Overall (n=22) 4.20±1.85 «LDL -7.18)* 
Adult (n = 19) 3.94± 2.36 «LDL-8.15)* 
Paediatric (n = 3) 6.63±1.55 (8.08-9.18)* 
CD4 distribution (percentage 
of total population) 
<500 cellsllf.ll 15 (25%) 7 (18%) 8 (36%) 
>500 cellsllf.ll 24 (40%) 15 (40%) 9 (41%) 
Missing data 21 (35%) 16 (42%) 5 (23%) 
Median Abs CD4+ counts in 
cellslf.ll (range) 
Adults (n=31) 619 (100-1370)* 643 (281-1370)* 496 (100-1081)* 
Paediatric (n=8) 945 (400-2254)* 1390 (400-2254)* 885 (474-1005)* 
Missing data (n=17) 
Mean % CD4+ counts in 
cellslf.ll (range) 
Adults (n = 37) 34.0 (8.8-72.0)* 643 (281-1370)* 28.0 (8.8-53.0)* 
Paediatric (n = 10) 27 (12.0-51.0)* 1390 (400-2254)* 21.37 (12.0-23.0) 
Missing data (n=9) 
Median Abs CD8+ counts in 
cellsllf.ll (range) 
Adults (n = 31) 661 (194-1990)* 511 (194-1712)* 904 (314 - 1990)* 
Paediatric (n = 8) 1314 (315-2512)* 1155 (315-2469)* 1925 (879-2512)* 
Missing data (n=17) 
Median CD4:CD8 ratio (range) 
Adult (n = 35) 0.80 (0.10-2.23)* 1.04 (0.40-2.23)* 0.51 (0.10-1.29)* 
Paediatric (n = 10) 0.99 (0.34- 1.75)* 1.23 (0.34-1.75)* 0.46 (0.41- 0.50)* 
Missing data (n=ll) 
Key: * = significant difference 
70 
2.4 Discussion 
The findings of this study, demonstrated a 37% incidence of HIV co-infection among 
patients diagnosed with TB spondylitis, which was consistent with provincial and global 
demographic of HIV/TB co-infection (WHO, 2006). This cohort of 60 patients was 
representative of the patient intake at King George V (KGV) referral hospital, which 
received patients from the KZN and Eastern Cape regions. Annual spinal TB intake at 
KGV is 150 patients per year, approximately 100 of which require surgical 
interventions. The KZN region has the highest HIV and TB incidence rates of the 9 
provinces of South Africa (Ige et al., 2005). This cohort was also representative of a 
significant portion of the nationwide disease burden of infectious spondylitis. 
This study demonstrated that clinical and radiological markers of TB spondylitis 
between HIV -infected and -uninfected patients are distinctive, on presentation, yet 
outcome measures following surgery are not HIV specific. All patients presented with 
an extra-dural granuloma, vertebral collapse and reported limited response to 
conventional anti-TB therapy. Despite pre-surgery anti-TB therapy, progressive 
pathology and neurological involvement was evident, particularly in the HIV -infected 
group. However, there was no difference in the clinical outcomes following surgical 
intervention, enhanced nutritional support and sustained anti-TB drug therlJ,py when 
comparing HIV -infected with -uninfected or adult with paediatric patients. The 
primary determinant of outcomes was their clinical status on presentation. In general, 
patients with severe deformity and neurological deficit fared worse than those with pain 
and limited pathological manifestations. This was independent of HIV status. The 
findings of this study were consistent with previous reports for KZN (Go vender et al., 
2000a, Govender et al., 2001b), (Govender et aI., 2001a), which described a more 
severe disease pathology in HIVITB co-infected patients. 
In the present study, plasma and tissue viral loads were in excess of 410g IO copies/ml 
despite pre-operative anti-TB therapy (mean 8 weeks), improved clinical status, CD4+ 
T-cell counts >500cpsl/-l1 in >40% of cases and pauci-bacillary disease. These fmdings 
were consistent with a report by Wolday et al (Wolday et al., 2003) who demonstrated 
high viral loads following anti-TB chemotherapy despite clinical resolution of the 
pUlmonary TB infection. However, unlike the Wolday et al (Wolday et aI., 2003) 
71 
cohort, the prognosis and clinical outcomes of the HIV -infected patients in this study 
were favourable and comparable to the HIV -uninfected group. The present findings 
demonstrated that age was a significant contributor to site-specific disease pathogenesis. 
HIV replication in paediatric patients proceeded unrestrained as demonstrated by 
significantly greater tissue viral loads when compared with the adults (p<0.05). The 
significant inverse correlation between tissue viral loads and age confirmed this finding 
even in patients with CD4+ T-cell counts of >500cells/ml. Physiological and 
developmental differences between adult and paediatric patients, particularly with 
regards their immune responses, may account for these findings. High viral load at the 
site of infection, as demonstrated in the present cohort, may indicate site-specific 
immune or drug mediators, which up-regulate viral replication. As a result more 
virulent viral variants and escape mutants are likely to emerge. 
This investigation substantiated previous findings from KZN (Go v ender, 2005, 
Govender and Charles, 1987) and emphasised the efficacy of enhanced nutritional 
status, surgical removal of the infected lesion and conventional anti-TB therapy to 
favourable clinical outcomes, even in immune compromised hosts (CD4 <200celllml). 
Although four patients displayed diminished immune responses and none of the patients 
in the cohort (n=22) received ARVs (the SA national rollout had not reached this 
population at the time of sample collection) there were no significant differences in 
either CD4+ T-cell counts or patient outcomes between HIV -infected and -uninfected 
patients. Patients were thus reliant, solely, on nutritional support, surgery and anti-TB 
chemotherapy for disease resolution. This suggests other mediating factors to clinical 
outcomes. A CD4+ T-cell count less than 200cells/1!1 has been used as a preoperative 
indicator of the level of risk of post-operative wound infection and poor clinical 
outcomes , as it reflects both the vigour of the host immune response and the stage of 
HIV pathogenesis in co-infected patients (Bono, 2006). Also, diminished immune 
responses were shown to aggravate the localized pathology resulting in irreversible 
neurological damage in certain instances (Jutte et al., 2005). Nutritional deficiency 
impacts on both the cellular and humoral immune responses manifesting in altered 
chemotactic and phagocytic potentials and the relative abundance of immune cells 
(Cunningham et al. , 2006). In developing nations, utilizing ARVs to elevate the host 
immune response of co-infected patients may not be accessible, practical or economical. 
Delaying ARVs also has the additional benefit of prolonging ARV therapy prior to 
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development of drug resistance. Thus these findings would suggest that the treatment 
regime applied to patients in this cohort may be adopted as a practical, effective and 
economical strategy for co-infected patients particularly since neither previous nor 
concurrent ART is required. 
The large proportion of culture-negative (68%) and AFB-negative microscopy (98%) 
findings may either reflect an emergence of NTM disease in the local setting or the 
impact of pre-surgical anti-TB therapy. An escalating HIV pandemic coupled with 
severe immune-suppression as a result of malnutrition has culminated in an increase in 
atypical and/or opportunistic spinal infections particularly in developing nations 
(Archibald et al., 1998, Bono, 2006, Castagnola et al., 1997) (Looney, 2005). Atypical 
opportunistic pathogens have been implicated more often than Mtb (39%) in blood 
stream infections (Archibald et al., 1998) thereby enabling haematogenous spread to 
remote anatomical sites such as the spine. An association between CD4+ T-cell counts 
<50cells/)l1 and atypical Mycobacterial infections primarily among HIV -infected 
patients, has been shown (MacGregor et aI., 1999). Moreover, TB spondylitis is 
characteristically a pauci-bacillary disease. In contrast to pulmonary TB, 
musculoskeletal disease is AFB negative in approximately 60% of cases (Walsh et aI., 
2004). Pre-operative anti-TB therapy initiated, at peripheral referring clinics and/or 
hospitals (mean = 8 weeks; range = 5-24 weeks), is likely to have contributed to the lack 
of confirmatory laboratory diagnoses in this cohort (Section 2.3.2). Initiation of anti-
TB therapy in endemic developing nations and patients at a high index of suspicion 
often precedes laboratory confirmation of the disease (Jutte et al., 2005). As 
demonstrated in the present cohort, this severely complicates diagnosis and must be 
taken into account in paucibacillary disease. Moreover, immune suppression, while a 
known risk factor for TB, elicits a greater number of false negative tuberculin reactions 
and diagnoses (Jutte et aI., 2005). 
2.5 Summary 
The findings of the present cohort confirmed previous findings in the KZN region of 
positive outcomes in clinically and radiologically diagnosed TB spondylitis patients 
following nutritional support, surgery and anti-TB therapy. These outcomes were 
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independent of CD4+ T-cell count, HIV status and viral load. Clinical and radiological 
markers remain the primary distinguishing features of HIV co-infection as no laboratory 
markers were distinctive. Pre-surgical anti-TB therapy was shown to be effective at 
reducing bacterial load but was unable to halt or resolve disease pathology. High viral 
replication rates were indicated by higher tissue versus plasma viral loads. Favourable 
clinical outcomes following the treatment strategy outlined in this chapter are 
achievable even in immune compromised hosts and in the absence of ARTs. Although, 
spinal TB is AIDs-defining, it can effectively be treated while still delaying ARTs. 
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Chapter 3 - Microscopy 
3.1. Introduction 
Granuloma formation is the hallmark of an effective immune response against a 
pathogenic or irritant challenge (Desjardin et al., 2002a) (Kaufmann, 2002). It acts to 
contain active disease and prevent dissemination. A typical granuloma is infiltrated 
with immune cells (Adams, 1983), and is surrounded by an outer cuff of fibrosis (Fig. 
1.1) (Roitt et aI., 2001). 
The primary effector cells against a TB infection are CD4+ T -cells and phagocytes, 
including macrophages and macrophage-derived cells. As disease progresses, 
macrophages differentiate into epithelioid cells, which later coalescence to form multi-
nucleated giant cells (Roitt et al., 2001). Phagocytes may be distinguished by their 
expression of the CD68 endosomalllysosomal-membrane restricted antibody (Ab). 
These include macrophages from the germinal centre, tonsils, splenic red pulp, dermal 
connective tissue, hepatic Kupffer cells; alveolar macrophages and blood monocytes 
(Roitt et al., 2001). Although histopathological studies of pulmonary and pleural TB are 
well documented (Beers and Berkow, 1999, Engers et al. , 1986, Kaufmann, 2002, Raja, 
2004) related non-clinical investigations of the spine are rare (Govender et al., 2000a). 
Since spinal disease is debilitating, and results in severe pathology and neurological 
damage (Govender, 2005) understanding the disese pathology is important to future 
treatment strategies and patient outcomes. 
This study hypothesised that HIV co-infection significantly impairs macrophage 
infiltration of spinal granulomas and induces ultrastructural changes reflecting greater 
degeneration, necrosis and caseation. It also proposes that histopathological features of 
co-infected granulomas may be distinguished from HIV -uninfected specimens at similar 
stages of pathology. Spinal granuloma biopsies were investigated at a light and electron 
microscope level to address these questions. 
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3.2. Methods 
3.2.1 Study population 
As described previously (Chapter 2, Section 2.2.2-2.2.3), epidural granuloma biopsies 
were collected at surgery, from 60 patients (38 HIV-uninfected and 22 HIV-infected) 
(Fig. 3.1). A sub-set of this population was processed for histological (n=35) and 
ultrastructural (n=13) evaluation. 
A B 
Figure 3.1: Graphical illustration of the patient cohort selected for (A) histopathological 
(Ziehl Neelsen, Haematoxylin & Eosin, Periodic Acid Schiff staining), CD68 immune-
localisation (Immunohistochemistry) and (B) ultrastructural investigations 
(Transmission Electron Microscopy). 
3.2.2. Tissue processing for Light Microscopy (LM) 
3.2.2.1 Tissue collection and pre-processing 
Tissue biopsies collected at surgery were fixed immediately to minimize morphological 
aberrations resulting from post-surgical decay. Samples were cut into ±lcm3 and 
±0.5cm3 blocks. The former (±lcm3) were immersed in 5% buffered formal-saline 
(41 % formaldehyde/0.9% NaCl, 1:8 v/v) (Drury and Wallington, 1980) for routine light 
microscopy (LM). 
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3.2.2.2 Processing for light microscopy 
Following a 12-24 hour incubation in 5% buffered formal saline (5% 
formaldehyde/0.9% NaCl, 1:8 v/v), specimens were processed for light microscopy by 
conventional means (Drury and Wallington, 1980, Bunea and Zarnescu, 2001). Serial 
sections of 2 and 3Jlm thickness were cut on a Jung RM2135 microtome (Leica, UK), 
and prepared for treatment with an appropriate staining technique. 
3.2.3. Histopathology 
3.2.3.1 Histopathology techniques 
Following re-hydration, serial sections (3J..Lm thickness) were stained with Haematoxylin 
and Eosin (H&E), Ziehl-Neelsen (ZN) and Periodic Acid Schiff (PAS) stains. Detailed 
descriptions of these techniques appear in Drury and Wallington (Drury and Wallington, 
1980). Appropriate positive and negative control specimens were stained concurrently. 
Stained tissue sections were permanently mounted in distyrene tricresyl phosphate 
xylene (DPX) (Sigma, St. Louis, MO). The H&E stain was used to investigate the 
general histology of the specimens while ZN stains localised acid fast bacilli (AFB) 
such as Mycobacterium tuberculosis. Since the PAS stain localizes glycogen, mucin, 
mucoprotein, and glycoprotein of fungi, as well as human basement membranes, 
capsules and blood vessels. In this study, the PAS technique was applied to investigate 
possible fungal infections. Please consult Drury and Wallington (Drury and 
Wallington, 1980) for detailed descriptions of the H&E, ZN and PAS procedures. 
3.2.3.2 Evaluation of histopathology 
All analyses were confIrmed by an independently pathologist I blinded to the HIV status 
of the specimens to reduce potential observer bias. The presence of granulomas, 
caseation! necrosis, lymphocytes, epithelioid cells and plasma cells were scored 
I Dr Ashwin Bramdev,Speciali st Pathologist, Lancet Laboratories, Durban, SA 
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according to their relative prevalence in the infected tissue. Morphometric 
quantification of these pathological features and cell types allowed for the specimens to 
be divided into distinct patterns on the basis of their prevalence in the tissue sections. 
They were classified as moderate to profuse when their distribution in the field of 
interest was >45% or sparse to moderate when their prevalence accounted for 0-45% of 
the region of interest. Specimens were further classified as displaying 
histolopathological features diagnostic or atypical of TB forming the basis of 
histopathological comparisons between HIV -infected and -uninfected specimens. The 
presence or absence of AFBs was not taken into consideration during these analyses in 
order to ensure an unbiased evaluation of the occurrence and severity of 
histopathological features consistent with a TB infection in both study groups. 
3.2.4. Immunohistology 
3.2.4.1 CD6S, CD4 and CDS immunolocalisation 
Serial sections (2/-lID thickness), picked up on poly-L-Iysine coated glass slides (Sigma, 
St. Louis, MO) were used to immunolocalize CD68, CD4 and CD8 Ab (Appendix B). 
The CD68 peptide is an 11OkDa-glycosylated trans-membrane glycoprotein located in 
the lysosomes and endosomes of non-Langerhans histiocytes, monocytes, macrophages 
and multi-nucleated giant cells (Pulford et al., 1989). The commercially available 
antibody (Clone KPl, Dako) was used in this study. The CD4 marker (Clone IF6, 
Novocastra) was used to localise CD4+ T -cells. This antibody is a monoclonal 
prokaryotic transmembrane glycoprotein specific to the CD4+ T-cell population. The 
CD8 antibody marker (Clone C8/144B, Dako) was used to localise CD8+ T-cells. The 
antibody is a synthetic peptide, which consists of 13 c-terminal amino acids from the 
cytoplasmic domain of the CD8 polypeptide. 
The primary antibody (CD68, CD4, CD8) was immunolocalised in re-hydrated tissue 
sections using a modified indirect immuno-peroxidase assay. Phosphate buffered saline 
(PBS) was used throughout the procedure, with the exception of the chromogen step, 
which required Tris-HCI (0.05M). The detailed methodology used is described in 
Appendix B. Each section was incubated with the appropriately diluted (1:1000 in 10% 
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milk protein) primary antibody and visualised using the Dako LSAB® kit (DAKO) and 
the chromogen diarninobenzidine (DAB). Replacement of the primary antibody with 
non-immune sera of the same IgG class produced no immunoreactivity (Fig. 3.6 b, c). 
Normal lymph node tissue sectioned as positive (Fig. 3.6a) controls were included. 
3.2.4.2 Image analysis 
Image analysis was performed using the Soft Imaging System (SIS) software package. 
This software system allows the user to acquire digital images, store them in a database, 
process and analyse them by performing various spatial and colorimetric measurements. 
A defined area or field referred to as the region of interest (RO!) was chosen for 
analysis in which the Ag-Ab-chromogen immunoprecipitate complex appeared as a 
collection of particles. These particles are essentially a quantity of connected pixels 
within a defined range of colour values, which correlate well image structure. 
A quantitative analysis of CD68 immunoreactivity and a qualitative analysis of CD4 
and CD8 reactivity were performed. Following capture, images were calibrated to a 
defined magnification. The frame area was defined to limit image processing and 
analysis to the region of interest. Segmentation was first conducted to selectively define 
the brown DAB chromogen from the background tissue based on selective thresholds, 
which were set interactively in a histogram. Phase analysis, a quantitative measure of 
intensity of the area of the defined phase or colour thresholds, was then performed 
according to a grey-scale (range = 0-255 dens units) hence not true colour 
densitometry. All micrographs are represented at their initial magnifications. 
3.2.5 Transmission Electron Microscopy (TEM) 
3.2.5.1 Tissue processing for TEM 
The specimens analysed by TEM were processed in the Reichert Lynx automated EM 
tissue processor (Leica, UK). Tissue was fixed in 4% glutaraldehyde/5% 
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paraformaldehyde in 0.2M sodium cacodylate buffer, dehydrated through a graded 
ethanol series, prior to embedding in Spurr epoxy resin (Spurr, 1969) (Sigma, St. Louis, 
MO) according for 48 hours at 60°C. Ultra-thin tissue sections (50nm thickness) were 
cut with glass knives on an RM- ultra-microtome (Leica, UK) and collected onto 200-
mesh copper grids prior to contrast enhancement with saturated ethanoic uranyl acetate 
and Reynolds lead citrate (Reynolds, 1963). 
3.2.5.2 TEM viewing and analysis 
The J eol JEM -1011 Transmission electron microscope (TEM) was used to visualize and 
digitise the ultrastructural features of the tissue. The iTEM imaging software enabled 
image acquisition and morphometric analyses. 
3.3. Results 
3.3.1 Histopathology 
3.3.1.1 Patient demographics 
The demographics of the cohort is outlined in Table 3.1. Conventional culture 
identification was negative in a large proportion of both the HIV -infected (66.7%) and _ 
uninfected (75%) groups (Table 3.1). The mean percentage CD4+, CD8+ T-cell counts 
and CD4/CD8 ratios were significantly greater in the HIV-uninfected group (p < 0.01) 
while median CD4+, CD8+ cells were in the normal range for both paediatric and adult 
patients apart from CD4+ T-cell counts in the HIV-infected group (Table 3.1). 
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Table 3.1: Demographics of patients evaluated histopathologically, following H&E 
staining of granuloma biopsies 
All patients HIV· group HIV+ group 
(N = 35) (N = 20) (N = 15) 
Age in years ± SD 34.1 ± 20.3 36.1 ± 23.7 31.9 ± 16.5 
(range) (2 -71) (2 -71) (2 - 65) 
Gender 
Male (%) 12 (34.3) 9 (45) 3 (20) 
Female (%) 21(60.0) 9 (45) 12 (80) 
Missing 2 (5.7) 2 (10) 0(0) 
Culture identification 
No growth (%) 25 (71.4) 15 (75) 10 (66.7) 
Mtb (%) 8 (22.9) 3 (15) 5 (33.3) 
MOTT(%) 2 (5.7) 2 (10) 0(0) 
Median CD4+ T-cell count 
( cells/).Ll) 
643 379 Adult 571 
Paediatric 680 1390 474 
Median CDS+ T-cell count 
( cells/).Ll) 
Adult 898 874 920 
Paediatric 1177 1474 879 
Median CD4/CDS ratio 
Adult 0.52 0.86 0.44 
Paediatric 0.92 1.14 0.46 
Log plasma viral loads ± SD N/A N/A 4.19 ± 1.30 
(copies/ml) (3.61- 5.74)* 
Log tissue viral load ± SD N/A N/A 6.32 ± 1.37 
(copies/ml) (3.00 - 8.15)* 
. . 
SD = standard deVIatIOn; Mtb = Mycobactenum tuberculosIs; MOTT = Mycobactenum other than 
tuberculosis; *=range 
3.3.1.2 Ziehl-Neelsen stain 
The Ziehl-Neelson (ZN) stain was employed to identify AFBs in TB-infected tissue. 
The stained bacilli in the control section appeared bright red against a background of 
blue-stained cytoplasm (Fig. 3.2a). All specimens (both HIV-infected and -uninfected) 
were devoid of AFBs (Fig. 3.2b). 
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3.3.1.3 PAS stain 
The absence of AFBs following ZN staining alluded to a possible atypical opportunistic 
pathogen. To investigate this possibility, sections were stained with PAS to detect / 
exclude mycoses. Although hyphae and fruiting bodies were clearly visible in the 
positive control (Fig. 3.2c) there was no evidence of fungal infection among any of the 
HIV-infected or HIV- negative patients in this cohort (Fig. 3.2d). 
3.3.1.4 Semi-quantitative analysis of H &E stained specimens 
Despite the negative AFB findings, histopathology fmdings revealed that 91.4% of 
specimens (HIV -infected and -uninfected) displayed features typical of a TB infection. 
Granuloma formation, caseation and lymphocyte infiltration were detectable at varying 
degrees (Table 3.2). Discrete compartments were discernable and the four zones, 
characteristic of granulomatous tissue, were identified. These zones comprised of: 
1. An inner acellular core of caseation composed of highly necrotic tissue 
2. A cellular zone consisting of macrophages, giant cells (Fig. 3.3), and 
lymphocytes (Fig. 3.3). 
3. A sheath-like layer composed of epithelioid and plasma cells and 
4. An outer fibrotic zone that formed a thickened physical barrier to the spread of 
infection 
An overview of the histopathological fmdings is presented in Table 3.2. The 
absent/sparse distribution pattern of granuloma formation predominated in the HIV-
infected patients (Table 3.2) while the moderate/profuse pattern was common to 
uninfected patients (73.3% versus 55.0%; p < 0.05). CD4+ T-cell counts were 
associated with greater granuloma formation in the HIV-uninfected group (r = 0.635; 
p=0.027). Caseation was noted in the HIV -infected group however, there was no 
statistically significant difference in the median degree of caseation when compared 
with the HIV -uninfected group (p>0.05). 
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HIV· Group HIV+ Group 
Figure 3.3: Light micrographs of H&E stained sections depicting variable 
morphologies of multi-nucleated giant cells (G) in HIV -uninfected (a, b, c) and HIV-
infected specimens. Nuclei distribution was peripheral in b, c and d, and diffuse in a, 
e and f. Note the polymorphonuclear lymphocytes (arrows). [Initial Mag. a-f: xlOO] 
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Table 3.2: Pattern and cellular composition of epidural granuloma biopsies following 
hisopatbological evaluation of H&E stained specimens. 
Tissue Absent to Sparse Moderate to Profuse 
Morphology No of patients (%) No of patients (%) 
All patients (N=35) 
No. of Granulomas 20 (57.1) 15 (42.9) 
Degree of Caseation 20 (57.1) 15 (42.9) 
Lymphocytes 16 (45.7) 19 (54.3) 
Epithelioid cells 25 (71.4) 10 (28.6) 
Plasma cells 33 (94.3) 2 (5 .7) 
HIV" group (N=20) 
No. of Granulomas 9 (45.0) 11 (55.0) 
Degree of Caseation 11 (55.0) 9 (45.0) 
Lymphocytes 11 (55.0) 9 (45.0) 
Epithelioid cells 17 (85.0)* 3 (15.0)* 
Plasma cells 19 (95.0) 1 (5.0) 
HIV+ group (N=15) 
No. of Granulomas 11 (73.3) 4 (26.7) 
Degree of Caseation 9 (60.0) 6 (40.0) 
Lymphocytes 5 (33.3) 10 (66.7) 
Epithelioid cells 8 (53.3)* 7 (46.7)* 
Plasma cells 14 (93.3) 1 (6.7) 
*Statistically significant difference between HIV -infected and -uninfected group; p<O.O 1 
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3.3.2 Immunohistology 
3.3.2.1 CD68 immuno-Iocalisation 
CD68 immuno-reactivity was variable (sparsely (Fig. 3.Sa, b), moderately (Fig. 3.Sc, d) 
or densely (Fig. 3.Se, f) distributed) within CD68+ cells. Positive reactivity was 
observed in specimens infiltrated with mononuclear cells and well-formed granulomas 
(Fig. 3.Sa, c, d) distinctive of the HIV-uninfected group. Reactivity was also noted in 
highly necrotic and caseous specimens particularly among the HIV co-infected group 
(Fig. 3.Sb, d, f). Multi-nucleated giant cells were observed in both HIV -infected (Fig. 
3.6a) and -uninfected specimens (Fig. 3.6b). Negative controls displayed no immune-
reactivity (Fig. 3.4). 
Image analysis quantified the distribution of the chromogen as a percentage of the area 
of interest (AOI) and the intensity of immunoreactivity, as a measure of the percentage 
CD68 reactivity and antibody aggregation respectively (Table 3.3). Although not 
statistically significant (p>O.OS), HIV -1 co-infected specimens displayed greater 
percentage CD68 reactivity compared with the HIV-uninfected group (Table 3.3). 
Despite this association, higher plasma viral loads were negatively correlated with 
maximum area of immuno-reactivity (r= -0.S80; p<O.OS). The data also demonstrated a 
weak association between the mean intensity of CD68 reactivity and higher percentage 
CD4+ T-cell counts (r=0.400; p=0.048). 
Table 3.3: Quantitative evaluation of CD68 immuno-reactivity in HIV-infected and _ 
uninfected spinal TB-infected granuloma biopsies 
All patients HIV- group HIV+ group 
(N = 35) (N = 20) (N -15) 
Percentage of CD68 
6.19 ± 3.81 5.30 ± 3.68 7.39 ± 3.76 immuno-precipitation 
(%/ field) (1.05 - 15.69) (1.05 - 12.42) (2.83 - 15.69) 
Mean intensity of CD68 
178.14 ± 24.48 181.00 ± 25.24 immuno-precipitation 174.32 ± 23.74 
per field! (dens units) (143.62 - 221.66) (143 .83 - 221.66) (143.62 - 214.74) 
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Figure 3.4: Light micrographs of (a) normal lymph node showing CD68 immuno-
reactivity (positive control). Figures band c show an absence of CD68 immuno-reactivity 
and represent (b) the buffer control and (c) the replacement of the primary antibody with 
non-immune sera of the same IgG class [Initial Mag. a-c: x40]. 
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HIV -infected HIV -uninfected 
Figure 3.5: Light micrographs illustrating (a,b) sparse, (c,d) moderate and (e,f) 
dense CD68 immunoreactivity in (b, d, f) HIV-infected and (a, c, e) HIV-
uninfected specimens. Note (e, f) giant cells (arrows) observed in both groups. 
[Initial Mags. a-f: x20]. 
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Figure 3.6: Light micrographs indicating CD68 immunoreactive cells in (a) HIV-
infected and (b) -uninfected specimens. Note the immunoprecipitation of CD68 in 
multi-nucleated giant cells (arrows) [Initial Mag. a-c: xlOO]. 
3.3.2.2 CD4 immunolocalisation 
Both HIV -uninfected (Fig 3.8a-c) and -infected (Fig. 3.8 d-f) specimens displayed 
sparse or an absence of immune-reactivity to the CD4 antibody. Lympph node tissue 
served as the positive control while substitution of the primary antibody with non-
immune sera of the same IgG produced an absence of immune-reactivity (Fig. 3.7a). 
3.3.2.3 CDS immunolocalisation 
Both HIV - uninfected (Fig 3.9a-c) and - infected (Fig 3.9d-f) specimens were reactive 
to CD8 antibody. Greater immune reactivity was observed in the HIV -infected (Fig 
3.9d) compared with the -uninfected group (Fig 3.9a). CD8 immune reactive cells were 
noted scattered (Fig 3.9a), surrounding granulomas (Fig 3.9b), centres of caseation (Fig 
3.ge, f) and adjacent to a giant cell (Fig 3.9c). 
Figure 3.7 : Micrographs showin an absence of CD4 (a) and CD8 (b) immuno-
reactivity and represent the replacement of the primary antibody with non-
immune sera of the same II!G class rInitial Mal!. a.b: x201. 
89 
Figure 3.8: Micrographs of illustrating CD4 immunoreactivity (arrows) in (a-c) 
HIV-uninfected and (d-f) HIV-infected specimens. Note the (a, b) presence of 
granulomas, and (a-c) greater immune reactivity in the HIV -uninfected specimens 
compared with (d) sparse distribution of reactive cells, (arrow heads), extensive 
caseation and (d, e) an absence of granuloma formation in the HIV-infected group. 
[Initial Mag. a, d: x 20; b, e: x40; c, f: xlOO] 
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Figure 3.9: Micrographs illustrating CD8 immuneoreactivity in HIV -uninfected (a, b, c) and 
HIV-infected (d, e, f) specimens. Sparse immune reactivity was noted in HIV-uninfected 
specimens (a-c) but greater reactiviey was observed in the HIV-infected (d-f) group. Note 
granuloma formation (g) and a giant cell (G) in the HIV-uninfected specimens; (a-f) and 
caseation (arrows) in both groups. [Initial Mag: a, d: x20; b, e: x40; c, f: xlOO] 
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3.3.3 Transmission electron microscopy (TEM) 
3.3.3.1 Ultrastructural features in HIV uninfected specimens 
Semi-thin toludine blue-stained sections of an HIV-uninfected (Fig 3.10a-c) and an -
infected (Fig 3.lOd-f) specimen revealed granuloma formation (Fig 3.lOb,e), immune 
cell infiltration (Fig 3.10b,c,e,f), giant cell (Fig 3.lOc) and extensive caseation (Fig 
3. lOa-f). In contrast to the HIV-infected group, macrophages and immune cells (Fig. 
3.11) were pervasive in 3 HIV-uninfected specimens (Patients 2,13,21). Various poly-
morphonuclear leucocytes and immune cells (Fig. 3.11) were present including 
granulocytes (Fig. 3.11a), neutrophils (Fig. 3.11b) and plasma cells (Fig. 3.11c). 
Lymphocytes were noted (Fig. 3.11d) with characteristically large nuclei and a thin rim 
of cytoplasm. Multinucleated giant cells were detected in 5 HIV -uninfected samples 
(Patients 1, 9, 17, 19, 23). Evidence of apoptosis, nuclear necrosis and pyknosis of the 
nucleus was also observed (Fig. 3. 12a-f) in both HIV-infected and -uninfected groups. 
3.3.3.2 Ultrastructural features in HIV -infected specimens 
Four HIV -infected specimens (Patients 12, 16, 20, 22) were largely caseous consisting of 
amorphous material mixed with cells at varying stages of necrosis (Fig. 3.lOd-f; 3.12). 
A qualitative ultrastructural evaluation confirmed the histological findings of the HIV-
infected versus the -uninfected group consistent with a pathogenic insult. Despite the 
occurrence of features similar to the HIV -uninfected group, the severity in the HIV-
infected group was more extensive and degenerative. A multinucleated cell was 
detected, (Fig. 3.13a) localised together with plasma and epithelioid cells in an HIV-
infected specimen (Fig 3.13b,c) (Patient 14). Nuclear changes included peripheral 
heterochromatin aggregation (Fig. 3.12e), micro-segregation of heterochromatin (Fig. 
3.12f), and nucleolemma swelling, (Fig. 3.12f) occurring, predominantly, in the HIV-
infected group. A predominance of degenerative features such as dilated cisternal 
whorls of rER (Fig. 3.14b,c) and profuse cytosolic ribosomes (Fig. 3.15fa) was evident 
in the majority of HIV -infected specimens. There was evidence of an amorphous intra-
cisternal content indicating that oedema was not the cause of ER swelling. Other 
92 
specimens showed cisternal inclusions of Russell bodies (Fig. 3.15c-e). Lysosomes 
were widely distributed in both HIV -uninfected and -infected specimens (Fig. 3.16a-d) 
and contained lysed material or debris (Fig. 3.16a, b), intact bacilli (Fig. 3.16c, d, 17c), 
and/or viral-like particles (Fig. 3.17a-c). Virus-like particles measuring lOO-207flm in 
diameter (Fig. 3.17a-c) were characterised by their size and morphology. Lysosomal 
inclusions of 500-1500nm in diameter and resembling bacilli with thickened cell walls 
were also observed within the same lysosomal compartment as the virus-like particles 
(Fig.3.17c). 
3.3.3.3 Ultrastructural features in both HIV -unininfected and infected specimens 
Plasma cells (Fig. 3.11c) and giant epithelioid cells (Fig. 3. 13b,c) were rich in ER. The 
distribution of cisternae in the latter ranged from closely packed parallel stacks (Fig. 
3.14a). Mitochondria (Fig. 3.15a-f) varied in shape and size, were double membrane-
bound and contained cristae. In addition, mitochondria were observed in close 
proximity to ER and within dilated cisternal whorls of ER (Fig. 3.15). Degenerative 
mitochondria in the form of myelin bodies (Fig. 3.18a, b), were noted intracellularly or 
as part of the degenerative cellular debris. Intra- (Fig. 3.19a) in addition to a wide 
distribution of collagen fibrils (Fig. 3.19b) occurred in both HIV-uninfected and -
positive specimens. Collagen deposits displayed characteristic cross-striations (Fig. 
3.19b). 
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Figure 3.10: Representative micrographs of toludine blue stained semi-thin sections of (a-c) 
HIV-uninfected and (d-f) HIV-infected specimens. Note (b,e) granuloma formation, (arrows) 
caseation and an infiltration of immune cells (b,c,e,f) in both HIV -uninfected and - infected 
sections. Giant cells (G) and fibrosis (arrow head) were observed in the HIV -uninfected 
section. [Initial Mag. a,d: x20, b,e: x40; c,f: x 100] . 
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Figure 3.11: Electron micrographs depicting (a) a granulocyte (basophil or 
eosinophil) with granular cytoplasmic inclusion, (b) a neutrophil with characteristic 
multi-lobed nucleus, (c) a plasma cell displaying characteristic profusion of ER and 
(d) a lymphocyte which is a-granular, has a large nucleus with a thin rim of 
cytoplasm [Initial Mag. a: xI5 000, b: xI2 000, c: xlO 000, d: xI2 000]. 
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Figure 3.12: Electron micrographs illustrating the predominance of typically necrotic 
features such as degenerative nuclei (n), vacuolation (v), extensive intra- (i) and extracellular 
(e) fibrin deposits observed in (a,b) HIV-infected specimen. Nuclar features such as (c) 
apoptotic neuleus, (d) heterochromatin degranulation (e) a pyknotic nuleus and (f) oedma of 
nucleolemma (dashed arrows), vacuolation (v), and cytoplasmic lysis were also observed. 
Note micro-segregation of the heterochromatin (arrows). [Initial Mag. a: x3 000, b,c: x2 
500; d, e: x8 000, f: x25 000]. 
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Figure 3.13: Electron micrograph showing (a) a mulit-nucleated giant cell (G) observed in an 
HIV-infected specimen, (b,c) epitheliod cells (E), (c) an apoptotic nucleus (n) and 
degenerative mitochondria (m)[Initial Mag. a: x 8 000; b, c: x 4 000] 
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Figure 3.14: Electron micrographs illustrating ER distribution in (a) in an HIV-
uninfected and (b, c) HIV-infected specimens. Figures b and c illustrate a 
predominance of dilated cisternal pools of rER with an amorphous content. [Initial 
Mag. a: x30 000; b, c: x25 000] 
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Figure 3.15: Electron micrographs illustrating cisternal inclusion of Russell bodies 
(arrows) in (b,c) HN-uninfected and (c-e) HN-infected specimens. Note the close 
proximity of ER to mitochondria and dilated cisternae and (f) profuse accumulation of 
free cytosolic ribosomes in an HIV -infected specimen. [Initial Mag. a: x25 000, b: x60 
000; c: x15 000; d: x60 000, e: x40 OOOf: x30 000] 
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HIV -negative HIV -positive 
Figure 3.16: Electron micrographs illustrating lysosomal actIvIty in (a,c) HIV-
uninfected and (b,d) HIV -infected specimens. Note degenerative material degenerative 
material and debris in a and b, whilst c and d contain phagocytosed degenerative bacilli 
(arrows) [Initial Mag. a: x50 000, b: x15 000, c: x20 000, d: x50 000]. 
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Figure 3.17: Electron micrographs showing (a,b) intra-lysosomal viral-like 
particles (arrows). Note the (c) thickened cell walls of the bacilli-like 
inclusions (dashed arrows). [Initial Mag. a: x 50 ODD, b: x 40 ODD, c: x6 000] 
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Figure 3.18: Electron micrographs of (a) myelin body (m) occurring intra-
cytoplasmically in an HIV-uninfected specimen and (b) within degenerative 
debris of an HIV -infected specimen. [Initial Mag. a: x25 000, b: x20 000] 
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Figure 3.19: Electron micrographs displaying (a) intracellular fibrin bundles (arrows) and (b) 
collagen showing the regular periodicity of the cross-striations typical of the collagen fibrils. 
[Initial Mag. a: x40 000, b: x30 000]. 
3.4 Discussion 
3.4.1 Hisopathological features 
No statistical difference in granuloma formation between HIV -infected and uninfected 
patients could be demonstrated in the present cohort. It has been proposed that TB 
infections specifically, lepromatous lesions, do not differ pathologically between HIV-
infected and -uninfected patients with comparable levels of cellular infiltration such as 
epithelioid and giant cells (Faye et al., 1996, Lawn et al., 2002). At a radiological level 
they present similarly despite a more rapid disease progression in the co-infected patient 
(Kuri saki , 2000, Villoria et aI., 1992, Villoria et al., 1995). The findings of the present 
study were consistent with these findings. 
Histopathological evaluations of HIV -infected and -uninfected specimens in the present 
study, were consistent with previous descriptions of granuloma presentation as 
comprising of solid epithelioid cells, one or more giant cells and fibroblastic 
proliferation with central or no necrosis; or minute, peculiar foci of necrosis with little 
cellular material in co-infected patients (Roitt et aI., 2001). This is despite differences 
in anatomical sites of infection. Atypical features of TB-infection were noted in the 
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present study such as a predominance of plasma cells. While the anti-TB immune 
response is cell-mediated other bacterial species elicit a humoral or Ab-mediated 
response in which plasma cells play a prominent role (Roitt et aI., 2001). Their 
presence may therefore be indicative of an atypical mycobacterial infection. 
A further atypical feature of a TB infection was the predominance of epitheliod cells in 
selected specimens where significant assoction between greater tissue granulation and 
reduced epitheliod cell infiltration was demonstrated. The importance of epithelioid 
cells to an effective anti-TB immune response has been demonstrated in murine models 
of pulmonary TB (Dormans et al. , 2004). In addition, epithelioid cells predominate in 
non-caseating granulomas (Fujita et al., 2000), illustrating their protective role. 
However, others have reported HIV localised to macrophages and epithelioid cells of 
TB co-infected patients (Kurisaki, 2000) demonstrating that this protective role may be 
inevitably altered or disrupted in HIV ffB infected patients. 
Multi-nucleated giant cells, the hallmark of an effective anti-TB immune response 
(Jordaan et al., 1994), were identified at both the light and ultrastructural level primarily 
in the HIV-uninfected group. However, in HIV pathology, CD4+ T-cells also aggregate 
to form a giant cell referred to as a syncytium (Huff, 2003). The induction of syncytia 
formation is characteristic of CXCR4-tropic HIV variants (Korber et aI., 1994) and 
heralds late-stage disease. While syncytia formation is usually associated with T-
lymphocytes, it has also been reported in Langerhans cells, which may also occur in TB 
granulomas (Jordaan et aI., 1994, Stingl et al., 1990). CD+ T-cell depletion progresses 
rapidly in HIV -infected patients as a result of apoptosis, giant cell formation and 
degeneration of these aggregations of multiple CD4+ cells (Roumier et aI., 2003). 
Interestingly, Roumier et al, (Roumier et al. , 2003) were able to map HIV-initiated 
syncytia apoptosis to the mitochondrial pathway. 
3.4.2 ZN staining 
Spinal TB is a pauci-bacillary disease (Walsh et al., 2004), which contributed to the 
negative AFB (ZN technique) findings in this study. It is also plausible that the 
paraspinal tissue evaluated in the present study were biopsied from pauci-bacillary 
regions within the spinal lesion. Others have described micro-anatomical niches within 
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granulomas where foci of bacilli occur at the surface of a TB cavity or in lesions 
connected to an airway, rather than in the cellular or necrotic regions (Kaplan et al., 
2003). Moreover, the oxygen concentration within the tissue can not equate to that of 
pulmonary tissue and related airway structures. Bacterial populations in the spine are 
expected to therefore be impacted accordingly and this was demonstrated, in the present 
study, by the absence of AFBs in specimens. 
Secondly, patients were maintained on conventional anti-TB therapy and enhanced 
nutritional support prior to surgery and sample collection. Consequently, site-specific 
bacterial loads would have been radically reduced. Since the epidural tissue is an 
oxygen-deficient environment relative to pulmonary tissue, bacterial clearance may be 
augmented a low oxygen content greatly enhances the sterilizing activity of drugs such 
as pyrazinamide (PZA) (Wade and Zhang, 2004). On the other hand, persistence of 
approximately 8% viable bacilli has been noted in pulmonary TB granulomas even with 
anti-TB chemotherapy (Fenhalls et al., 2002a). 
Finally, in paediatric patients and those with HIV co-infection, demonstration and 
isolation of AFBs is rare (Anane and Grangaud, 1992) and challenging. The use of 
molecular technology to diagnose (Kivihya-Ndugga et al., 2004) and localise (Fenhalls 
et al., 2002a) Mtb has shown notable success over conventional microscopy. Negative 
AFB staining, but positive immunolocalisation of Mtb antibody (Humphrey and 
Weiner, 1987) and DNA (Fenhalls et al., 2002a) suggested the persistence of cell wall 
deficient (Hulten et al., 2000) or remnants of lysed bacilli (Kaplan et al., 2003) in 
infected tissue. It may therefore be argued that similar bacterial remnants were present 
in this study resulting in negative ZN findings. 
3.4.3 Immunolocalisation of CD68 cells 
The importance of monocyte/macrophage phagocytic cells to the anti-TB immune 
response focused mc investigations in the present study on the CD68+ cells 
representing phagocytic/endocytic cells. While, other cell types, such as the CD4+ and 
CD8+ T -cells playa significant role particularly at the initial stages of infection (Mehta 
et aI., 1996), the primary cells targeted and exploited by the bacilli are macrophages. It 
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was hypothesised that macrophage infiltration in spinal TB granulomas would parallel 
that of pulmonary disease and this was demonstrated both histopathologically (H&E) 
and by immunolocalisation of CD68+ cells. It was also anticipated that disparate 
CD68+ immunoreactivity patterns would be noted in HIV -infected and -uninfected 
specimens. However, this hypothesis was refuted, following a quantitative analysis of 
CD68 immunoreactivity. 
It would be misleading to assume that the prevalence of CD68 immuno reactive cells in 
both study groups represented an active and robust immune response since it must be 
remembered that infected macrophages, despite their presence, may simply be incapable 
of a killing-response and consequently ineffectual against the pathogen (Barker et al., 
1996). Since the CD68 peptide is a glycosylated lysosomal membrane protein involved 
in endocytosis and lysosomal trafficking (Barois et al., 2002, Kobayashi et al., 2002) 
localised within immature dendritic cells (Barois et al., 2002) and epithelial cells 
(Povysil et al., 2001) its localisation provided a relative indicator of lysosomal activity. 
While not significant, greater distribution and reactivity of CD68 was noted in the HIV-
infected compared with the -uninfected group. Thus lysososmal activity, while greater, 
did not result in efficient resolution of disease, rather, greater pathology, necrosis and 
degeneration. It may be speculated that lysosomal function was altered or redirected by 
HIV co-infection. 
The present study demonstrated CD68 immunoreactivity in regions rich in mononuclear 
cells, granulomas and in highly necrotic specimens. These findings were consistent 
with those of Kaplan et aI, (Kaplan et al., 2003) who described abundant CD68+ cells in 
regions of the granuloma with greater phagocytic activity such as the surface of the 
granuloma cavity and fibrotic zone. In addition, the authors (Kaplan et al., 2003) 
reported remnants of degenerative or necrosed macrophages in the necrotic zone. 
Similarly, the present study demonstrated that caseous, necrotic regions devoid of cells 
but rich in cellular debris were CD68 antibody reactive. Moreover, ultrastructural 
investigations in the present study demonstrated bacilli within intra-cellular membrane-
bound compartments rather than in the extra-cellular matrix. Others have localised 
bacilli and bacterial DNA within CD68+ cells of macrophage morphology (Kaplan et 
aI., 2003) and giant cells (Fenhalls et aI., 2002a, Fenhalls et al., 2002). 
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In addition, tissue macrophages represent a source of productive HIV infection. It has 
been reported that replication efficiency and the accumulation of mutations is elevated 
in patients with OIs commonly associated with AIDS such as M.avium and P.carinii 
(Orenstein et al., 1997). The paradoxical increase of vira110ad at late-stage disease, 
despite severely depressed CD4+ T-cell counts, has been attributed to viral reservoirs in 
monocyte/ macrophage-derived cells (Casso1 et al., 2005, Orenstein et al., 1997). The 
greater infiltration of CD68+ cells in the spinal granulomas may represent a significant 
potential for viral sequestration within these cells. 
3.4.4 Immunolocalisation of CD4 and CDS cells 
In direct contrast with CD8 immune reactivity, CD4 reactivity was sparse or absent in 
the present study. Both cell types are essential to an effective immune response against 
acute infection although the specific role of CD8+ cells remains controvertial (Chan and 
Flynn, 2004). 
A reduced or depleted CD4+ T-cell population is usually associated with HIV infection 
therefore was not an unexpected finding in the HIV co-infected group. However, in the 
HIV-uninfected group, depletion of CD4+ T-cells and a sparse distribution of CD8+ T-
cells were atypical. However, when one considers its insidious onset spanning, it is 
clear that the paradigm of acute infection cannot be applied to spinal TB - rather the 
disease represents a chronic infection. As demonstrated in a murine model, there is an 
influx of CD4+ and CD8+ during the first weeks of infection however as the infection 
progresses, the role of CD8+ cells become more prominent (Gonzalez-Juarrero et al., 
2001). Similarly, immuno10calisation of CD4 and CD8 cells in the present study 
demonstrated sparse CD4 reactive cells but greater CD8 reactive cells. Although 
controvertial, the contention of Gonzalex-Juarrero et al, (2001) that CD8 cells 
perpetuate chronic disease may, therefore, be applicable to the present study. Earlier 
studies have established similar kinetics where CD4+ T -cells predominate in the acute 
phase and CD8+ cells in the chronic phase (Hernandez Pando et al., 1996). 
The HIV -uninfected group displayed distinct granuloma formation and less caseation. 
The findings of CD4 and CD8+ T-cell immunolocalisation were therefore consistent 
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with the observed histopathology in the present study since th~se cells contribute 
significantly to IFNy production (Villarreal-Ramos et al., 2003), which ensures a robust 
immune response and efficient clearance of disease. In pulmonary-TB patients 
displaying cavitation, the percentage CD8+ T-cell is significantly greater (p<0.05) than 
in their non-cavitary counterparts in which CD4+ T-cells are also elevated (Mazzarella 
et al., 2003). Not only do T-cells mediate the immune response against infection, but 
they also aid in the killing of infected macrophages (Oddo et al., 1998). Consequently, 
the pathogenicity of the bacilli is reduced. In this way, depletion of T-cells contributes 
to the greater pathogenesis and infectivity of TB in HIV co-infected individuals (Kaplan 
et aI., 2003). These findings may also account for the more severe pathologies in co-
infected spinal TB patients in the present study. 
Lymphocytes and cells of macrophage appearance were observed in close proximity in 
the present study. Interestingly, it has been shown that the proximity of HIV -infected 
macrophages and CD4+ T-cells in HIVITB co-infection, activates HIV-l LTR (Nakata 
et al., 2002) thereby initiating viral replication. 
3.4.5 Ultrastructural features 
3.4.5.1 Ultrastructural features of TB 
Recently, Dahl (Dahl, 2005) described the ultrastructural features of Mtb from nutrient 
cultures. However, caution must be applied when viewing clinical specimens since the 
fine structural details of the bacilli can be well characterised in culture but may be more 
difficult to discern them in clinical samples particularly those receiving treatment. 
Particles resembling intact bacteria were noted in the present study. Since the cell walls 
of phagocytosed bacilli undergo lysis within phagolysosomes, morphological and 
functional changes result (Gerasimov et al., 2003), thus observation of a double 
membrane cell envelope for instance would be exceptional in treated clinical samples. 
The findings of the present study may thus represent morphologically altered bacilli. 
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3.4.5.2 Ultra-structural features of the granulomas 
A prominent feature of both groups, particularly the co-infected specimens, was the 
presence of distended ER within epithelioid, plasma and immune cells. Dilation of ER 
is a result of either ingress of water into the cell or storage of secretory proteins within 
the ER (Ghadially, 1982). In the former instance, the contents appear more electron-
lucent, while in the latter, the ER appears electron-dense. It is hypothesised that the 
latter results from a rate of protein synthesis which exceeds the capacity of the cell's 
transport mechanism; a mechanical or enzymatic defect; or production of an atypical 
peptide (Ghadially, 1982). 
It can be speculated that enhanced production of immune complexes or up-regulated 
viral replication may be responsible for the distended ER in the present study. Thus the 
inclusion peptides may be comprised of up-regulated secretory products, or atypical 
peptides such as viral proteins. In the context of an active TB infection, particularly in 
association with HIV, elevated immunoglobulin production is highly likely. Moreover, 
Facke et al, (Facke et aI., 1993) reported immature virus-like particles resembling the 
intracisternal A-type particles (murine endogenous retrovirus elements) within the ER 
of infected cells. These viral particles were non-infectious while those observed extra-
cellularly had the typical morphology of mature viral particles. Others have 
demonstrated similar findings where a single amino acid substitution in the matrix gene 
redirects virion assembly and budding to cytoplasmic vacuoles identified as Golgi 
elements (Facke et al., 1993, Freed and Martin, 1994). 
An additional account for the distended ER may lie in changes associated with cell 
injury. Atypical appearance of ER has been correlated with early cytological changes 
due to cell injury; while dilation and versiculation of ER is a known feature of apoptosis 
(Ghadially, 1982). Whatever the reason, hypertrophy of the ER is a manifestation of 
altered cellular activity. In the present study, increased prevalence of rER in epithelioid 
and plasma cells exemplified increased cellular activity and upregulation of protein 
synthesis. The present investigation therefore, reflected possible HIV exploitation of 
the cellular protein synthesis machinery and the host's attempt to mount an effective 
Immune response. 
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The mitochondrial changes and disruption observed in this study conforms to similar 
reports in HIV -infected cells (Raidel et al., 2002). In their study (Raidel et al., 2002), 
the ultrastructural and consequent degenerative changes to the cellular mitochondria 
were attributed to HIV-l tat protein. Both TB and HIV, contribute to mitochondrial 
changes induced by oxidative stress. The multi-centric structures bound by a single 
membrane were identified in this study as myelin bodies and indicated mitochondrial 
degeneration and increased turnover. Duan et aI, (Duan et al., 2002 ) associated 
mitochondrial membrane disruption with necrosis, increased bacterial replication and a 
failed antibacterial response. Hernandez-Pandor et aI, (Hernandez-Pando et al., 2001) 
also presented evidence of the role of mitochondria in disease progression. 
The present cohort of HIV-infected patients did not receive ARVs therefore the 
observed mitochondrial changes cannot be attributed to their toxic effects. It is, 
however, known that nucleoside reverse transcriptase inhibitors (NRTIs) disrupt 
mtDNA and resultant enzyme malfunction (Lewis et al., 2003, Nolan et al., 2003). 
Commonly, abnormalities of the mitochondria in treated patients included accumulation 
of glycogen, reduction or loss of crystae and matrix density (Verucchi et aI., 2004). 
Morphologically, the mitochondria appear swollen, the cristae and internal structures 
are disrupted, and there is acute thinning of the mitochondrial membrane (Tolomeo et 
aI., 2003). Recently, it was demonstrated that an anti-TB drug, Isoniazid (INH), also 
induces mitochondrial dysfunction in hepatic cell lines (Bhadauria et al., 2007). Thus, it 
is more likely that the mitochondrial pathologies observed in the present study result not 
from ARV toxicity but reflect the impact of either, anti-TB chemotherapy or the 
Immune pressures. 
The occurrence of Golgi complexes, which function to condense, modify and package 
peptides transported from the ER into secretory granules, illustrated that cells were 
functional and actively involved in protein synthesis. High concentrations of Golgi 
complexes furthermore, reiterate the increased cellular activity alluded to by the 
morphology of the ER. This may be due to either immune activation or active HIV 
replication and the exploitation of the cell's replication mechanisms by the virus. 
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Both intra- and extra-cellular fibrin was noted in both HIV -infected and -uninfecteed 
specimens. Fibrosis is typical of late stage granuloma formation (Mornex et al., 1994)" 
is important in preventing disease dispersion (Adams, 1983) and is initiated by 
leukocyte infiltration (Kelley, 1990, Kovacs, 1991). However, fibrosis increases the 
risk of permanent tissue and organ damage of adjacent structures (Kovacs, 1991, 
Mornex et al., 1994) and is arguably the main cause of post-treatment morbidity 
(Jayasankar et al., 2002). While not all granulomas develop a fibrotic cuff; fibrosis was 
clearly demonstrated in both HIV -infected and uninfected specimens representing a 
discrete anatomical compartment of co-infection where both the viral and bacterial 
latency may be sequestered. 
3.4.5.3 Apoptosis, necrosis and related nuclear changes 
Characteristic nuclear changes noted in the present cohort were all indicative of necrosis 
and apoptosis while pyknosis and karyolysis, in particular, are characteristic of a viral 
infection (Ghadially, 1982). In an HIV/ herpes virus co-infected patient, ultrastructural 
features included marginated and condensed chromatin (Guccion and Redman, 1999). 
Since the authors failed to characterise HIV -induced ultrastructural changed, these 
features cannot solely be attributed to the herpes virus. Moreover, comparable findings 
demonstrated in the present study suggested that HIV co-infection also contributed to 
the morphological changes described by Guccion and Redman (Guccion and Redman, 
1999). 
Mycobacterial infection induces both apoptosis and necrosis of infected monocytes and 
macrophages (Gil et aI., 2004). Monocyte-derived macrophages for example, undergo 
apoptosis in response to an Mtb infection (Ciaramella et al., 2004), cells from reactive 
TB-exposed individuals undergo apoptosis, while cells from actively-infected patients 
undergo both apoptosis and necrosis (Gil et al., 2004). However, more virulent strains 
of bacilli disrupt the process of apoptosis (Fratazzi et al., 1999) or induce necrosis 
instead, resulting in uncontrolled TB replication (Duan et al., 2002 ). Macrophage 
apoptosis is advantageous since it not only retards bacterial replication but may also 
reduce tissue damage (Fratazzi et al. , 1999, Kornfeld et al., 1999). In addition, halting 
the release of intracellular debris and promoting the sequestration of bacilli in apoptotic 
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bodies prevents the spread of disease (Chen et aI., 2006, Fratazzi et al., 1999). In a TB 
infection alone, TNFa mediated macrophage apoptosis is protective, but in HIV co-
infected patients high TNFa concentrations up-regulate HIV replication. 
While features consistent with apoptosis were observed in selected specimens, necrosis 
predominated in the present study. A primarily necrotic rather than apoptotic response 
would substantiate the gross pathology and tissue damage in the absence of high 
bacterial numbers that were observed in the present cohort. It was therefore 
demonstrated that cell death in TB spondylitis regardless of HIV status" reflects 
previous reports in pulmonary TB (Chen et al., 2006). 
Enlarged nucleoli or nucleolar hypertrophy are strongly associated with an up-
regulation of protein synthesis particularly in relation to malignancy (Ghadially, 1982). 
Like features were evident among HIV -infected specimens in this study. Whether these 
changes were reflective of active processes or events that had drawn to a close yet still 
manifest morphologically, can be speculated upon. The induction of increased protein 
synthesis may have occurred via an activated immune response in an attempt to control 
progressive disease or may reflect HIV exploitation of the cellular machinery for its 
own replication cycle. 
3.4.5.4 Viral and bacterial sequestration 
Evidence of sequestration of bacilli in membrane-bound intra-cellular compartments 
was noted in the present study, suggesting a possible bacterial reservoir. They were 
observed containing degenerative material of varying electron density in addition to 
bacilli- and virus-like particles in the present study. 
Lysosomes are single membrane bound organelles involved in the intracellular digestion 
of various endogenous and exogenous materials including pathogens (Ghadially, 1982). 
Consequently, functional disruption, by preventing the fusion of phagosome and 
hydrolase-containing lysosomes (Ghadially, 1982), is the primary mechanism by which 
the bacilli is able to evade destruction and induce latency (Nguyen and Pieters, 2005). 
Others describe lysosomes in rCSF-treated monocytic cells where a number of electron-
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dense lysosomal compartments were observed (Gendelman et al., 1988). Similar 
observations were made in the present study. 
Viral-like particles were identified, at the ultrastructural level, in the present study, but 
varying in size and morphology. This finding represents the first report of intra-
cytoplasmic viral particles in spinal TBIHIV co-infected granulomas suggestive of a 
sequestered compartment of latent infection. This was not an unexpected finding since 
viral particles exist in varying stages of maturation (Pudney and Song, 1994), may vary 
in size from 100nm (Raposo et al., 2002) to 207nm (Briggs et al., 2003) and may occur 
as single- and double-cored particles ranging in size from 134nm to 159nm (Briggs et 
al., 2003). Consequently, viral morphology, in vivo, is diverse and it is rare that viral 
particles are observed depicting the typical core structure. 
The virus-like particules observed III the present study may represent 
phagocytosed/endocytosed virions or particles misdirected to bud into the vacuole by 
polymorphisms in the viral genome. It has been shown that alveolar macrophages (AM) 
from HIV Ipulmonary TB infected patients endocytosed/phagocytosed both bacilli and 
viral particles but the phagolysosome formation and acidification of these vacuoles was 
halted (Mwandumba et aI., 2004). Viral particles have been observed within phagocytic 
and non-phagocytic endosomal vacuoles of epithelial cells (Bourinbaiar and Phillips, 
1991, Deretic et al., 2004) plasma cells (Weiss, 2002) and follicular dendritic cells as 
well as in their cytoplasm (Tacchetti et aI., 1997). In an earlier study Pudney and Song 
(Pudney and Song, 1994) localised virions specifically to endocytic compartments. The 
receptor mediating e~docytosis is independent of CD4 but is a Langerhans-associated 
surface molecule (Dezutter-Dambuyant et aI., 1991). 
A further account for these intra-lysosomal virus-like particles may lie with its assembly 
and budding properties within non-T -cells. Studies have shown virions to bud into the 
lumen of late endosomes in macrophages (Lindwasser and Resh, 2004, Meltzer et al., 
1990a, Meltzer et al., 1990b, Meltzer et al., 1990c, Ono and Freed, 2004, Pe1chen-
Matthews et al., 2003, Raposo et al., 2002). Gendelman et aI, (Gendelman et aI., 1988) 
also noted several immature virions in a transition period preceding viral assembly in 
these vacuoles. The mechanisms of virion budding and assembly therefore, mimic that 
of internal vesicle formation in macrophages (Raposo et al., 2002). Fusion of these 
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multi-vesicular compartments with the plasma membrane actually facilitates the release 
of huge numbers of virions (Raposo et al., 2002). These viruses acquire MHC class II 
proteins and CD63 when budding into these compartments, thus acquiring a mechanism 
for immune evasion and forming an important reservoir of escape mutants. Recruitment 
and fusion of macrophages and lymphocytes to form multi-nucleated giant cells, 
furthermore, aids in the spread of virions 
It was important to note that prevention of phagosomellysosome fusion commonly 
associated with TB latency and survival may also enhances HIV infectivity and 
virulence. In these instances, HIV infection is facilitated via the endocytic pathway 
(Wei et al., 2005) enhancing viral infectivity by up to 400-fold and is independent of 
viral isolate and co-receptor usage. Both HIV and TB disrupt the steps during or after 
the synthesis of P13P, a membrane-bound signalling molecule that controls endosomal 
and phagosomal sorting (Deretic et aI., 2004). Not only is phagosome maturation 
halted, but HIV replication and assembly in macrophages is enhanced. 
3.4.6 Diagnostic relevance of microscopy 
The utility of microscopy over more advanced immuno-Iocalisation methods such as 
flow cytometry has been demonstrated. Microscopy is highly functional demonstrating 
specific cellular morphologic features otherwise indistinguishable by any other means 
(Ghadially, 1982), (Giulian et al., 1995). The value of antibody localisation using 
immuno-histochemistry (IRC), in the clinical, as well as, the research setting has proven 
highly sensitive and specific (Gutierrez et aI., 1999) for a range of immune cells and 
pathogens. The related technology is, moreover, constantly evolving and advancing 
(Bunea and Zamescu, 2001) allowing an ever-increasing range of applications. 
Unfortunately one of the primary restrictions to microscopy is the lack of appropriate 
and specific markers for various cells and their products. The findings of this study 
demonstrated the efficacy of IRC and TEM as adjunct diagnostic and research tools, 
particularly in pauci-bacillary disease and diagnostically problematic specimens (Walsh 
et al., 2004). 
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3.4.7 Limitations of the study 
This study was conducted in a small subset of the cohort which, if expanded, may have 
yielded greater statistical power to the subsequent analyses. It may be argued that the 
efficiency of immune localisation in wax embedded sections may not be as informative 
as cryosections. This is because processing and embedding tissue biopsies may result in 
disruption or blocking of antigen sites while cryoblocks are unprocessed, flash-frozen 
specimens. The former requires preparation and treatment to expose antigen sites while 
the latter can be treated with the antibody of interest, directly and is often more sensitive 
and specific (Barrett et al., 1993). However, the utility of mc on wax embedded 
sections has been demonstrated (Pudney and Anderson, 1995). Authors argue that 
while cryosections may afford many advantages, the loss of structural features, and the 
biohazard risk of unfixed specimens make this an unattractive alternative. It is for these 
reasons that paraffin-embedded wax blocks were chosen for this investigation. Since 
any histological and ultrastructural investigation represents a snap-shot of the disease 
condition, these investigations allowed a study of TB spondylitis at late stage disease 
when progressive pathology had resulted in extensive tissue damage. Monitoring 
disease progression in HIV -infected and -uninfected patients would be an important 
contribution to the understanding of both HIV and TB pathogenesis, but was beyond the 
scope of this investigation. 
3.4.8 Summary 
This report constitutes the first histopathological and ultrastructural description of 
clinically and radiologically diagnosed infectious spondylitis contrasting, the HIV-
infected and -uninfected specimens. Patients biopsied were at similar clinical stages of 
disease despite greater immune competence (>CD4+/CD8+ T-cell counts) in the HIV-
uninfected group. All specimens were AFB negative, illustrating the diagnostic 
limitation of the ZN stain when applied to pauci-bacillar diseases such as infectious 
spondylitis. These findings confirm that negative TB microscopy and culture findings 
reported in previously (Chapter 2). There was no association between negative AFB 
microscopy and mv co-infection. The PAS stain, used to demonstrate the presence of 
fungal pathogens, was negative in all instances confirming a bacterial mediator of 
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disease. Whether the organisms were all Mtb or included non-tuberculous 
Mycobacterium (NTMs) was not established at this juncture. 
Histopathological features were diagnostic of spinal TB in the majority of cases (91.4%) 
and were associated with HIV status. The atypical features noted in the remaining 
patients may be ·a result of non-tuberculous pathogens. Pathologies ranged from 
distinctive granuloma formation and simple necrosis to caseation and suppuration 
similar to features typical of pulmonary TB. Also consistent with previous findings of 
pulmonary TB was that the HIV -infected group displayed greater caseation relative to 
their HIV -uninfected counterparts. However in direct contrast to pulmonary TB, 
distinctive differences between the HIV -uninfected and -infected groups were 
demonstrated in the current study. These included limited granuloma formation, and an 
inverse correlation between granuloma formation and epithelioid, as well as lymphocyte 
infiltration. Immunolocalisation of CD68+ cells, however, illustrated that the 
phagocytic/endocytic potential within the lesions was not related to HIV status. 
However, as expected, CD4 and CD8 immune reactivity was HIV related. Moreover, 
the distribution and reactivity of CD4 and CD8 localisation was strongly suggestive of 
chronic rather than an acute TB infection, which is consistent with the insidious nature 
of spinal TB. 
Ultrastructural evaluation was indicative of either, necrosis and degeneration or a strong 
cellular immune response. The most distinctive feature associated with HIV co-
infection was grossly dilated ER. Virus-like particles and bacilli were identified based 
on their size and morphology at the ultrastructural level representing a novel finding in 
association with TB spondylitis. Demonstration of virus- and bacterial-like particles 
within membrane-bound intracellular compartments was suggestive of sequestration of 
the pathogens and a possible reservoir. Extensive fibrosis and collagen deposits were 
noted, affurning the similarity in histological and ultrastructural features between 
infectious spondylitis and pUlmonary TB. Thus the hypothesis, that macrophage 
infiltration is impaired by HIV co-infection, was rejected. However, ultrastructural 
differences comparing HIV -infected versus the -uninfected specimens, confirmed the 
hypothesis that HIV co-infection manifests as greater degeneration and caseation, at an 
ultrastructural level. 
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Chapter 4 - Bacterial Genotyping 
4.1 Introduction 
Timely interventions in TB patients even in extra-pulmonary disease, significantly 
improves patient morbidity and mortality regardless of HIV status (Alvarez et al., 2004, 
Day et al., 2004b) illustrating the importance of accurate and rapid diagnosis. Despite 
technological advances, traditional TB diagnostic methods (Garg et aI., 2003), still 
prevail, which may not be robust enough to detect paucibacillary diseases, such as 
spinal TB. In addition, symptoms of an Mtb infection may intersect with those of other 
pyogenic diseases (Swaminathan, 2004) further obscuring diagnosis. 
Infectious spondylitis results from a range of pathogenic and opportunistic organisms 
such as Mtb, M.avium and M.intracellulare (Collins, 1989, Beggs et al., 2000, Sakatani, 
2005, Koh et al., 2005, Lima et aI., 2005, Morita et al., 2005). In pulmonary disease, 
Mtb and HIV are closely linked (Ferreira et aI., 2002) however, atypical or non-
tuberculous Mycobacterial infections are increasingly being associated with HIV-
uninfected, immune compromised individuals (Corbett et al., 1999a, Henry et al., 2004). 
Whether HIV co-infection impacts the occurrence of non-tuberculous or atypical 
opportunistic infections in the context of spinal TB has yet to be established. 
The recent sequencing of the full genomes of several bacteria has assisted in developing 
molecular techniques including genotyping and restriction fragment length 
polymorphisms (RFLP) (Hazbon, 2004, Brown et aI., 2005, Zink et aI., 2003, Zink and 
Nerlich, 2004, Zink et al. , 2005) for diagnostic purposes. 
Previous clinical observations have reported the occurrence of pyogenic (Charles et al., 
1989) and cryptococcal (Govender and Charles, 1987, Govender et al., 1999a, Govender 
et aI., 1999b) spinal infections in KZN, SA. This chapter examines the hypothesis that 
atypical bacterial spondylitis is associated with HIV -infection using a broad-range 
bacterial genotyping assay. 
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4.2 Methods 
4.2.1 Specimen collection 
As described earlier (Chapter 2, Section 2.2.2-2.2.3), open biopsies of granulomatous 
tissue were collected from 60 patients (38 HIV-negative and 22 HIV-positive) during 
spinal decompression and submitted to two independent accredited pathology 
laboratories for conventional APB microscopy and culture identification (BACTEC 
MGiT Bacterial Identification assay; Beckton Dickenson,). 
4.2.2 DNA isolation 
4.2.2.1 DNA isolation from clinical samples 
DNA was isolated directly from 1O-20mg of fresh-frozen granulomatous tissue (Fig. 
4.2) using the Qiagen DNA Mini Kit. Tissue was macerated in Lysis Buffer, further 
homogenized using a QiaShredder (Qiagen, Hilden, Germany) and the resultant 
homogenate was applied to the Qiagen DNA isolation spin columns (Qiagen, Hilden, 
Germany). The isolation procedure complied with the manufacturer' s protocol, and 
DNA was eluted in 25/l1 sterile, filtered deionised water. DNA samples were quantified 
on a 1 % agarose gel. 
In cases where the isolation procedure was unsuccessful, other isolation methods were 
attempted including the PrepMan Ultra reagent (Applied Biosystems, Foster City, 
Calif., USA); 5% Chelex (Sigma, St. Louis, MO); a TEo.1 (lOmM Tris-HCl and 1O-4M 
EDTA) buffer/Chelex (5%w/v)lProteinaseK protocol; and an alkaline-lysis buffer 
method. In order to purify and concentrate the DNA, a precipitation using glycogen 
(lfll); sodium acetate (3M) and absolute ethanol was performed. Thereafter, samples 
were centrifuged (maximum speed; 20 minutes), washed in cold 70% ethanol and re-
suspended in 50-100fll sterile I filtered water. 
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4.2.2.2 DNA isolation from pure culture 
The human MDRI gene was amplified from extracted DNA to determine the integrity 
of the extracted product (results not shown). For samples not amplifiable directly from 
clinical samples, DNA was isolated from pure bacterial cultures (BACTEC MGiT 
culture). All positive cultures were heat inactivated at 95°C for 10 minutes at the TB 
pathology laboratory prior to transportation (at -20°C) to the molecular facility where 
subsequent DNA extraction and genotyping was conducted. 
Bacterial DNA was isolated using the Qiagen DNA Mini Kit (Qiagen, Hilden, 
Germany) from heat-inactivated pure cultures according to the manufacturer's protocol 
for bacterial cultures. The PrepMan Ultra Sample Preparation Reagent (Applied 
Biosystems Inc., Foster City, Calif., USA), was applied to those specimens that failed to 
provide an ample DNA yield. In instances where the yields were low, DNA was 
precipitated as described in Section 4.2.2.1. 
Mtb • NTM 0 Postive unidentified 0 Negative 
Figure 4.1: Graphical representation of diagnostic culture findings (BACTEC MGiT 
system), illustrating the large proportion of negative results and a predominance of 
Mycobacterium tuberculosis (Mtb) isolates. Non-tuberculous Mycobacteria (NTM) 
were also represented. 
119 
4.2.3 16S rDNA PCR amplification 
4.2.3.1 In-house PCR 
An in-house PCR adapted from Edwards et al (Edwards et al., 1989) was used to 
amplify the extreme 5' and 3' regions (primers A and H) of the l6s gene. The reaction 
mix is described in Table 4.1. 
The thermal cycling conditions included a 12 minute denaturation at 94°C, 36 cycles of 
95°C for 30 seconds, 55°C for 45 seconds and 72°C for lminute with a final extension 
of 72°C for 7 minutes. 
Table 4.1: A description of the components of the in-house PCR reaction amplifying a 






lOx PCR buffer 2.5 
MgCh (2.5mM) 1.5mM 1.5 
dNTP(200~) 4J!M 0.5 
Primer A (25 pmolhtl) 2.5pmo1lJ!l 2.5 
Primer H (25 pmo1lJ!l) 2.5pmo1lJ!l 2.5 
AmpliTaq Gold (SU/J!l) 0.05U 0.25 
Sample (-lug/J!l) 5.0 
Total volume 25 
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4.2.3.2 MicroSeq SOObp 16S rDNA Bacterial Identification 
The MicroSeq 500bp 16S rDNA Bacterial Identification Kit (Foster City, Ca., USA) 
was used as per the manufacturer's protocol to produce a 460-560bp product at the 
5' end of the gene (Fig. 4.2). Briefly, equal volumes (l51l1) of the PCR module reaction 
mix and the isolated DNA were subjected to the thermal cycling conditions as per the 
manufacturer's protocol. The precise primer sequences are trademark protected as part 
of the Bacterial Identification Kit and, as such, are not available to customers. A 500bp 
segment at the 5' end of the 16S rDNA gene was targeted. Negative (water) and 
positive (lng/ul E.coli) controls were included in each PCR reaction. The presence of 
the amplified product (460-560bp) from each PCR reaction was confirmed on an 






Full length 16S gene (--1500bl)) 
-+ = location of primer sequences and orientation 
Figure 4.2: An illustration of the 500bp region targeted by the MicroSeq 500bp 16S 
rDNA Bacterial Identification Kit and sequenced from pure bacterial cultures. 
4.2.4 Cycle sequencing 
4.2.4.1 Sequencing reaction 
Following quantification on an agarose gel, the purified PCR products were subjected to 
the sequencing reaction. One reaction for each strand (Forward and Reverse) was 
prepared by adding 7 III purified PCR product to 13 III of the sequencing module reaction 
mix (ABI, Foster City, Calif. USA). The thermal-cycling conditions were as per the 
manufacturer's protocol. 
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4.2.4.2 Clean-up of sequencing product 
Following the cycle sequencing reaction in a 96-well plate, excess dye terminators and 
primers were removed. Fifty-five micro litres of freshly prepared solution of 3M-
sodium acetate in absolute Ethanol (4% v/v) was added to each sample, the wells were 
sealed, vortex-mixed and centrifuged (3000g; 20 minutes). Plates were inverted onto 
absorbent paper to remove supernatant and centrifuged inverted at 150g for 5 minutes. 
Fresh preparations of 70% ethanol were added to each well (150~l/well); vortex-mixed 
and centrifuged (3000g; 5minutes). Inverting the plates onto absorbent paper and 
centrifuging (150g; 1-1.5minutes) removed excess ethanol. Plates were dried at room 
temperature for 1-5 minutes in the dark; thereafter sealed and stored at -20°C. 
The purified extension products were re-suspended in 1O~1 Hi-DilM Formarnide 
(Applied Biosystems Inc., Foster City, Calif., USA), denatured (5 minutes at 95°C) and 
sequenced on the ABI 3100 genetic analyzer (Applied Biosystems Inc., Foster City, 
Calif., USA).2 
4.2.4.3 Sequence analysis 
The resultant 16S rDNA sequences were codon aligned (Clustal W, GDE). Basic Local 
Alignment Search Tools (BLAST) at the National Centre of Biotechnology Information 
(NCBI), Ribosomal Differentiation of Medical Micro organisms (RIDOMM) and DNA 
Data Bank of Japan (DDBJ) sequence repositories compared these 16S sequences with 
published reference strains. An agreement between the query and reference sequences 
(NCBI, RIDOMM and DDBJ) of greater than 90% was accepted as a positive match. 
Confirmatory phylogenetic reconstruction was performed using an appropriate model 
selected in MODELTEST 3.0 and PAUP4blO bioinformatics software tools. Trees 
were bootstrapped using 100 replicates and rooted against an E.coli bacterial strain. The 
resultant trees were viewed in Treetool and Treeview. The reference sequences from 
the NCBI repository that were used in the construction of the tree included 
2 For more information regarding the Big Dye terminator sequencing reactions, refer to tbe ABI PRISM Automated DNA 
Sequencing Cbemistry Guide (pN 4305080). 
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M.tuberculosis (AJ536031,NC000962, X58890, S45301); M.africanum (AF480605); 
M.kansasii (AY43075); M.intracellulare (AJ536036, M61682, X52927); M.avium 
(AJ536037); M.chelatum (Z46664); M.xenopi (AJ536033); M.fortuitum (AY513243, 
AY 457066); M.flavescens (X52932); Norcardia spp. (X80611, X8061O); B.sanguinis 
(AJ628351); B.casei (AY468375); Stenotrophomonas maltophilia (AF533952); 
Pseudomonas spp. (AJ551156); Vibrio parahaemolyticus (X56580, AHOO0275, 
S83383, S83386, S83391); E.coli (NCOOO913); Klebsiella pneumoniae (DQI85604); 
Serratia marscescens (A Y 498856); Uncultured environmental bacilli (AB 193886); 
Propionibacterium acnes (NC006085); Salmonella typhimurium (DQI53191); 
Streptococcus pneumoniae (AMI57443) and E.coli (JOI859). 
4.3 Results 
4.3.1 Culture identification 
Nineteen (31.1 %) of the granuloma specimens were positive for a mycobacterium by 
BACTEC MGiT culture: 12 (19.7%) for Mycobacterium tuberculosis, and 7 (11.4%) for 
non-tuberculosis Mycobacteria (NTMs). 
4.3.2 Patient demographics of genotyped specimens 
Dfthe nineteen samples that were culture positive, nine (47.4%) yielded non-analyzable 
16S rDNA sequences with multiple stop codons. The remaining cultures (52.6%) 
provided high-quality sequence data and the demographic, immunological and 
microbial data for these patients are listed in Table 4.2. These were predominantly adult 
patients (80%) who were largely HIV -uninfected (70%). The mean age in this subset 
(n= 10) was 43 years (range, 2-71 years) while 2 patients were <3 years old. All 
patients, irrespective of their HIV -1 status, had inversed (or substantially reduced) 
CD4/CD8 T-cell ratios. Two HIV-l-negative patients (1 Mtb-infected (Patient 36) and 
one with an unclassified pathogen (Patient 23)) displayed CD4+ lymphopenia. 
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4.3.3 16S rDNA genotyping 
There was agreement between BACTEC MGiT culture identification and genotyping in 
4 of 10 culture positive specimens (3 Mtb and 1 NTM). As detailed in Table 4.2, three 
isolates identified as Mycobacterium tuberculosis (Mtb) (Patients 26, 32 and 36) by the 
BACTECT MGiT system were subsequently confirmed by 16S rDNA genotyping. The 
16S rDNA sequence from patient TB21 was identified as Mtb by BACTEC MGiT 
culture but was homologous with Mycobacterium intracellulare following BLAST 
analyses. Isolates that did not segregate with any published sequences in any of the 3 
repositories accessed was given the designation "unclassified". 
4.3.4 Phylogenetic analysis 
Bootstrap values were significant and strongly supported the tree (Fig. 4.3). 
Phylogenetic reconstruction confirmed the genotyping (BLAST) findings in all 10 
cases. Three isolates (Patients 26, 32 and 36) clearly clustered with Mtb, 1 (Patient 21) 
with M.intracellulare and another with (Patient 24) M.fortuitum. 
Table 4.2: Patient demographics corresponding to the 10 isolates that yielded analyzable 16S rDNA 500bp sequences. 
I-< E-4 
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TB5 65 M P l35.4 920.6 13000 NR NH 
TB18 2 M N 2254.2 2469.0 - NTM S.maltophilia 
TB21 47 M N NR NR - MTB M. intracellulare 
TB23 23 M N 497.8 614.8 - MTB NH 
TB24 71 M N 954.5 1711.6 - NTM M.fortuitum 
TB26 39 M N NR NR - MTB MTB 
TB32 2 M P 1004.8 2512.0 2500000 MTB MTB 
TB33 50 F P 376.4 443.7 210 000 MTB S.marcescens 
TB36 28 F N 487.9 488 - MTB MTB 
TBS4 20 F N 685.0 1043.0 - NR B.sanguinis 
, Mean±SD 34.7± 23.98 799.5±655.05 1275.34±85 1.23 
(range) (2-71) (135.4-2254.2) (4443.7-2512) 
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Figure 4.3: Represeptative Maximum Likelihood tree showing clustering of 3 isolates 
with M.tuberculosis} 1 each with M.intracellulare, M.fortuitum, B.sanguinis, 
S.maltophila and S.marscesens. Two previously uncharacterised isolates clustered with 
environmental bacilli. Branches indicated in Red correspond to a bootstrap value of 
?.75%. The tree was rooted against E.coli (J01859) 
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4.4 Discussion 
4.4.1 Main findings 
This study confirmed equal proportions of infections that were attributed to 
Mycobacteria as there were atypical environmental pathogens. There was no 
association between atypical opportunistic spondylitis and HIV co-infection. These 
findings were consistent with those of Corbett et al (Corbett et al., 1999a), (Corbett et 
aI., 1999b) in their study of South African mine workers. Others (Govender and 
Charles, 1987, Mahaisavariya et al., 2005) have also reported NTM spondylitis in which 
patients were HIV -negative yet severely immune-suppressed as a result of malnutrition 
and socio-economic factors. In addition, results of the present study were consistent 
with recent studies in India (Jesudason and Gladstone, 2005, Karak et al., 1996) 
(Mousa, 2003) (Vander Spoel van Dijk et al., 2000) where a higher prevalence of non-
Mtb pulmonary and extra-pulmonary infections were reported in immune suppressed, 
HIV -1 negative patients from low socio-economic settings. In contrast similar 
escalations in developed nations were attributed primarily to HIV co-infection and 
improved diagnostic assays (Jesudason and Gladstone, 2005). The impact of nutrition, 
demonstrated in Chapter 2 of this dissertation, was emphasised by the findings of 
bacterial genotyping and a lack of association with HIV immune-suppression. 
Although Mtb and HIV co-infections have been significantly inked (WHO, 2006), a 
similar association was not established in the present cohort. However, in agreement 
with other reports of spinal Mtb infections (Arnold et aI., 1997), (Uppal et al., 2004), 
patients in the current cohort, reported a previous or current pulmonary component 
particularly among the adult patients. While patient CD4 and CD8 counts were 
indicative of a relatively robust immune response their CD4/CD8 ratios were inversed 
or reduced. CD4+ lymphopenia was noted in two HIV -uninfected patients further 
implicating poor nutrition in immune suppression in this cohort. Lower than expected 
CD4+ counts that normalise following anti-TB therapy have previously been reported in 
HIV/pulmonary TB co-uninfected patients (Uppal et al., 2004). This would suggest 
factors, other than HIV -1, may be independent mediators of CD4+ depletion and 
immune suppression. 
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Failure to isolate bacteria from 68.9% of specimens in the present cohort highlighted the 
limitations of culture diagnosis when applied to spinal TB and treated specimens 
(Mousa, 2003) (Perronne et al., 1994). These findings were consistent with previous 
reports demonstrating a low incidence of culture positive findings in spinal TB (Migliori 
et al., 1998). Traditionally, negative diagnostic assays associated with spondylitis have 
been attributed to its paucibacillary state. In addition, all patients in the present cohort 
received pre-surgery anti-TB therapy and enhanced nutritional support which is likely to 
have significantly reduced the bacillary counts. 
This findings of this study indicated that a multi -disciplinary approach to diagnosis of 
TB spondylitis would be advantageous. The utility of a multi-disciplinary approach, 
including the use of 16S genotyping, was demonstrated by Lu et al, (Lu et al., 2000) in 
the diagnosis of bacterial CSF infections. The previous chapter (Chapter 3) 
demonstrated that, despite being AFB negative, histopathological (H&E staining) 
features distinguished typical from atypical Mycobacterial infections (Chapter 3). 
Histopathological findings for Patients 23, 24 and 33 provided evidence for an atypical 
or opportunistic infection and genotyping confmned these findings. However, in the 
remaining patients, including the NTMs, histopathological features were diagnostic of 
TB. Failure to accurately identify the organism delays and/or prevents initiation of 
individualized treatment strategies and exerting a significant impact on patient outcomes 
(Duttaroy et aI., 2004). There is little clinical difference, between infections resulting 
from Mtb and atypical bacterial infections of the spine (Duttaroy et aI., 2004) 
necessitating robust diagnostic assays to distinguish them. Thus alternative or 
supplementary diagnostic methods may be extremely important to accurate, timely 
diagnosis and implementation of appropriate treatment strategies. 
4.4.2 Mycobacteria 
4.4.2.1 Mycobacterium tuberculosis (Mtb) 
M.tuberculosis is an established human pathogen (Jesudason and Gladstone, 2005) and 
has a long history in the context of spondylitis (Zink et aI., 2005). In the present era of 
HIV and elevated incidence of immune suppression, disseminated mycobacterium 
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infections are prevalent in both developed and developing countries (Reller et al., 2002). 
M.avium and M.intracellulare commonly cause disease in developed countries while 
Mtb is a widespread infective agent in less developed nations (Archibald et aI., 1998), 
(Archibald et al., 1999),(McDonald et al., 1999). Patients presenting with Mtb mediated 
spondylitis usually report a previous active pulmonary infection (42%; p<O.OOl) and 
display a high rate of neurological complications (32%; p<O.OOl) (Perronne et aI., 
1994). 
The present study reported Mtb infection in two HIV -infected patients; both patients 
displaying severe, progressive pathology and insidious onset suggesting exploitation of 
a diminishing immune response. Interestingly, Mtb seems to have targeted the very 
young (2-year-old) and the elderly (50 year old) immune-compromised host in the 
present study. The immunological status of dually infected spinal TB patients is 
variable (Belzunegui et al., 2004) with no significant difference in immunological 
markers between HIV -infected and uninfected patients (Go vender et al., 2000a). 
Clinical outcomes, even in HIV -infected patients remain positive following surgery, 
nutritional support and anti-TB therapy (Belzunegui et al., 2004) (Govender et al., 
2000a). In direct contrast, others have demonstrated severe disease pathology in co-
infected patients (Archibald et al., 1998, Archibald et aI., 1999) (Govender et al., 2000a) 
(McDonald et al. , 1999) (Perronne et al., 1994). 
4.4.3 Atypical organisms 
The present study illustrated an insidious emergence of atypical opportunistic infections 
of the spine in the local setting. Clinical accounts of spinal NTM infections 
(M.fortuitum) have been reported in severely malnourished HIV-negative patients 
(Duttaroy et aI. , 2004) substantiating these findings. Isolation of atypical bacterial 
infectants has previously been attributed to contamination, transient colonizers 
(Duttaroy et al., 2004) or minor variants. A likely source of infection may be the 
domestic, informal or rural environment where a high index of exposure to large 
numbers of opportunistic pathogens may be encountered Thus, non-tuberculous 
Mycobacterial infections remain a significant problem to both HIV -uninfected and 
infected individuals, alike (Henry et al., 2004). 
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4.4.3.1 Non-tuberculous Mycobacteria (NTM) 
The findings of the present study reiterate those of Corbett et al (Corbett et aI., 1999a) 
which reported a high incidence of non-tuberculous Mycobacteria (NTMs) with no 
correlation between HIV infection, and NTMs. In addition, there was no significant 
difference between the average CD4 counts between HIV -positive and -negative 
patients nor were clinical outcomes following surgery and anti-TB therapy dissimilar 
between the groups. Others have shown that patients with an M.kansasii infection 
display high CD4+ T-cell counts and positive outcomes in the short term (Corbett et aI., 
1999a). The impact of the HIV epidemic on related incidence rates cannot be 
discounted (Corbett et al., 1999b), (Ferreira et al., 2002) and must be included among 
the primary risk factors of related pathologies. 
NTMs comprise more than 95 species of naturally occurring saprophytic organisms 
causing 4 types of human diseases: TB-like pulmonary infections; extra-pulmonary 
infections of the lymph nodes, skin and soft tissue; multifocal disease and infections in 
immune suppressed hosts (Karak et al. , 1996). The incidence of related pathology has 
escalated in recent years due, in part, to the HIV epidemic but also to improved 
diagnostic assays (Jesudason and Gladstone, 2005), malnutrition and poverty. While 
developed countries have noted a decline in the incidence of NTMs, current incidence 
rates in developing countries remain ambiguous (Ferreira et al., 2002). The primary 
reason for the lack of clarity is, often, failure to identify the infective organism to 
species level (Ferreira et aI., 2002). A further concern is that NTMs are resistant to a 
number of conventional anti-TB therapies culminating in increased treatment failure, 
disease morbidity and mortality. 
It may be argued that the NTM and environmental bacilli isolated in this cohort may 
represent infection with multiple opportunistic pathogens. Dual Mycobacterial and 
pyogenic infections of the spine are rare (Govender and Charles, 1987), (Mousa, 2003). 
A Mycobacterial and concurrent Norcardia asteroids and Moraxella catarrhalis spinal 
infection has been reported (Mousa, 2003) while a similar pathology involving Mtb and 
Crytococcus neoformans was described in the local setting (Go vender and Charles, 
1987). TB infections involving 2 to 4 Mycobacterial organisms, in the same patient, 
have been reported in India (Raja, 2004). In the era of the HIV pandemic, super-
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infections may not be as unusual as previously assumed. Indeed, immune suppression, 
psoas muscle calcification, low-virulence infectants, treatment non-responders and 
recurrent infections feature among the risk factors for multiple bacillary infections. 
4.4.3.1.1 M. intracellulare 
The present study identified an M.intr~cellulare isolate in an HN-negative patient 
confirming the predilection M. intracellulare for HN -uninfected hosts, even in an HN 
endemic region. Mycobacterium intracellulare, together with M.avium constitutes the 
M.avium complex (MAC) and accounts for an excess of 85% of human pathogenesis in 
HN -infected and -uninfected patients (Beggs et aI., 2000). They have been implicated 
in an increasing number and severity of infections at pulmonary, extra-pulmonary and 
osteoarticular sites (Beggs et al., 2000), (Collins, 1989) (Koh et aI., 2005) (Raszka et 
al., 1994a) (Raszka et aI., 1995) (Raszka et aI., 1994b) (Scoular et aI., 1991). 
Associated infections are independent of geographical and anatomical sites (Sakatani, 
2005) and have been linked with HN-uninfected individuals (Collins, 1989) (Guthertz 
et aI., 1989) (Kyriakopoulos et al., 1997) (Raszka et al., 1994b, Yakrus and Good, 1990) 
and HN-infected individuals (Singh et al., 2007). Crowle et al (Crowle et aI., 1992) 
attributed the greater incidence of M. intracellulare infection among HN -negative 
patients to differences in relative infectivity of macrophages. 
4.4.3.1.2 M.fortuitum 
Genotyping identified a Mycobacterium fortuitum infectant in one patient of the present 
cohort. These organisms are obligate pathogenic, atypical, rapidly growing 
mycobacterium and are characteristically resistant to the majority of anti-TB 
chemotherapeutic measures (Matos et aI., 2004), (Vincurova et aI., 1984). These 
organisms pose significant therapeutic challenges often requiring aggressive surgical 
interventions and appropriate anti-bacterial therapies (Duttaroy et al., 2004), 
(Muthusami et al., 2004), (Vincurova et al., 1984). Similar interventions were 
necessary in the M.Jortuitum-infected patient in the present study. 
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Related pulmonary disease has been noted (Katoch, 2004), while infections at various 
anatomical sites occur with greater regularity than other NTMs (Chakrabarti et al., 
1990) (Muthusarni et al., 2004). However, infection of the spine is rare (Duttaroy et al., 
2004), (Smith, 1976) (Vincurova et al., 1984) with no associated predisposing factors. 
4.4.4 Environmental bacteria 
Pyogenic infections of the spine involving non-Mycobacterial organisms have been 
documented (Arnold et aI., 1997), (Perronne et al., 1994) even in the local setting 
(Charles et al., 1989). Indeed, infections of the spine have implicated pyogenic 
organisms (61 %) more often than Mtb (39%) (Perronne et al., 1994). Diabetes is the 
primary predisposing factor with immune suppression and HIV infection exerting an 
equal influence on incidence rates (Arnold et al., 1997). 
4.4.4.1 Serratia marcescens 
One patient in the present cohort was infected with Serratia marcescens, an 
opportunistic environmental pathogen also associated with hospital-acquired and 
nosocomial infections (Iwaya et al., 2005). A primary risk factor of infection is 
immune-suppression and was, accordingly, displayed in the present study (CD4+ count 
< 500 cellS/ill). Related infections hold a high probability of fatality (Hadjipavlou et al., 
2002). Infection of the spine has been reported but relates primarily to surgical 
contamination (Carmichael, 2003), (Hadjipavlou et al., 2002) (Liu et al., 1994) or 
trauma (Lowe et aI., 1989). Clinical presentation is comparable to TB spondylitis. 
These similarities are likely due to both organisms sharing selected biochemical features 
that are important to virulence (Hejazi and Falkiner, 1997), (Hejazi et aI., 1997). 
Using 16S rDNA genotyping, Lu et al, (Lu et aI., 2000) identified S. marcescens in CSF 
emphasizing the utility of genotyping at distinguishing atypical pathogens. The present 
study further confirmed the utility of 16S genotyping. 
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4.4.4.2 Brevibacterium sanguinis 
Brevibacterium sanguinis is an emerging human pathogen rarely isolated from clinical 
samples (Gruner et al., 1993), (Gruner et aI., 1994) (Janda et aI., 2003) (McCaughey and 
Damani, 1991, Wauters et aI., 2004), and was identified in a patient of the present 
cohort. In addition, these organisms are extremely difficult to isolate, therefore their 
incidence may be severely underestimated. It was thus a novel and significant finding 
in the context of infectious spondylitis and the local setting. 
These gram-positive organisms are characterized by an irregular, rod-shaped 
morphology; are non-acid-fast obligatory aerobic organisms (Janda et al., 2003) and 
propagate preferentially at 25-37oC (Wauters et aI., 2004). They are generally 
undetectable on conventional AFB diagnostic tools. It is therefore not surprising that 
the B.sanguinis-infected patient in the present study was AFB and culture negative. 
Infections from Brevibacterium species such as B.caseii have been reported but are 
believed to be underestimated due to diagnostic constraints (Castagnola et al., 1997). 
Representatives of the genus are commonly associated with milk products or human 
skin (Gruner et al., 1994). They had no relevance to human pathogenesis prior to 1991 
when the first case of a catheter infection was reported (McCaughey and Damani, 
1991). Subsequent isolation has been primarily from blood (Janda 'et al., 2003) 
suggesting that haematogenous spread to a remote site such as the spine is not 
improbable. In general, Brevibacteria infections are associated with the immune 
compromised host particularly those with cancer or HIV infection (Castagnola et al., 
1997), (Janda et al., 2003) (Wauters et al., 2004). Wauters et al, (Wauters et al., 2004) 
isolated B.sanguinis from 4 immuno-compromised hosts including patients with HIV 
infection, a Hickman catheter, an acute myeloid leukaemia and a febrile child. These 
patients had no invasive procedure and no injury therefore a nosocomial source of 
infection was discounted. Similarly no prior nosocomial source was identified in the 
present study. 
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4.4.4.3 Stenotrophomonas maltophilia 
An unusual finding in the present study was a Stenotrophomonas maltophilia infection. 
This is an environmental pathogen, which displays notable morbidity, limited 
pathogenicity and may be fatal (Looney, 2005). These organisms are associated with 
nosocomial infections, the aquatic and agricultural environments (Looney, 2005) 
(Skorska et al., 2005). The organism is an airborne contaminant of valerian root farming 
and sewage treatment plants (Prazmo et al., 2003), (Skorska et al., 2005) suggesting an 
agricultural or aquatic source of exposure in the S.maltophilia-infected patient in this 
cohort. 
Individuals with impaired immunity are at highest risk (Looney, 2005). Sites of human 
infection include soft tissue (Bello et aI., 2005) the respiratory tract (Schewe et al., 
2005) bloodstream, skin, urinary tract, endocardium (Dignani et aI. , 2003) and small 
bowel (Hellmig et aI., 2005). Since these organisms rarely infect pulmonary tissue the 
absence of active pulmonary involvement was not unexpected in the present study. 
Infections with S.maltophilia also pose therapeutic challenges since they readily acquire 
and transfer antibiotic resistance. This may provide an explanation for the progressive 
and gross pathology noted in the S.maltophilia-infected patient and their failure to 
respond to pre-surgery anti-TB treatment. 
4.4.5 Previously uncharacterised bacteria 
Two of the organisms isolated in the present study did not display homology to 
published sequences in all 3 repositories accessed. In addition, sequences that were 
presented as possible matches were rejected since phylogenetic analysis failed to yield 
clustering patterns supported by acceptable bootstrap values. The failure to genotype 
these organisms may be a consequence of a mixed bacterial population. Alternatively, 
these organisms could represent previously uncharacterised variants. It must be 
remembered that the universality of current sequence repositories may be questionable 
as they may not be representative of a wide range of genera. Sequences generated in 
this study were submitted to 3 independent sequence repositories. Of the 3, RIDOM 
provides a comprehensive and high quality database of bacterial isolates (Mellmann et 
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al., 2003). Mellmann et aI, (Mellmann et al., 2003) demonstrated a 71 % specificity of 
RID OM compared with the ABI Microseq databases (26%) and Genbank: (59%). The 
greatest criticism of sequence repositories is that they often contain erroneous entries, as 
there is no quality control. Submitting query sequences to multiple sites, as performed 
in the present study, is thus an important verification exercise. In addition, the 
organisms isolated in this study may be variants of existing environmental pathogens 
and obligate infectants that have, as yet, not been characterized fully. 
4.4.6 The utility of 16S rDNA genotyping 
Various novel tools have, to date, been applied to TB diagnosis in an attempt to enhance 
the efficiency of conventional assays. 16S genotyping was attractive for several 
reasons. Firstly, the almost universal occurrence of this gene, which is common to all 
Eurbacteria, enables the identification of aerobic and anaerobic bacilli, Mycobacteria 
and even fungi. Secondly, it is a more accurate and objective means of identification as 
it does not selectively isolate a specific organism or category of organism. Finally, rare, 
recombinant or quasi-species may be identified through genotyping. 
Unfortunately, the cost of genotyping and the need for specialised personnel makes this 
application inaccessible to many health care systems particularly in marginalized 
developing nations. An additional disadvantage of 16S genotyping is that this gene is 
homogenous in M.bovis, M.microti, M.tb tuberculosis and M.africanum. There is thus a 
need for multiple database searches and the inclusion of different genotypes in the 
analysis of a wild type. This limitation was accounted for in the present study by 
multiple sequence repository searches (RIDOMM, NCBI, DDBJ). 
4.4.7 Limitations of the study 
A primary limitation is that the extraction and amplification of the 16S rDNA gene was 
unsuccessful directly from clinical samples. It is assumed that amplification of a 
specific region has been optimized to detect template down to a single copy, however, 
not all reactions proceed optimally and in most instances, only reach 60-70% efficiency. 
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Detection of low copy number templates may therefore fail. In treated patients the copy 
number of bacterial DNA will be severely diminished. Drug therapy may also result in 
DNA fragmentation and mitochondrial dysfunction (Bhadauria et aI., 2007) further 
complicating PCR amplification and genotyping. 
While the quality of DNA in a subset of samples was screened using the MDRI gene, 
the entire sample population was not. This was a limitation as it is unknown whether 
the remaining clinically-derived DNA samples were negative due to poor template 
quality or simply an absence of bacterial DNA. In addition, other extraction methods 
such as TrizolPlus (Invitrogen, Corp., San Diego, CA) or conventional phenol-
chloroform extraction may yield better results and must be considered in future studies 
of this kind. These extraction methods were not available for use at the time of this 
study. 
It may be argued that the environmental bacilli isolated in this study were contaminants. 
Every precaution was taken to eliminate this possibility. A strict chain of sterility was 
maintained from the point of tissue excision, to the routine laboratory where cultures 
were inoculated and maintained. In addition, this study was the only investigation 
genotyping bacterial species in the molecular laboratory where the work was conducted 
ensuring that no amplicon contamination was possible. 
Finally, the small sample size may not reflect the larger demographic. However, it must 
be remembered that infectious spondylitis is not as prevalent as pulmonary TB. The 
sample population of this cohort represents a substantial sample size compared with 
other settings (Pertuiset et aI., 1999). 
4.5 Summary 
This study extends the findings from other socio-economically constrained nations, by 
demonstrating a higher incidence of NTMs among HN -uninfected patients in the 
context of infectious spondylitis. Consequently, it may be speculated that host 
susceptibility and immune suppression relates more to high indices of exposure to 
opportunistic pathogens, which is exacerbated by poor nutrition rather than HIV 
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infection. In addition, these findings demonstrated that the range of organisms 
implicated in infective spondylitis is vast, ranging from Mtb to previously 
uncharacterised environmental bacilli. Broad-range genotyping provides an important 
and useful adjunct to conventional diagnostic tools particularly in cases of treatment 
failure, progressive pathology and diagnostically challenging cases. 
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Chapter 5 - HIV -1 Heterogeneity 
5.1 Introduction 
A more rapid HIV disease progression has been strongly associated with high viral 
loads and greater heterogeneity, low CD4+ counts and higher mortality rates (Collins et 
al., 2000) in pulmonary TB. Similar associations have, as yet, not been established for 
extra-pulmonary TB. 
At transmission, HIV isolates are homogenous but transform to a progressively more 
heterogeneous population (Learn et al., 2002). Co-infections, particularly TB, greatly 
influences HIV evolution since immune activation at sites of TB co-infection is 
frequently associated with a marked increase in HIV -1 replication and viral 
dissemination (Collins et al., 2002b), (Toossi et aI., 2001a) (Toossi et al., 2001b). This 
increased activity, is mediated by pro-inflammatory mechanisms, such as TNFu-
stimulated transactivation of the viral LTR (Hoshino et al., 2002). Studies have 
provided evidence to suggest that infection with M.tuberculosis results in increased 
heterogeneity and compartmentalization of HIV -1 in pulmonary tissue. This is 
followed by dissemination of lung-derived variants into the systemic circulation, 
leading to more rapid disease progression and increased mortality (Collins et al., 
2002a). However, findings in TB-infected pulmonary tissue were not conclusive of 
viral compartmentalisation. 
This chapter tested the hypothesis that TB co-infection induced HIV-l viral 
compartmentalization and divergent evolution in the anatomically remote spinal 
granulomas of the co-infected patients in the present cohort. It was hypothesised that the 
fibrotic encapsulation of the spinal granuloma provides a unique permissive 
compartment for divergent viral evolution and latency. This investigation represented 
the first investigation of the role of the epidural granuloma as an anatomical site of virus 
evolution. 
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5.2 Materials and Methods 
5.2.1 Patient subset 
All 22 HIV -infected patients were included in these investigations. Matched plasma 
and tissue specimens were processed and PCR amplified, concurrently. Only those 
specimens which yielded paired plasma and tissue sequences were analysed further 
(n=7). 
5.2.2 Sample preparation 
HIV-l RNA was isolated from plasma (lOOfll) and tissue (10-12mg) samples using the 
guanidine-silica Boom method (Nuclisens isolation kit, Organon Teknika) as per the 
manufacturer's protocol. 
5.2.3 Reverse transcription 
HIV -1 RNA templates, extracted as described above (5.2.2) were reverse transcribed 
using 200 U of Superscript II reverse transcriptase (Invitrogen, Paisley, UK) as per the 
manufacturer's protocol. A 20-fll reaction with Ix reaction buffer, 10 mM dithiothreitol 
(DTT), and 0.5 mM of each deoxynucleoside triphosphate (dNTP) was prepared 
(Gordon et aI., 2003). 
5.2.4 peR amplification 
The C2V5 env region was amplified from cDNA in a nested-PCR using MK605 (5'-
AATGTCAGCACAGTACAATGTACAC-3'; positions 6945 to 6969) and CD4R2 (5'-
TATAATTCACTTGTCCAATTGTCC-3'; positions 7652 to 7675) as outer primers and 
M13F-ES7 (5'-tgtaaaacgacggccagtCTGTTAAATGGCAGTCTAGC-3'; positions 7002 
to 7021) and M13R-ES8 (5'-caggaaacagctatgaccCACTTCTCCAATTGTCCCTCA-3'; 
positions 7648 to 7668) as inner primers. Each reaction contained Ix PCR buffer, 2.0 
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mM MgCh, 0.2 mM each deoxynucleoside triphosphate, 2.5 pmol of each primer, and 
1.25 U of Amplitaq Gold (Gordon et al., 2003). Thermocycling conditions were as 
outlined in Table 5.1. 
Table 5.1: Thermocycling conditions for the amplification of an approximately 621bp 




95 13 min Denaturation 1 
95 30 sec Denaturation 
65 45 sec Annealing 
72 60 sec Extension 
95 30 sec Denaturation 
60 45 sec Annealing 
72 60 sec Extension 
72 10 inin Final extension 
Amplified DNA was verified by agarose gel electrophoresis, purified on either a 
Microcon (Ami con) or Qiagen PCR purification kit (Qiagen, Hilden, Germany) spin 
column using the manufacturer's protocols and quantified by agarose gel 
electrophoresis (Appendix Dl and 2). 
5.2.5 Cloning and sequencing the C2V5 region 
The purified -621bp PCR product (50ng/IlI) was cloned using the TOPO TA Cloning® 
kit (Invitrogen, San Diego, Ca., USA) which utilizes the pCR®2.1-TOPO plasmid 
vector in a 5-minute, one-step cloning reaction (Evans et aI., 2004). Chemically 
competent E.coli cells were transformed and plated to distinguish single colonies. 
Positive cultures were PCR screened using the ES7 and ES8 primers. The plasmids of 
positive clones were extracted using an alkaline lysis method (Appendix C) and 
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subsequently sequenced on an automated ABI 3100 genetic analyzer (Applied 
Biosystems Inc., Foster City, Calif.) with M13 (Forward and Reverse) sequencing 
primers and the Big-Dye terminator cycle sequencing reaction (Applied Biosystems 
Inc., Foster City, Calif.) (Gordon et al., 2003). The cycle sequencing reaction was as 
per manufacturer's instructions. A minimum of 5 sequences per compartment were 
selected for further analysis. Generating clones in two instances failed as the vector did 
not incorporate the insert despite repeated cloning reactions. As a result, 7 pairs of 
tissue- and plasma-derived sequences were generated. 
5.2.6 Sequence analysis 
Consensus sequences were obtained, from the electropherograms, in Phred and Phrap 
(Linux) and compared with env sequences concurrently, or previously amplified in our 
laboratory (Y137011-AY137073, AY196497), in order to eliminate any possibility of 
contamination. In order to further exclude any potential contamination, newly derived 
sequences were compared to subtype reference strains in the Los Alamos database 
(http://hiv-web.laril.gov/contentJhiv-db/SUBTYPE REF/align.html) and to HIV-l 
subtype C sequences previously amplified in our laboratory. 
Phylogenetic trees were constructed using all sequences generated (plasma- and tissue-
derived) and selected reference sequences, following degapping (Degap option) in 
PAUP* Version 4.0blO. Trees were generated (PAUP* Version 4.0blO) using the F84 
substitution model and the neighbour-joining method. To examine intra-subtype 
relationships, appropriate evolutionary models selected with the Akaike identification 
system executed in MODELTEST 3.0, were used to construct neighbour-joining and 
maximum likelihood (ML) trees. One of three (TVM, GTR or K84) basic models was 
used; each modified to include/exclude invariable and variable site distributions (y) and 
a a-shape. Trees were rooted against the -AFI10967 (C-96BW05.02 isolate) strain of 
HIV -1 SUbtype C and viewed in Treetool and Treeview. Bootscanning (1,000 
replicates), the Recombination Identification Program (RIP) and Simplot were used to 
assess reproducibility and test for inter- SUbtype recombination. 
Mean distances among nucleic acid sequences were determined using a Kimura two-
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parameter model calculated with the DNADIST program of PHYLIP. Amino acid 
diversity was measured using a Poisson distribution method implemented in the same 
MEGA package. P-values for diversity measurements were calculated by applying the t 
test to the distance matrix of each data set. Three independent software programs were 
used to calculate the ratio of synonymous to non-synonymous amino acid substitution 
as a measure of natural selection pressure at the protein level. These programs included 
SNAP and MEGA, which calculate a synonymous-to-non-synonymous (ds/dnn) 
substitution ratio, and Codem!, which calculates a w (dn,ldss) value. In Codem!, a tool 
included in the P AML software package, four different codon-based substitution 
models; MO (one ratio), M1 (neutral), M2 (selection) and M3 (discrete); were used to 
assess positive selection, as previously described (Gordon et al., 2003). High rates of 
synonymous mutations (m < 1) were indicative of conservation and a strict requirement 
for biological function, while high rates of non-synonymous substitution (m > 1) were 
attributed to adaptive change in response to selection pressure. To identify signature 
patterns that were characteristic of granuloma tissue, nucleotide sequences were 
translated aligned and the consensus sequences analyzed using the Viral Epidemiology 
Signature Pattern Analysis (VESPA) program. Granuloma and blood sequences were 
also screened for the presence of important functional domains using Prosite, a database 
of protein families (De Oliveira et al., 2003, Gordon et al., 2003). 
Variations of the Swofford-Maddison and Slatkin-Maddison (Swafford, 2002) tests 
were used to determine whether the HIV -1 env sequences derived from spinal 
granuloma tissue differed significantly from those found in the plasma of the same 
patient. The null hypothesis for these analyses was that the distribution of sequences 
was due to chance rather than tissue compartmentalization. The rate of migration 
between the two compartments was determined with the Likelihood Analysis with 
Metropolis Algorithm using Random Coalescence (LAMARC) software package. The 
Ancestry of the sequences was determined in Migrate, a program available in the 
LAMARC package. LAMARC software is based on models that use Maximum 
Likelihood (ML) estimates of population dynamics over all likely lineages and 
ancestries and extends coalescence theory to encompass migration events (Beerli and 
Felsenstein, 2001), (Beerli and Kuhner, 2000). 
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5.2.7 Optimisation of experimental assays 
A corresponding tissue and plasma derived amplified PCR product could not be 
generated for 4 plasma- and 4 tissue-derived products. In 9, neither a PCR product nor 
an analysable sequence could be generated. Several strategies to generate analysable 
products were attempted, including: 
1. The HIV RNA extraction was repeated using the Nuclisense NASBA extraction 
protocol and varying input volumes of plasma or masses of tissue (Section 
5.2.2). 
2. RNA was eluted in the elution buffer provided in the kit or in depC treated water 
(Section 5.2.2) 
3. Multiple cDNA synthesis assays (Section 5.2.3) were undertaken and varying 
input volumes of template RNA was used 
4. Template concentration was titrated (Section 5.2.4) in order to dilute out 
inhibitors 
5. Increased input volume of template was used in the PCR amplification assay 
(Section 5.2.4) 
6. Running a known positive confirmed the presence of inhibitors (Section 5.2.4) 
7. Cloning reactions were repeated using varying input concentrations of amplified 
product (30ng/fJI, 45ng/ fJI ,50ng/ fJI) (Section 5.2.5) 
8. Cloning was repeated using failed templates and a new cloning kit, which 
contained a new set of reagents and competent E.coli cells. 
9. Plasrnids were re-extracted using an alkaline lysis methods (Appendix C ) 
5.3 Results 
5.3.1 Clinical data 
All HIV-infected samples were selected for analysis of viral diversity. However, PCR 
amplification failed to yield a positive amplified product in 11 unmatched plasma and 
tissue-derived samples. The remaining 11 specimens yielded an acceptable PCR 
product but failure to obtain positive inserts (2 samples) and/or analysable sequences (2 
pairs), resulted in a final samples size of 7 plasma and tissue-derived sequence pairs. 
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Appendix D1 is an illustration of an agarose gel of the PCR amplified C2-V5 env 
regIOn. 
Table 5.2 shows the demographic characteristics and laboratory results of this subset of 
patients. Four patients were M. tuberculosis positive; and three had an unclassified 
Mycobacterium infection (Table 5.2). Clinical data was only available for 4 (3 
paediatric; 1 adult) of the 7 patients. Of the paediatric group, Patient12, a 2-year-old 
female presented with no neurological deficit (Frankel E) and clear chest sounds 
indicating no pulmonary involvement. Patient25 was a 3-year-old female who 
experienced spastic paraplegia and was immobile for 3 months prior to presentation. 
Patient32, a 2-year-old male, whose TB contact was parental, was observably 
malnourished with oral thrush and nodes clearly indicative of advanced AIDS. This 
patient was diagnosed with milliary TB. Both Patients25 and 32 displayed symptoms of 
a possible pulmonary component. One adult patient; Patient16, (28-year-old male), was 
symptomatic for 3 months prior to admission. On presentation he was incontinent, 
immobile (Frankel A), febrile and experiencing sharp chest pain. 
Table 5.2: Demographics and basic laboratory parameters of study population subjected to HIV -1 heterogeneity 
Patient Age CD4 CDS CD4:CDS Plasma viral load Tissue viral load Culture 
number (years) (cells/Jd) (cells/,ll) ratio (lOglO copies/ml) (lOglO copies / ml) Identification 
Tb12F 2 474 879 0.50 4.2 8.08 
No isolate 
obtained 
Tb16M 28 No result No result No result 4.48 6.52 
No isolate 
available available available obtained 
Tb20F 25 100 661 0.15 5.74 5.41 Mtb 
Tb22F 32 379 1848 0.20 4.36 4.98 Mtb 
Tb2SF 3 855 1925 0.46 4.26 N 
No isolate 
obtained 
Tb32M 2 1004 2512 0.41 6.40 9.18 Mtb 
Tb3SF 43 No result No result No result 4.95 8.15 Mtb 
available available available 
Mean 32.0 ± 7.87 240 ± 197.6 1255 ± 839.1 0.18 ± 0.04 4.88 ± 0.63 6.26 ± 1.41 
(Adults) (25 - 43) (l00 - 379) (879 - 2512) (0.15 ± 0.20) (4.36 - 5.74) (4.98 - 8.15) 
Mean 2.3 ± 0.58 788 ± 278.5 1772 ± 827.1 0.46 ± 0.05 4.95 ± 1.25 7.42 ± 2.17 
(Paediatric) (2-3) (474 - 1004) (879 - 2512) (0.41 ± 0.50) (4.20 - 6.40) (5.00 - 9.18) 
Mean 19.3 ± 16.8 569 ± 372.5 1565 ± 773.5 0.34 ± 0.16 4.91 ± 0.84 6.76 ± 1.71 
(Overall) (2 - 43) (100-1004) (661-2512) (0.15 - 0.50) (4.20 - 6.40) (4.98 - 9.18) 
Key: F = female; M = Male; Mtb = Mycobacterium tuberculosis 
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5.3.2 Sequence analysis 
A total of 108 sequences (58 plasma and 50 tissue-derived sequences) were analysed. 
The number of plasma- and tissue-derived sequences from each compartment was 
mismatched but it was ensured that a minimum of 5 sequences from each compartment 
were represented in the analysis. A representative agarose gel of a PCR reaction from 
the plasmids of Patientl2 generated from plasma and tissue-derived sequences appears 
in Appendix D2. 
5.3.2.1 Inter- and intra-patient Diversity 
Measures of the percentage diversity between plasma and tissue derived sequences for 
each patient (intra-patient diversity, Table 5.3) revealed greater diversity among adult 
(range = 4.1% to 20.7%; median = 11.0%) compared with the paediatric study group 
(range = 0.8% -5.5%; median =4.0%) due primarily, to extensive variation in the tissue 
sequences of-2 patients (Patient 20 and 22). These findings supported a clear separation 
of plasma and spinal sequences into distinct mono-phyletic clusters in 66.6% (2/3) 
paediatric and 75% (3/4) adult patients (Table 5.3). The percentage diversity comparing 
all plasma versus tissue-derived sequences (distance between the compartments) was 
greater in the former (15.3 ± 1.1 % versus 12.5 ± 1.0 %). 
5.3.2.2 Phylogenetic Reconstruction 
To demonstrate the inter-relatedness and the SUbtype of HIV variants, phylogenetic 
trees were constructed using published HIV -1 reference sequences (Los Alamos 
database) representing subtypes A, B, C, D, F1, F2, H, J and K (Fig. 5.1). This 
confirmed that all sequences were HIV -1 SUbtype C. As expected plasma and tissue-
derived sequences from the same patient were more closely related to each other (Fig. 
5.2) than to those derived from unrelated HIV-1 C-infected patients. 
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Table 5.3: Mean diversity measures of tissue- and plasma-derived sequences from 
paediatric and adult patients 
% diversity of tissue-vs-
% diversity in plasma % diversity in tissue 
plasma 
.. 
Mean Median Mean Median Mean Median 
Intra-I!atient diversity 
Paediatri 
3.0 ± 0.0 2 (1-6) 3.0 ±O.O 3 (1-4) 4.0 ± 1.0 4 (0.8-5.5) 
cs 
Adult 4.0 ± 1.0 5 (0-7) 1.0 ± 0.0 1 (0-1) 12.0 ± 1.0 11 (4.1-20.7) 
Overall 4.0 ± 1.0 4 (0-7) 1.0 ± 0.0 1 (0-4) 8.1± 1.0 5.5 (8.0-20.7) 
Inter-I!atient diversity 
Overall 15.3 ± 1.1 12.5 ± 1.0 
Phylogenetic reconstruction of individual patient sequences (Fig. 5.3a-g) revealed three 
clustering patterns. In 317 datasets (Fig. 5.3a; 5.3c; 5.3f), tissue-derived sequences were 
more tightly clustered relative to plasma sequences while, in a further 2 datasets, plasma 
sequences were widely dispersed relative to the tissue (Fig 5.3e; S.3g). Plasma and 
tissue-derived sequences fell into two distinct phylogenetically separated lineages 
suggesting tissue compartmentalization and independent viral evolution. The greater 
branch lengths separating the two compartments in the adult group may reflect a longer 
period of co-infection and divergent evolution in adults. In the remaining 2 datasets 
(Fig. 5.3b and S.3d), plasma and tissue-derived sequences was intermingled illustrating 
migration or trafficking of HIV -1 variants between compartments. These findings were 
supported by bootstrap values of >75%, for both ML and neighbour-joining (NJ) trees. 
In addition, phylogeny confirmed the findings of the diversity analysis showing 
unrestricted bi-directional migration between plasma and tissue in 2 patients (Fig. 5.3b; 
5.3d) and viral sequestration in the rest of the patients. Distinct monophyletic clustering 
and separation of variants, according to anatomical site, was observed, predominantly 
among adult datasets with one exception, Patient38 (Fig 5.3d); displaying limited 
migration between plasma and tissue. 
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Correlating the clinical status of patients with their respective migratory and clustering 
patterns indicated anatomical sequestration was more common to patients at a more 
acute clinical state such as Patient16 (Fig. 5.3f) and Patient25 (Fig. 5.3a). 
Ultrastructural investigations (Chapter 3; Section 3.3.3) of related tissue specimens of 
these patients revealed features characteristic of necrosis and apoptosis; including 
nuclear changes, extensive myelin bodies and degenerative mitochondria. Furthermore, 
extensive fibrin deposits were observed in Patient 16 (Fig 5.3f) and 22 (Fig. 5.3g), both 
displaying distinct sequestration of viral variants according to anatomical site. On the 
other hand, sequences from patients who were clinically stable, such as Patient12 (Fig. 
5.3b), were intermingled, indicative of migration between compartments. While all 
patients displayed indications of dilated rough endoplasmic reticulum (rER) , grossly 
dilated rER was noted, particularly, in Patient 12 (Fig. 5.3b). In addition, ultrastructural 
(Chapter 3; Section 3.3.3) evaluation revealed moderate to profuse polyribosome 
infiltration in three of the four adult (Patient 16 [Fig. 5.3f], 20 [Fig. 5.3e], 22 [Fig. 
5.3g]) specimens compared with none of the paediatric specimens. Patient 20 (Fig. 
5.3e) displayed distinctive features of degeneration with moderate/profuse 
polyribosomes and myelin bodies. Characteristic features of apoptosis and necrosis 
were observed in this patient, who, in addition, displayed discrete monophyletic 
clustering of plasma and tissue-derived sequences, and greater diversity in this 
compartment (Table 5.3). 
Despite a negative AFB microscopy findings, in all cases, specimens displayed features 
(H&E, Section 3.3.1) diagnostic of TB, including granuloma formation, caseation and 
lymphocyte infiltration. All patients, apart from Patients 22 (Fig. 5.3g) and 32 (Fig. 
S.3c), displayed elevated epithelioid cell infiltration. This was indicative of advanced 
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Figure 5.1: Phylogenetic tree of plasma- and tissue-derived sequences against HIV1 
reference sequences representing HIV-1 sUbtypes A, B, C, D, F1, F2, H, J and K. 
Sequences generated in this study clustered with HIV -1 subtype C variants from South 
Africa (ZA) and BOthswana (BW). 
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Figure S.2: Phylogenetic tree illustrating monophyletic clustering of sequences from 
each patient. Plasma (dots) and tissue (squares) sequences formed discrete clusters or 
intermingled with each other. Trees were rooted against the -AFll0967 (+, c-
96BWOS.02) isolate. Branches in Red represent bootstrap values >80% 
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Figure 5.3: Phylogenetic trees of plasma- (dots) and tissue- (squares) derived sequences of individual patients illustrating monophyletic clustering 
of sequences from each compartment. Plasma- and tissue-derived sequences fonned (a, e, f, g) discrete clusters or (b, c, d) intermingled with 
each other. Trees were rooted against the -AFll 0967 (+, C-96BW05.02) isolate. Branches in Red represent bootstrap values >80% 
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5.3.2.3 Analysis of migration (M) and coalescence (0) 
In patients Patient12, 16 and 25, analysis of migration (Table 5.4) suggested movement 
of viral isolates from tissue (1893.49; 248.81; 209.79 migrations per generation 
respectively) to plasma (377.27; 25.20; 150.12 respectively) while in patients Patient20 
and 22 the direction of migration was reversed (Table 5.4). Coalescence data verified 
these findings . Greater coalescence forces (0) were computed for tissue sequences in 
Patients 12 (0 = 0.04), 16 (0 = 0.222) and 25 (0 = 0.20) but for plasma in Patient20 (0 
= 0.224) and 22 (0 = 0.514). Greater than lO-fold differences were noted between the 
migration rates from plasma-to-tissue compared with tissue-to-plasma (Table 5.4). No 
migration or coalescence data was generated for 2 patients (Patient32 and 38) and 
relates to the level of variation of the datasets. 
Table 5.4: Migration rates and measures of coalescence forces comparing plasma- and 
tissue-derived sequences 
Migration rate per generation (M) Coalescence Force (0) 
From plasma From tissue to 
to tissue plasma 
Plasma (y) Tissue (y) 
Patient 12 377.27 1893.49 0.002 (3.40) 0.04 (3.40) 
Patient 16 25 .20 248.81 0.002 (0.568) 0.222 (0.568) 
Patient 20 2334.91 33.03 0.224 (2.172) 2.43E-06 (2.172) 
Patient 22 152.62 15.95 0.514 (0.123) 0.005 (0.123) 
Patient 25 150.12 209.79 0.03 (6.77) 0.20 (6.77) 
Patient 32 No result generated 
Patient 38 No result generated 
'Y 4Nem where Ne effectlve populatIon SIze and m - rrugratIon rate 
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5.3.2.4 Analysis of putative functional sites 
In comparison to other putative functional sites evaluated, N-glycosylation sites 
occurred most frequently in both plasma and tissue-derived sequences (Table 5.5). 
There were no statistical differences in the number of sites, between the plasma- and 
tissue-derived sequences, although a greater number of N-glycosylation, protein kinase 
C phosphorylation (PKC), arnidation, sulphation and the gram positive anchoring 
nuclear RGD binding sites (RDG) occurred in the plasma, compared with tissue 
sequences of adults. However, in the paediatric group, N-glycosylation, casein kinase IT 
phosphorylation (CK2) and PKC sites were more abundant in the tissue compared with 
plasma sequences (Table 5.5). Sequences from the spinal granuloma and plasma 
derived virions showed equal conservation of N-glycosylation sites, with the exception 
of Patient 32, which lacked this site in both plasma and tissue. 
Table 5.5: The mean percentage putative functional sites in tissue- and plasma-derived 
sequences 
N-glycos- Myristo Amidat- Sulphat RGD 
PKC CK2 
ylation ylation ion -ion binding 
PIa Grt PIa Grt PIa Grt PIa Grt PIa Grt PIa Grt PIa Grt 
Paediatric 14.3 14.7 4.7 4.3 4.3 5.0 2.0 2.7 0.3 0.3 0.7 0.3 0.0 0.0 
% diff 3* 3 7* 7* a 3 a 
Adults 14.5 12.8 4.5 4.5 5.8 3.5 3.8 3.5 0.3 0.0 0.5 0.0 0.3 0.0 
% diff 18 a 23 3 3 5 3 
* - number of sItes In tIssue exceeds number In plasma denved sequences 
There was no statistical difference in the mean of the overall charge of the V3 loop (p 
>0.05) when comparing plasma and tissue-derived sequences, nor were there 
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differences in the overall charge between paediatric and adult groups (Table 5.6). 
Despite amino acid substitutions, biochemical properties at the specific sites remained 
unchanged (Fig. 5.4; Table 5.6). No changes were tolerated in residue 13(R), which 
remained highly conserved in both compartments. 




Patient 12 5.0 4.6 
Patient 16 3.9 4.0 
Patient 20 4.2 5.0 
Patient 22 4.1 4.0 
Patient 25 3.9 4.0 
Patient 32 4.0 4.2 
Patient 38 4.4 3.9 
Average Paediatric 4.3 ± 0.61 4.3 ± 0.31 
A verage Adults 4.2 ± 0.21 4.2 ± 0.52 
Apart from 2 plasma sequences (Patient 20) where a 2 amino acid insertion resulted in a 
shift in sequence from CCR5-like to CXCR4-like variant, isolates were all CCR5-tropic 
(Fig. 5.4). These insertions resulted in disruption of the GPGQTF signature pattern 
(subtype C) of the tip of the V3 loop. All other plasma and tissue derived sequences 
retained the characteristic KZN-subtype C signature pattern, with the exception of 
Patient 20 (GIGGIPGWTF) (Fig. 5.3) and 38 (GPGQAF). The first (G), third (G) and 
last (F) residues were highly conserved, regardless of the anatomical site and relative 
number of polymorphisms, alluding to their conformational importance. The cystein 
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Figure 5.4: A representative image of the plasma (p) and tissue (g) derived sequences of 
the V3 loop from Patient 20 illustrating the two amino acid insertion (*) in two plasma 
sequnces and the resultant disruption of the GPGQ signature of the hairpin loop of the 
V3 region. Disruption of this region resulted in the downstream disruption of the third 
amino acid residue (") which determines viral tropism. 
Table 5.7: Details of polymorphisms of the residues determining tropism and overall 
charge of the V3 loop indicating properties of the residues and their respective charges 
lIS residue 13R residue 25E residue 
-
Plasma Tissue Plasma Tissue Plasma Tissue 
Patient 12* Sn Sn RD RD Ln Ln 
Patient 16# Sn Sn RD Rb Ln Ln 
Patient 20# Sn Gn Rb Rb KD,I Sn 
Patient 22# Sn Sn Rb Rb Da Da 
Patient 25* Sn Sn RD Rb Ea Ea 
Patient 32* Sn Sn Rb RD An / Da,L Da 
Patient 38# Sn Sn Rb Rb An / Da,3 Da 
Overall -
N N B B A A 
Paediatric 
Overall -
N N B 
Adult 
B A A 
.. 
N neutral, A aCIdIc, B - baSIC, 1- 30% sequences = K; 2 = 40% sequences = A; 3 = 50% sequences 
= A; # = adult; * = paediatric, n= neutral residue, b=basic residue, a= acidic residue 
155 
5.3.2.5 Positive selection 
Of the 7 patients studied, sequences from all paediatric and 3/4 adult patients displayed 
neutral selection. Evidence of positive selection was demonstrated in only one of the 
four adult patients. These findings may prove more significant should longitudinal 
comparisons be made. Unfortunately follow-up samples were not available for this 
study therefore such comparisons were not possible. 
5.4 Discussion 
5.4.1 Main findings 
This investigation was undertaken to explore the impact of HIV and TB co-infection at 
a remote, isolated compartment on viral evolution. Although the prognostic value of 
greater viral diversity has been questioned (Poss et al., 1998) it is unquestionable that 
greater heterogeneity increases the incidence of CTL escape mutants; and drug resistant, 
fitter or more virulent strains of HIV. The hypothesis that HIVrrB co-infection induces 
the generation of such variants was tested. The findings of this study demonstrated 
separation of HIV variants into 2 discrete monophyletic clusters in 517 patients. This 
was highly suggestive of compartmentalisation and restricted trafficking into and out of 
the spinal TB granuloma in the majority of the patients. These findings confirmed the 
hypothesis that epidural HIV rrB co-infection leads to divergent viral evolution within 
the granuloma. Furthermore, the present investigation represents novel findings as this 
phenomenon has not been previously demonstrated in the context of infectious 
spondylitis. 
In addition, tissue derived variants appear to have evolved independently following a 
single introduction, the source of which is likely haematogenous. Phylogenetic analysis 
of sequences from paediatric and adult patients demonstrated greater divergence 
between plasma and tissue derived sequences in the latter. This is a likely consequence 
of a mature, more robust immune response in adults compared with children. The 
findings of this study, further suggested that differences between the plasma- and tissue-
derived strains do not translate to putative conformational and functional differences. 
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Since patients in this cohort did not receive ARVs, there was no impact of drug 
selection pressure. 
5.4.2 Anatomical compartmentalisation 
This report represents the first account of viral sequestration within epidural infectious 
spondylitis. Anatomical compartmentalisation has been conclusively demonstrated in 
the brain (Korber et aI., 1994), semen (Choudhury et aI. , 2002) and lymph nodes and 
strongly suggested in the lungs (Collins et aI., 2000), genital tract, cerebrospinal fluid 
(CSF) (Cinque et aI., 2001) (Stingele et al., 2001) and blood (Zhu et al., 1996). For 
instance, despite establishing that cerebrospinal fluid (CSF) harbours diverse viral 
variants compared with plasma in early disease and in the presence of opportunistic 
infections, conclusive evidence for compartmentalisation in the CSF was lacking 
(Cinque et aI., 2001). There are however indications that trafficking of various cell 
populations as well as the physical barriers of the central nervous system (CNS) and 
CSF mediate divergent evolution at these sites. 
Clinical and histopathological findings of related patients revealed an association 
between clinical status and viral sequestration where anatomical compartmentalisation 
was common to patients at advanced disease pathology. These patients additionally 
displayed ultrastructural features consistent with a pathogenic insult such as extensive 
necrosis, apoptosis, and degenerative cellular organelles including mitochondria and 
rER. Grossly dilated rER, suggestive of up-regulated protein synthesis, synthesis of 
proteins atypical to the cell or storage of atypical peptides within these cellular 
organelles was noted in acutely infected patients, particularly Patientl2, who displayed 
viral sequestration. This implies that the virus may be actively exploiting the replication 
machinery of the host. How this impacts on viral evolution remains to be established. 
Interestingly, patients who displayed distinct monophyletic clustering of viral isolates 
also displayed features of fibrosis which heralds late stage granuloma formation and an 
attempt by the immune response to physically isolate the infection. An alternative 
account for elevated protein synthesis may therefore be a reflection of elevated 
synthesis of immune modulators. It would therefore appear that this physical barrier 
creates a permissive environment for divergent viral evolution. Moreover, a lack of 
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association between viral diversity and CD4+ T-cell counts, but correlation with CD68+ 
infiltration (p<O.OS) indicated the, possible, importance of macrophages and 
macrophage-derived cells, in promoting viral sequestration. The impact of patient 
clinical status was illustrated by Patient 38, who presented with milliary TB, and 
displayed three ancestral lineages (Fig. S.3) of HIV isolates, representing the circulating 
haematological variants and variants from remote anatomical sites of infection, 
including the spinal granuloma. 
The findings of the present study are similar to that of Collins et aI, (Collins et al., 
2002a) who investigated viral heterogeneity in pleural TBIHIV co-infected patients. In 
both instances, physical separation (pleural space and spinal granuloma) was consistent 
with divergent evolution in blood and TB infected tissue. An additional commonality is 
the high improbability that a localised HIV infection prior to TB infection occurred in 
the pleura and spinal tissue. The influx of leukocytes, followed by activated 
lymphocytes and macrophages, including an HIV -infected cellular SUb-popUlation, is 
the likely mechanism of initial entry of HIV. Latent HIV may then be activated by 
cytokines such as tumour necrosis factor alpha (TNF-a) and monocyte chemoattractant 
protein (MCP) as a result of constant immune stimulation by the TB infection (Collins 
et al., 2002b). Moreover, TB increases the susceptibility of HIV cellular targets 
particularly lymphocytes, to infection and the transmission of macrophage-tropic 
variants in the lower mucosa (Santucci et al., 2004). 
Korber et al (Korber et al., 1994) suggest the range of variants within compartments is 
sensitive to immune pressure, changes in tropism and replication efficiency. When 
disease is established, the tropism of virions is restricted to the particular cell population 
that carried the virus into the compartment, therefore a distinct "clade", with 
corresponding tropism, emerges (Korber et al., 1994). Macrophage-tropic isolates 
(CCRS exploiting) predominate in TB-infected individuals (Santucci et al., 2004) but 
conservation of RS- to X4-utilizing variants was demonstrated even with progressive 
disease (Collins et al., 2002a). Similarly, in the present cohort, variants were all RS-
utilizing variants with the exception of two sequences (Patient 20) which demonstrated 
amino acid residues and overall charge of the V3 loop characteristic of an X4-utilising 
variant (Fouchier et al., 1992). The impact of the bacterial infectant was illustrated, in 
vitro, by a Mycobacterium avium-induced increase in HIV -1 replication and CCRS 
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expression rates (Wahl et al., 1998). In contrast, CXCR4 expression was up-regulated 
in MtblHIV infected alveolar macrophages (Hoshino et al., 2004). Patient 32 in the 
present cohort was infected with Mtb as identified by 16S rDNA genotyping (Chapter 
4) and demonstrated divergent viral evolution with two distinct clusters of tissue-
derived sequences (Fig. S.2c). Whether these clusters are indicative of an emerging 
population expressing a switch of co-receptor usage may be established by an 
appropriate bioassay, but this was beyond the scope of this investigation. Differences 
between these findings may be a result of disparate assay platforms (in vitro versus and 
ex vivo) and infective organism (M.avium versus Mtb). It may additionally reflect an 
expansion of the initial infecting variant rather than a switch from one co-receptor to 
another as suggested by reports of the expansion of RS tropic variants (Morris et aI., 
2001), (Santucci et al., 2004). Morris et aI, (Morris et al., 2001) established that despite 
advanced disease in a South African cohort of HIV subtype C/ TB infected individuals, 
there was no change in co-receptor usage suggesting up regulation of macrophage-
tropic RS-utilising variants. In contrast, expansion of macrophages and microglial cell 
populations was associated with distinct sequestration of brain and blood viral variants 
while, lymphocyte infiltration correlated with unrestricted migration between the 
compartments (Korber et al., 1994). Others reported distinct sequestration of 
macrophage-tropic variants in the nervous system and testicles demonstrated in 
autopsied individuals (Sanjuan et al., 2004). The present findings include a 
predominance of RS-tropic variants but a dual-tropic (RSIX4) variant (Patient 20) was 
also observed. Since dual tropism suggests a transitional variant between the non-
syncytium inducing macrophage tropic (RS) to the syncytium inducing T-cell tropic 
(X4) isolates (Doranz et al., 1997) their presence in this cohort may suggest a similar 
phenomenon. 
Collins et al (Collins et al., 2002a) were unable to conclusively demonstrate 
compartmentalisation of HIV in pleural tissue, a site that is infiltrated by activated 
leukocytes in response to TB infection. Spinal tissue on the other hand is infiltrated by 
macrophages that mature to giant cells and epithelioid cells. It is thus most likely that 
the predominant cell type infiltrating the infected tissue is one of the primary 
determinants of tissue-localised divergent HIV evolution. Increased viral heterogeneity 
in circulation has been attributed to migration of pleura-derived isolates as a result of 
increased viral replication at the site of TB infection and chronic immune stimulation 
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(Collins et aI., 2002a). Most notable in this study is that inftltrating cells were activated 
leukocytes and that these cells, a large proportion of which would be HIV infected, were 
not present in the pleura prior to TB infection. Furthermore, the close contact between 
HIV -infected lymphocytes and TB-infected macrophages at the site of infection 
invariably leads to interaction between them and ultimately to HIV activation and up-
regulation (Toossi et aI. , 2004a). 
5.4.3 Putative functional sites 
In the present cohort, functionally important residues were highly conserved despite the 
variability in flanking regions. For instance, cystein residues known to be essential to 
the formation of functional V3 and V 4 loop conformations (Leonard et al., 1990) were 
highly conserved in both plasma and tissue derived sequences. Similarly, residues that 
determine tropism and CD4 binding were also highly conserved. The role of the V3 
loop in viral tropism, cytopathicity, replication efficiency and fusion is known (Korber 
et aI., 1994). Polymorphisms at various sites throughout the env gene can potentially 
compel conformational changes to the env protein (Korber et aI., 1994). Ultimately 
these polymorphisms may be inactivating. Therefore despite highly variable domains 
within this region certain residues remain conserved alluding to their functional 
importance. 
5.4.4 Inter- and intra-patient diversity 
This study has shown a greater inter-patient diversity in plasma- (mean = 15.3% ± 1.1) 
compared with tissue- (mean = 12.5% ± 1.0) derived sequences. In addition, intra-
patient diversity of plasma- versus tissue-derived sequences was greater in adult (mean 
= 12.1 % ± 1.0) compared with paediatric patients (mean = 4.0% ± 1.0). Others have 
calculated mean intra-patient diversity at 2.6% (range = 0-13.6%) in SUbtype C viruses 
(Shankarappa et aI., 2001) and compares poorly with the figures calculated in the 
present study. 
The present study reported greater plasma-tissue diversity compared with tissue-tissue 
and plasma-plasma measures (Table 5.3). Similarly, when evaluating diversity of 
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sequences derived from brain and blood, Korber et al (Korber et al., 1994) reported 
greater blood-versus-blood (4.9%) compared with brain-versus-brain (3.5%) intra-
patient diversity, while blood-versus-brain (7.7%) diversity was greater than both these 
comparisons. Inter-patient diversity comparing blood-vs-blood (15.2%) was greater 
than brain-vs-brain diversity (11.8%) (Korber et aI., 1994) similar to the findings of the 
present study which compared plasma (15.3%) and tissue (12.5%) derived sequences. 
Both inter- and intra- patient diversity measures in the present study closely 
approximated those reported by Korber et al (Korber et al., 1994). Collins et al (Collins 
et aI., 2002a) determined greater diversity in pleura compared with blood-derived 
sequences but not to significance. Unlike Collins et al (Collins et al., 2002b), there was 
no correlation of the degree of diversity with CD4 and viral loads in the present cohort. 
The ancestry of the lineages of sequences derived from plasma and tissue was 
determined using coalescence. Coalescence describes the phenomenon of converging 
lineages to a common ancestor with temporal regression until all lineages merge to a 
point representing the most recent common ancestor of all the sequences (Rodrigo et al., 
1999). The time for populations to coalesce depends primarily on the rate of migration 
between compartments and secondarily on population dynamics (Rodrigo et aI., 1999). 
A lack of divergence with preservation of essential residues; termed convergence of 
variants, was demonstrated in the tissue compartment and among paediatric patients of 
the present cohort. However, in two patients (Patient 32 and 38) migration and 
coalescence data could not be generated, the reason for which may relate to the 
variation in the dataset. Datasets with little or no variation biases the dataset making 
almost any migration parameter possible (Beerli and Felsenstein, 1999). Adding either 
more sequences or base pairs may overcome this bias. Similarly, a high theta value that 
estimates coalescence will generate a high number of migration events, which expand to 
levels beyond the capacity of the data analysis resources (Beerli and Felsenstein, 1999) 
culminating in the collapse and/or failure of the analyses. 
5.4.5 Phylogenetic reconstruction 
Phylogenetic analysis revealed two clustering patterns namely, monophyletic tight 
clustering in 517 and mixing or migration in 217 patients (Fig. la-g). These findings 
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were consistent with those of Korber et al (Korber et al., 1994). In both instances, the 
phylogenetic trees generated were evidence of divergent evolution in the respective 
anatomical compartments. In contrast to the findings of Collins et al, (Collins et al., 
2002a), the evidence for monophyletic clustering of viral variants was unambiguous in 
the present study. In their study (Collins et al., 2002a) frequent migration events were 
unidirectional from pleura to blood representing a direct mechanism for systemic HIV 
heterogeneity. Comparable migration events also occur in ARV treated patients as a 
result of poor drug penetration to the tissue and the emergence of drug resistant isolates 
(Wang et al., 2000). In these instances heterogeneity is more pronounced in tissue 
compared with the plasma (Devereux et aI., 2002). In contrast, we show limited 
migration events (217 patients, 29%) indicative of limited contribution to systemic viral 
heterogeneity, but tissue heterogeneity was more pronounced as demonstrated by 
Devereux et aI, (Devereux et al., 2002). 
The findings of this study illustrated greater branch lengths between the monophyletic 
clusters of plasma and tissue-derived sequences in adult compared with the paediatric 
patients. This was indicative of greater evolutionary distance between the monophyletic 
clusters and their corresponding viral quasispecies. The association between clinical 
status and clustering patterns was most noticeable in Patient 32 (Fig. 5.3) who presented 
with milliary TB. The corresponding viral variants manifested as three distinct 
sequence clusters representing three separate lineages. A pulmonary component was 
suspected but had not been confirmed at the time of surgery. Ultrastructural morphology 
was indicative of acute infection and degeneration including polyribosome infiltration, 
necrosis and apoptosis. 
5.4.6 Positive selection 
There was no evidence for positive selection in the majority of the patients in the 
present cohort (617 patients). These findings confirm those of Collins et aI, (Collins et 
al., 2002a) and Sanjuan et aI, (Sanjuan et aI., 2004) where the findings were suggestive 
but not conclusive of positive selection in HIV ITB co-infection. In all three reports, 
including the present study, an ex vivo sample was collected from the respective organs, 
either during surgery (Collins et aI., 2002a) or at autopsy (Sanjuan et al., 2004). It is 
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likely that positive selection was not a recent event thus; polymorphisms evident in 
present viral populations were likely fixed at some point in the distant past relative to 
viral evolution. Sampling at a single point along the timeline of the emerging 
population will not reflect this evolutionary process. Genetic drift is a possible model to 
account for the divergent evolution between the tissue and plasma variants, however 
this hypothesis also requires longitudinal sampling which was not possible once the 
granuloma was surgically removed in the present study. 
It has been established that pulmonary TB exerts selection pressure on HN evolution 
(Collins et al., 2000). This emphasises that a more established HN infection may result 
in greater selection pressure as opposed to a recent introduction or an acute TB 
infection. HN evolves continuously in the lung a process that, in most instances, 
precedes the TB infection. An HIV infection which precedes the TB infection 
represents a pre-existing viral load prior to TB and is currently recognised as a 
significant contributor to outcomes (Day et al., 2004a). The authors, in the South 
African setting, demonstrated that TB infection was correlated with a minor increase in 
HN viral load, and suggest that this would not impact on outcomes in the individual. 
Instead they propose it may exert an important influence on HN transmission and 
disease progression at a population level. It is therefore important to investigate, 
longitudinally, polymorphisms that arise in dually infected individuals. The most 
compelling rationalization of a lack of positive selection is that of Leitner and Albert 
(Leitner and Albert, 1999), who propose that positive and purifying selection may result 
in less than expected heterogeneity. Since certain substitutions are not tolerated, they 
are eliminated, thereby reducing the genetic variation in the population. For example, 
changes in receptor fit of the env gene is a potential source of selection pressure since it 
impacts on the evasion of the immune response (Williamson, 2003), but these variants 
soon become fixed and expand to a homogenous population. The lack of evidence for 
either positive or purifying selection in this study would therefore imply a more variable 
genetic pool - a circumstance that would be highly beneficial to viral evolution and 
fitness. 
Finally, it is likely that the occurrence of positive selection could not be demonstrated 
because the analysis of the C2-V5 region rather than portions thereof would not have 
detected variations in individual regions. Different regions of the env gene have been 
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shown to experience varying rates of positive selection (Mani et al., 2002) (Williamson, 
2003). The VI-V2 region has the highest adaptive rate (1 eventl2.5 months) followed 
by the C2-V3 (1 eventl5.9 months.) and V4-V5 regions (1 eventl12.2 months.) 
(Williamson, 2003). Accordingly, calculating the rate of positive selection over the 
entire env gene or a substantial portion thereof may not fully illustrate selection 
pressures exerted at individual sites. There are strong associations between the stage of 
disease and the frequency and strength of positive selection (Ross and Rodrigo, 2002). 
The phenomenon of variable positive selection and evolutionary rates is reiterated at 
protein coding regions over the entire HIV genome (De Oliveira et aI., 2003). In 
addition, analysis of HIV sUbtype B and C sequences revealed that tat and rev, rather 
than the env gene are under positive selection (De Oliveira et al., 2003). It is thus, 
conceivable that the consequence of selection pressure would be evident in these early 
multiply spliced regulatory proteins in the present study. 
5.4.7 Limitations of the study 
Since the diseased bone and tissue are removed at surgery, longitudinal tissue samples 
were not available. Moreover, a single sampling event excluded the impact of sampling 
bias (Mani et al., 2002) such that measures subsequently conducted on blood and tissue 
were accurate point determinations of the in vivo dynamics. 
A further criticism of this study may be that viral heterogeneity was demonstrated 
following a single PCR amplification and cloning event therefore may have selectively 
amplified the dominant population. Minor variants, which may become dominant in 
time and in response to drug or immune selection pressure, would have been excluded 
from the analysis. However, it must be remembered that while a selection bias may be 
represented by the data, viral compartmentalisation and divergent viral evolution was 
demonstrated by this single PCR and cloning event. Multiple PCR reactions would act 
simply, as a confirmation of these findings. Cloning multiple PCR products would 
serve to further clarify ambiguous patterns of divergence therefore, the findings of this 




This investigation demonstrated restricted migration between TB infected spinal 
granuloma and blood in 5 of 7 spinal TB and HIV co-infected patients indicative of 
divergent HIV -1 evolution in spinal granulomas. These findings are novel in the 
context of HIV ffB co-infection and in relation to infectious spondylitis. 
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Chapter 6 - General Discussion and Conclusion 
6.1 Patient cohort and related clinical findings 
In the fIrst of four experimental chapters, the incidence, clinical features and 
demographics of a cohort of HIV -uninfected and -infected TB spondylitis patients was 
presented in order to investigate the differences between HIV -infected and -uninfected 
groups. The number of cases of TB spondylitis treated per annum (150pa) at King 
George V Hospital far exceeds previous related reports from other regions (Table 6.1). 
Approximately 70% of these patients undergo spinal decompression, insertion of an 
allograft and instrumentation, if required (Patient files, data not shown). These surgical 
interventions are implemented in addition to conservative anti-TB therapy. 
Approximately 30-40% is HIV co-infected. Despite a high rate of co-infection, severe 
neurological involvement and disability patients recover clinically following 
conventional anti -TB therapy and surgery regardless of HIV status. 
In light of the abovementioned as well as international statistics (Table 6.1), a patient 
cohort of 60 patients was an adequate coverage of the general popUlation. In addition, 
the rate of HIV co-infection noted in this study, corresponded with previous reports in 
the same demographic (Govender et aI., 2001a, Govender et al., 200lb) as well as, the 
incidence of HIV, TB and HIVrrB co-infection in the local region (81, 118, 119). In 
the present study, co-infection accounted for 37% of the study population consistent 
with global and national fIgures(Ige et aI., 2005, WHO, 2006), in addition to the 
demographics of the referral hospital in question (30-40%). The impact of co-infection 
is also evident in developed nations with TB defIned as the leading cause of HIV related 
deaths and the most common AIDS defining condition of 2002 in UK 
(Health_Protection_Agency _Tuberculosis, 2004). 
The fIndings of this study illustrated the devastating effect of infectious spondylitis on 
the primary economically viable demographic (mean age = 32 years) in KZN. This 
cohort was largely comprised of young adults who presented with spinal deformity and 
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neurological deficit particularly in co-infected individuals. It has previously been 
reported that the highest incidence rates of co-infection occur in younger individuals 
between the ages of 25-44 years (de 0 Liverato et al., 2004). In KZN, incidence rates 
following a population-based HIV survey in a rural community reported highest 
incidence rates among men aged 25-30years (8.0 per 100 person years) and peaked at 
25 years for women (Barnighausen, 2007). Again, this group represents an important 
demographic of the country and suggests a significant social, economic and political 
consequences. The findings of the present study highlighted a similar circumstance in 
relation to infectious spondylitis and HIV co-infection. 
In addition, the present study demonstrated the efficacy of enhanced nutritional support 
and surgical interventions at resolving an AIDS defining disease with advanced 
pathology even in patients with CD4 T-cell counts <200cells/IlI. The scientific 
outcomes of this study had no clinical bearing on the patient cohort since no change to 
the therapeutic interventions was implemented subsequent to the findings of this 
investigation. The same surgical, nutritional support and therapeutic regimes were 
implemented in all patients and sample collection was conducted at the same time point 
i.e. at surgery, in all instances. These findings were consistent with previous 
investigations of spinal TB in KZN which reported similar recovery rates and clinical 
outcomes in HIV -infected and uninfected patients (Govender, 2005). This is perhaps 
due to the similarity in the patient demographic, and therapeutic interventions 
implemented. Despite being ARV naive, patients recovered full or partial neurology 
(Chapter 2); and incorporated bone grafts. There was no difference in the scope of or 
time to clinical recovery between HIV -infected and uninfected patients nor between 
adult and paediatric patients. These findings do not detract from the benefits of AR V s 
but illustrate that they can be delayed in TB spondylitislHIV co-infected patients. The 
impact of ARV s on patient mortality rates have yet to be determined but it was shown 
recently that mortality rates decline significantly following the implementation of an 
ARV programme in a rural KZN community (Herbst, 2007). Moreover, the findings 
of present study was comparable to that of Arora et al, (Arora et al. , 2006) who reported 
positive clinical outcomes in anti-TB treatment non-responders (on 3 months of 
conventional anti-TB therapy) and those with reactivation disease following 
conventional therapy. Others also reported conventional anti-TB therapy to be effective 
at varying degrees ranging from 15%-73% (Butler et aI., 2006, Tasova et al., 2006). 
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This study reiterates the clinical benefits of anti-TB chemotherapy without ARV 
treatment since patients in this cohort recovered clinically with graft incorporation and, 
neurological improvement despite the absence of an ARV intervention. Treatment with 
anti-TB chemotherapy in the absence of ARVs, in co-infected patients has an acute 
impact on disease progression (Kirschner, 1999) with rebound of T-cell and 
macrophage populations and concurrent declines in viral loads in the context of 
pulmonary TB (Martin et al., 1995). This treatment option will be especially attractive 
to developing nations particularly in Africa and Asia as TB chemotherapies are more 
economical than ARVs. In addition, treatment is not encumbered by adverse drug 
interactions between selected ARVs and anti-TB chemotherapies. An equally 
imperative consideration to successful treatment is suppression of bacterial growth 
rather than enhancing the bacterial death/killing rate (Kirschner, 1999) since increased 
killing of macrophage-associated bacilli severely depletes immune cell populations. 
Consequently, mounting an effective "killing response" against the bacterial pathogen is 
likely to pose a greater risk to positive clinical outcomes. 
The present study confirmed that surgical interventions can be effective in both HIV-
infected and -uninfected patients over a range of CD4 T-cell counts and viral loads 
(Chapter 2). Of the approximately 150 cases treated annually at KGV, conservative 
treatment resolves disease in 30% of patients (Chapter 2). Surgery is necessary in the 
remaining patients. Spinal TB is AIDS defining and represents late stage disease. For 
this reason, it is widely accepted that HIV -TB co-infected patients are poor candidates 
for surgery, as they present with depleted CD4+ T-cell populations, a severely 
depressed immune response and advanced disease. However previous studies 
(Govender et al., 2000a, Govender et al., 2001b, Govender et al., 2001a) have 
demonstrated that sero-positive status and stage of HIV disease need not be a 
disincentive to surgical interventions even at advanced disease when CD4+ T-cell 
counts are <200cells/jJl. The present study confirmed these findings. 
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Table 6.1: Summary of recently published reports of infectious spondylitis 
Infective 









Tasova et al, 2007 
40 1997-2003 Adult 
(Tasova et al., 2006) TB 
Butler et al, 2006 
48 1992-2004 Adult Ireland 
(Butler et al., 2006) Pyogenic bacteria 
Arora et al, 2006 
51 Adult India 
(Arora et al., 2006) TB 
Cormican, et aI, 2006 
(Cormican et al. , 21 TB Adult UK 
2006) 
Key: N = number of patIents III cohort, TB = tuberculosIS, KZN ,SA - K waZulu-Natal, South AfrIca, 
UK = United Kingdom 
An additional novelty of the present cohort was the ability to incorporate bone grafts 
even in immune-suppressed patients with CD4 T-cell counts <200cells/fll (Chapter 2). 
Unlike conventional allografts, those used in this cohort were devoid of all 
immunogenic material since all marrow and other material are removed leaving only 
dead bone. In addition, fragmented autologous rib material was inserted into the femoral 
allograft before insertion, which prevented a rejection response. Not only does this 
strategy preclude the possibility of host rejection but the grafts may serve an 
immunogenic role. Ironically, patients lacking mature T-cells do not reject tissue 
transplants (Roitt et aI., 2001) therefore HIV depletion of the CD4+ T-cell 
subpopulation may in fact, aid in graft incorporation. The staging of surgery was 
determined by the nutritional status of patients as reflected by their albumin and ESR 
markers (Chapter 2) - not their CD4+ T-cell counts. Yet, clinical outcomes were 
positive regardless of CD4+ counts implying that ESR and albumin levels may serve as 
useful surrogate markers of clinical outcomes in addition to directing therapeutic 
interventions. 
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6.2 Histopathology and ultrastructural morphology of spinal TB and mv 
The second experimental chapter aimed to distinguish histopathological and 
ultrastructural features of HIV -uninfected from HIV -infected extra-dural granulomas. 
An additional objective was to assess the efficacy of conventional microscopy diagnosis 
in paucibacillary and treated spinal TB disease. The immunohistologcal and 
ultrastructural findings of this chapter represented novel work in the context of spinal 
infections since related evaluations of extra-dural granulomas has, to our knowledge, 
not been previously undertaken. 
The Ziehl-Neelsen (ZN) technique, for the detection of acid-fast bacilli, failed to 
demonstrate AFBs in this cohort (Chapter 3). The complete absence of staining was 
contratry previous reports, however, low detection rates using this technique have been 
published. Previous reports have indicated specificity in untreated pulmonary (Kivihya-
Ndugga et aI., 2004) (Zajac and Melcher, 1991) and spinal disease (Tasova et al., 2006) 
of 50-80% and 47% respectively. Assessment of clinical samples by direct staining and 
microscopy is widely used and purported to be one of the more economical and rapid 
techniques presently available to disadvantaged nations (Kivihya-Ndugga et aI., 2004). 
However, the present findings indicated that adjunct diagnostic assays must be applied 
to spinal TB for an accurate, conclusive and timely diagnosis largely due to its 
paucibacillary characteristic. As a result of failed laboratory diagnosis patients in this 
study were initiated on therapy based on clinical and radiological findings rather than 
histopathology or TB culture. This was consistent with previous reports where 
presumptive signs and progressive insufficiency directed diagnosis (Anane and 
Grangaud, 1992). On the other hand, the disadvantage of using presumptive diagnostic 
signs is that most NTMs produce granulomas identical to those induced by Mtb while 
those of other infectants such as fungi, are very similar. 
It may be speculated that the gross tissue and bone pathologies observed at surgery 
emerged prior to treatment and were not resolved with anti-TB chemotherapy. This is 
despite the impact of treatment on bacillary counts. A more severe pathology correlates 
strongly with high bacterial numbers in infected murine pulmonary tissue but not to the 
delayed type hypersensitivity (DTH) response (Dormans et al., 2004). But DTH is the 
proverbial "double-edged sword" since it aids in bacterial eradication while advancing 
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tissue damage (Kobayashi et aI., 2002). In addition, TNFa promotes a robust immune 
response if it is primarily Thl mediated but induces tissue damage in a mixed Thlffh2 
response (Hernandez-Pando and Rook, 1994). The latter is characteristic of an immune 
response against TB and of late-stage disease when the immune response is failing. 
In keeping with previous findings the present study demonstrated granuloma formation 
and features diagnostic of TB in HIV -infected and -uninfected specimens (Hakawi and 
Alrajhi, 2006) (Tasova et al., 2006) However, features that were not diagnostic of a TB 
infection were more common to the HIV-uninfected group. This represented novel 
findings in the context of spinal TB and an atypical finding in the context of mv 
pathogenesis since it is known that HIV -infected individuals are more susceptible to 
opportunistic infections as a direct result of a compromised immune response (Cassol et 
aI., 2005). In developing resource limited settings, poverty and malnutrition result in 
severly depressed immune responses and susceptibility to opportunistic pathogens. This 
coupled with the high index of exposure to a range of environmental and nosocomical 
bacteria may account for greater NTMs and DIs among HIV-uninfected patients. 
Unlike pulmonary TB (Ulrichs and Kaufmann, 2002) greater caseation was not 
associated with greater immune suppression and HIV co-infection in the present study. 
This may reflect the pauci-bacillary nature of TB spondylitis, pre-surgery TB treatment, 
enhanced nutritional support or the impact of a remote anatomical site of infection on 
disease pathology. 
Epithelioid cell infiltration occurred commonly and represented an additional atypical 
finding of a TB granuloma. Epithelioid cells associated with giant cells and fibrin, have 
been reported in cases of eNS (Kurisaki, 2000), pulmonary (Fujita et al" 2002) and 
gastric (Jain et aI., 2000) TB. This may allude to chronic or latent infection as it has 
been stated that in granulomas rich in epithelioid cells, there exists an enduring but 
unpredictable equilibrium between the host and bacilli (Fayyazi et aI., 2000). The 
spinal granuloma also contained macrophages and lympohocytes in close proximity. It 
has been shown that the spatial association between HIV -I-containing macrophages and 
CD4+ lymphocytes promotes HIV-l LTR activation and disease progression (Nakata et 
al., 2002). CD4 and CD8 immunolocalisation further suggested the chronic nature 
spinal TB. This is highly plausible when one takes into account the insidious onset of 
disesase in the present cohort. Others have reported similar temporal variations in 
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CD4+ and CD8+ cellular infiltration to the site of disease in chronically infected murine 
subjects (Gonzalez-Juarrero et aI., 2001, Hernandez Pando et al., 1996). The 
predominance of CD8 reactive cells in both HIV -infected and uninfected specimens 
also represented a possible source of IFNy and a greater cytotoxic potential (Gonzalez-
Juarrero et aI. , 2001, Hernandez Pando et al., 1996) that persisted even in CD4 
diminished or depleted specimens. In addition, the relative distribution of CD4+ and 
CD8+ cells was associated with the HIV -status of the patient. 
A novel finding of the present study was virus- and bacilli-like particles within 
membrane bound intracellular compartments. It is known that Mtb becomes established 
in occupant-friendly lysosomes within macrophages (Deretic et aI., 2004). Latent 
infection may re-emerge on suppression of the immune response and in co-infected 
patients represents a significant hazard. Removal of the granuloma removes latently 
infected cells ensuring complete eradication of the disease since anti-TB therapy does 
not ensure complete killing of bacteria. The demonstration of HIV within intracellular 
compartments was an additional novel finding and may be accounted for by the 
predator-prey analogy of Pope and Haase, (Pope and Haase, 2003). By decimating the 
very cellular sub-population on which it depends the virus reverts to latency until the 
immune system is able to rebuild its CD4+ T-cell population. Since co-infection 
accelerates disease pathogenesis, survival dynamics necessitate that either or both HIV 
and TB revert to survival behaviour rather than disease transmission and progression. 
The findings of this study support the occurrence of a similar phenomenon in this 
cohort. 
Both apoptosis and necrosis were noted in 4 of 5 HIV -infected specimens at the 
ultrastructural level. Apoptosis and necrosis are regarded as extremes of the anti-TB 
immune response where apoptosis is associated with disease containment while necrosis 
leads to disease dissemination (Chen et aI. , 2006). In the context of TB, apoptosis is 
protective against disseminated disease(Chen et aI., 2006, O'Sullivan et al., 2007), 
however in the HIV context, apoptosis leads to immune cell depletion and progressive 
pathology(Rodrigues et aI. , 2003). In both instances, mitochondria and lysosomes play 
an integral role in the apoptotic pathway (Roumier et aI., 2003). The present study 
demonstrated significant mitochondrial changes and lysosomal activity in the HIV co-
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infected TB spondylitis cohort. This association between pathology and apoptotic 
features in TB spondylitis was a novel finding. 
6.3 Bacterial genotyping and identification 
Bacterial genotyping, to our knowledge, has not been attempted directly from clinical 
samples in the context of infectious spondylitis. This study represented the first such 
attempt and aimed to classify the infective organisms in this cohort in order to test the 
hypothesis that atypical or NTM infections are more common to HIV -infected 
compared with -uninfected individuals. 
Since this was a broad screen of the infective organisms in a region with a high index of 
exposure, the 16S rDNA gene was chosen as the target gene. Genotyping using the 16S 
gene was successful directly from pulmonary specimens (Harris and Hartley, 2003) 
however proved unsuccessful in the context of spinal disease. The paucibacillary nature 
of spinal disease coupled with pre-surgery anti-TB treatment is expected to have 
significantly reduced bacterial numbers and chemotherapy-induced DNA fragmentation 
and nicking provided poor quality template for PCR amplification. 
Genotyping from pure cultures proved more successful and yielded unexpected results. 
A large proportion of atypical and NTM infections was detected alluding to a disturbing 
emerging trend. Of note was that the greater majority of atypical or NTM infections 
were common to the HIV -uninfected patient disproving our initial hypothesis. 
However, a recent study has similarly shown that genetic diversity of Mtb strains was 
not associated with HIV -infection and related immune suppression (Godreuil et al., 
2007). While OIs and NTMs represent a concern to the HIV-uninfected, they represent 
a devastating impact to the HIV -infected population. The pathogenesis of HIV INTM 
co-infection results in severe gross and ultrastructural pathologies as demonstrated in 
the present study and may be due to increased monocyte recruitment to the site of 
infection by MAC organisms which create a permissive environment for the progression 
of both diseases (Hale-Donze et aI., 2002). 
HIV and TB exacerbate each other in a vicious cycle. Similarly, HIV may advance the 
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transmissibility of zoonotic infections in human, with the result that co-infected patients 
become super-spreaders of disease (Weiss, 2003). The ability of HIV to promote 
transmissibility has already been observed in the TB epidemic and it is feared that other 
opportunistic infections will manifest a similar dynamic. Demonstrating the occurrence 
of environmental and NTM infections in the present study emphasised the reality of this 
possibility in KZN. Their association with HIV-uninfected hosts further illustrates the 
enormous impact of depressed nutritional status and associated immune-suppression on 
disease susceptibility. 
6.4 HIV heterogeneity and divergent viral evolution 
In the final experimental chapter of this study, the impact of co-infection at a remote 
anatomical site on HIV evolution was investigated. It was hypothesised that co-
infection results in immune selection pressures which induce divergent viral evolution 
and that the fibrotic ally encased granuloma forms an isolated viral compartment. Thus 
the Red Queen Hypothesis which states that a species must continue to evolve into 
multiple quasispecies to retain or gain fitness advantage. (Collins et al., 2002b) was 
tested. 
Analysis of env sequences from plasma and granulomas indicated up to 20% intra-
patient diversity in this cohort. A 20% variation in the env gene within a clade is not 
unusual and is continually expanding (Gas chen et al., 2002). However, as we have 
shown, variability within an individual patient illustrates the fundamental constraint to 
the development of effective vaccines and therapeutic interventions (Morgado et al., 
2002) which is the reason for the current concerted and worldwide effort to clarify the 
enormous global variability of the HIV genome (Gas chen et al., 2002). 
The direct impact of anti-TB drugs on HIV evolution was not explored in this 
investigation despite the paucity of related investigation in current literature. However, 
it may be speculated that the immune reconstitution and increased TNF-a production, 
induced by anti-TB therapy, would impact HIV replication and evolution. As a result, 
HIV diversity at the site of infection is expected to be high. Progressive granuloma 
formation leads to fibrosis in an attempt to contain disease progression creating a 
174 
sequestered site of immune stimulation. As the primary site of infection, drug levels 
will be elevated locally. Therefore, while anti-TB drugs may not impact HIV evolution 
directly, the immune response stimulated invariably exerts immune selection pressure 
on the HIV genome (De Oliveira et al., 2003, Price et al., 1997). 
A novel finding of the present study was the demonstration of virus-like particles within 
intra-cellular membrane-bound compartments. This coupled with recent reports of the 
persistence of TB in macrophages and their ability to activate the HIV-LTR region 
(Toossi et al., 2004a) suggests a site of latent infection and possibly low-level viral 
replication within macrophages. Greater HIV diversity in dually infected pulmonary 
TB patients as opposed to patients infected with HIV alone (Collins et al., 2000) further 
implies this association. The findings of this study confirmed a similar phenomenon in 
the context of spinal TB. Viral compartments represent an important source of escape 
mutants, drug resistant or more virulent variants and the spinal granuloma may 
epitomize such a compartment. 
It is important to note that this study was conducted in a region (KZN, SA) that is 
predominantly HIV-I SUbtype C infected. Findings of this study will invariably differ 
from similar studies of HIV heterogeneity in TB co-infected patients from other regions 
since they were predominantly conducted SUbtype B infected specimens. Our rationale 
in exploring spinal TB and its impact on HIV stems from the fact that despite the 
intensive search for HIV specific immune factors, no appropriate vaccine and/or 
immunotherapy has thus far been developed (Fauci, 2003). A further novelty of this 
study is that it is the first investigation to demonstrate divergent viral evolution in a 
HIV ffB co-infected tissue and in extra-dural granulation tissue. 
6.5 Future studies and Recommendations 
6.5.1 Future studies 
The role of neutralising antibody (Ab) in TB and HIV pathogenesis have, until recently, 
been highly contentious with the prevailing outlook being that Ab responses play a 
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minimal to no role in the immune responses. The complexity then lies in distinguishing 
the TB, HIV and TBIHIV Ab responses and how they impact on each other. Therefore, 
elucidating the related response at the remote anatomical site of infection and the 
subsequent response induced by allografts insertion, bone regeneration and the impact 
on HIV would be of great interest. 
Recent investigations in South Africa associated specific HLA variants and VitD 
receptors with resistance to pulmonary TB infection (Lombard et al., 2006). Similar 
studies in spinal TB may provide an account for the high incidence of spinal TB in KZN 
relative to global rates and the possible role of HLA molecules in susceptibility to 
infection, disease progression and recovery rates. Moreover, the region has recently 
seen an explosion of xMDR-TB (Sidley, 2006) which has yet to impact spinal disease. 
Clarifying this would greatly expand present knowledge of the disease. 
6.5.2 Recommendations 
The HIV ffB-infected granuloma was surgically removed in patients in this cohort while 
conservative treatment is the norm in co-infected pulmonary and extra-pulmonary 
disease. The present study demonstrated that co-infected spinal granulomas and 
macrophages infiltrating these granulomas serve as reservoirs of latent mv and TB 
infection. Despite a depressed immune response and severe pathology, patients 
recovered clinically, incorporated bone grafts and deformity was corrected. Removal of 
these viral and bacterial reservoirs may prevent disease resurgence and continued 
immune stimulation. In addition, this may account for the positive clinical outcomes 
observed in this cohort. Therefore, surgical interventions and the use of albumin levels 
and ESR rates as predictors of clinical outcomes, rather than CD4+ T-cell counts and 
HIV -1 viral loads, may prove beneficial for all forms of TB. This study illustrated that 
surgical interventions cannot be excluded even in seemingly immune-compromised co-
infected patients. Addressing HIV and TB co-infection is of critical importance and is 
unquestionably an enormous challenge in countries such as South Africa and India. 
Novel approaches to manage this disease in underprivileged, susceptible populations, 
must be implemented (Narain and Lo, 2004). The approaches described in the present 
study proved clinically beneficial regardless of HIV-status and should be considered. 
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Both applied and basic science approaches, such as the present study, towards improved 
diagnosis, a better understanding of their disease pathogeneses and recognizing 
correlates of immunity, will aid in developing vaccines and treatment interventions 
(Leke, 2001). 
6.6 Limitations of the study 
The study was conducted with patients on anti-TB medication, which may have 
impacted on the immune response, disease pathology and HIV evolution. Diagnosis of 
the infective organism was also impacted. 
This study demonstrated divergent viral evolution in spinal granulomas with distinct 
separation of quasi species into anatomically defined lineages. A criticism is that these 
findings may reflect a selection bias since they were deduced from a single PCR 
amplification. However, several confirmatory bioinformatics analyses were conducted 
to demonstrate divergent evolution including phylogeny and measures of diversity, 
coalescence and migration (Chapter 5). Multiple PCR amplification and corresponding 
cloning events would simply serve as confirmation of these findings. Previous studies 
confirming viral heterogeneity in brain, lymph nodes, blood and semen also reported 
viral heterogeneity and compartmentalisation following a single PCR 
amplification(Korber et aI., 1994, Collins et al., 2002a). 
6.7 Conclusion 
This study has highlighted that infectious spondylitis is a significant public health 
concern in KZN and affected both HIV -infected and -uninfected individuals alike 
(Chapter 2). Ultra-structural evaluation, which demonstrated virus-like particles within 
intra-cellular compartments of macrophage-infiltrated granulomas, indicated that the 
virus was able to exploit the survival strategies of the bacilli to advance its own latent 
state and replication requirements (Chapter 3). Immunolocalisation of selected immune 
cells confirmed the spinal TB to be a chronic infection. The need for adjunct diagnostic 
assays to identify atypical bacterial infectants was highlighted and the utility of a broad-
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range genotyping tool was illustrated (Chapter 4). Opportunistic infections and NTMs 
were more common to HIV -uninfected patients, highlighting that immunosuppressive 
factors such as poor nutrition and poverty may play an equally important predisposing 
role as HIV -co-infection in KZN. Finally, divergent viral evolution was demonstrated 
following a comparison of plasma- with tissue-derived HIV sequences (Chapter 5). 
Greater viral diversity was demonstrated in tissue as compared to the blood and was 
associated with greater CD68+ cellular infiltration indicating a possible role for 
macrophages and monocytes in divergent viral evolution. The implications of this 
phenomenon are important to viral latency, therapeutic failure and clinical decline. 
Two primary conclusions can be drawn from this study. Firstly, fibrous encapsulation 
of the TB -infected granuloma creates a unique microenvironment infiltrated with 
immune cells, virus and bacilli. Secondly, and in support of our initial hypothesis, this 
environment is permissive for divergent viral evolution. This has not previously been 
demonstrated in TB spondylitis. Encapsulated extra-dural granulomas may thus 
represent a new viral compartment. Studies to further define the phenotypic and 
genotypic characteristics of viruses that replicate in this isolated anatomic compartment 
in addition to defining the related immune responses are required. 
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Appendix A 
Details of the functions and localisation of mv structural, regulatory 
and accessory proteins (adapted from Kuiken et aI, (Kuiken et aI., 
2002) 
HIV!SIV PROTEINS 
NAME SIZE FUNCfION LOCALIZATION 
GagMA pI7 membrane anchoring; env interac- Ylnon 
lion; nuclear tr.ansp<lrt oh'iral core. 
imyristylated protein) 
CA p24 core capsid ymon 
NC p7 nucleocapsid, binds RNA vmon 
p6 binds Vpr virion 
Pl'Otease (PR) pIS gag/pol cleavage and maturation ymoll. 
Reverse o«n- p66 reverse transcription, RNase H virion 
sC'l-iptase (RT), pSt activity 
RNa3e H 
IlltelZrase (IN) DNA provirus integration YIrlOn 
Env gp120 external viral glycoprotein;; bind to plasma membrane, virion ellve-
gp41 (])4 lind "econnllry l' .. ..cept()l'S lope 
Tat pl61p14 viral trancriptional transacrivator primarily in nucleohts/nucleus 
Rev pl9 RNA transport, stability and miliza- primarily in nucleolus/nucleus 
tion factor (phosphoprotein) 5huttling bern-een nucleolus and 
cytoplasm 
Vif p23 promotes "ilion maturation and in- cytoplasm (c}tosol, membranes) 
fectivity vmOll 
Vpr pIO-I5 promotes nuclear localization of virion, nucleus (nuclear mem-
pl'eintegratioll complex, inhibits celJ brane?) 
division . arrests infected cells at 
U2JM 
Vpu pI6 pmmotes extracdlular release of integra] membrane protein 
viral p:trticles; degl'2des CD4 in d1e 
ER; (phosphoproteill only in HIV-l 
and SrVcpz) 
Nef p27-p25 CD4 and cia&<; I downregulation plasma memm'ane, cytoplasm 
Imyristylated protein) (vil'ion'n 
Vpx p12-16 'fpr homolog (not in HIV-l , only in virion (nucleus?) 
HIV-2 and SIV) 
Appendix B 
Modified peroxidase method for Immuno-Iocalisation of CD68 
antibody 
1. Pre-warm PBS and bake slides for 45-60min on a hot plate and place 
immediately in xylene and take through the rehydration protocol outlined in 
Section 3.2.2.3; Table 3.2 
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2. Place in warmed sodium citrate buffer (lOmM, pH6.0) and microwave at 100%, 
85°C for 10 minutes, then stand at room temperature (RmT) for 25 minutes. 
3. Rinse in deionised water. Blot dry around section and circle area of interest with 
DAKO PAP pen 
4. Place in peroxidase blocker (H20 2: methanol, 20:80 v/v) for 5min at RmT 
5. Wash in PBS, place in PBS bath and blot dry around section 
6. Incubate in 10% casein (in PBS) for 30 minutes at RmT 
7. Wash in PBS, place in PBS bath and blot dry around section 
8. Add dilute primary antibody (+/- 200/-111 section) to the section and incubate in a 
moisture chamber at 4°C, overnight 
9. Wash in PBS, place in PBS bath and blot dry around section 
10. Add dilute secondary antibody provided in the LSAB kit (DAKO) and incubate 
for 30 minutes at RmT in a moisture chamber 
11. Wash in PBS, place in PBS bath and blot dry around section 
12. Add prepared horse radish peroxidase (HRP) provided in the LSAB kit to each 
section, and incubate for 30min at room temperature in a moisture chamber 
13. Wash in PBS, place in PBS bath and blot dry around section 
14. Add approximately 200/-11 DAB chromogen to each section and incubate at room 
temperature for 10 minutes, or until a brown colour is observed macroscopically 
and microscopically (max. 20min) 
15. Wash in PBS, place in PBS bath and blot dry around section 
16. Add 200/-11 haematoxylin to each section and incubate at room temperature for 
90sec. 
17. Place slides into changes of hot (not boiling) water (stand in second change for 
90-120 sec); thereafter place under running tap water for 3-5min, before 
dehydrating (Section 3.2.2.3) and placing a cover-slip over section using DPX. 
Appendix C 
Alkaline lysis method of plasmid isolation 
Reagents 








Make up to 100ml. Autoclave before use. 
Solution 2 
Make up stock solutions of NaOH and SDS: 
Mw 












Add 10ml of 2M N aOH to 10ml 10%SDS and make up to a final volume of 100ml. 
Prepare immediately before use. 
Solution 3 (KAc) 
Prepare a stock solution of potassium acetate. Store at 4-8oC 
5M potassium acetate 
Make up the following: 
5M potassium acetate 


















• Pour 1.5ml of the LB culture into an Eppendorf tube (store the rest at 4-8°C) 
• Centrifuge at full speed for 1min 
• Aspirate the SU - as dryas possible 
• Resuspend the pellet in lOOll1 of Solution 1 
• Stand at room temperature (RT) for 5min 
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• Add 200111 fresh Solution 2 
• Mix by inverting the tube 2 -3 times (DO NOT vortex) 
• Stand on ice for 5min 
• Add 150111 cold Solution 3 
• Vortex with the tube inverted for 10sec 
• Stand on ice for 5min 
• Centrifuge at full speed for 5min 
• Transfer the SU to a fresh tube 
• Add an equal volume of phenol/chloroform to the SU 
• Vortex 
• Centrifuge at full speed for 2min 
• Transfer the supernatant to a fresh tube a 
• Add 2x the volume ethanol at RT 
• Vortex 
• Stand at RT for 2min 
• Centrifuge at full speed for 5min 
• Aspirate the SU and stand inverted on a paper towel 
• Add 1ml 70% ethanol 
• Vortex 
• Centrifuge at full speed for 2min 
• Aspirate the SU 
• Allow to air-dry 
• Re-constitute the pellet with 25111 sterile water containing 1llg/ml RNase A 
• Vortex and 2uick spin 
• Store at -20 C 
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Appendix D 
Agarose Gels of C2-VS env amplification products 
Figure D1: An illustration of an agarose gel of the approximately 621-700bp PCR amplified 
fragment of the C2-V5 HIV-1 env region against Molecular Weight Marker XIV (100bp ladder, 
Lane 1). The fragments illustrate the un-purified PCR product from plasma samples of Patient 12 
(Lanes 2-4), Patient 16 (Lanes 5-7), Patient 20 (Lanes 8-10), Patient 22 (Lanes 11-13), Patient 25 
(Lanes 14-16), Patient 32 (Lanes 17-19), Patient 38 (Lane 20) and a no-template control. 
Figure D2: An illustration of an agarose gel depicting a screening PCR reaction amplifying the C2-
V5 region of the HIV -1 env gene from plasmid DNA of clones which was subsequently purified in 
preparation for sequencing. Lane 1 represents Molecular Weight Marker XIV (lOObp ladder) and 
the clones representing plasma- (Lanes 2-11) and tissue-derived (Lanes 12-15) sequences of Patient 
12. Lane 16 is the no-template control. 
